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ABSTRACT 
 
Homogeneous Gold Catalysis: 
Ligand Design and Reactions of Alkynes 
 
by 
 
Yanzhao Wang 
 
In the past two decades, great progress has been made in developing efficient 
homogeneous gold catalysis. As soft “π” Lewis acids, cationic gold(I) complexes 
are particularly powerful in terms of activating alkyne/allene/alkenes towards 
nucleophilic attack, leading to a variety of synthetically versatile. In my dissertation 
study, several novel synthetic methodologies have been developed, including: (1) 
Au-catalyzed ligand-directed anti nucleophilic attack of alkynes; the new ligands I 
developed enable highly efficient gold-catalyzed nucleophilic additions of acids, 
anilines and water to the alkynes; and catalyst loadings could be lowered to 10 parts 
per million; (2) rapid access of chroman-3-ones via gold-catalyzed oxidation of 
propargyl aryl ethers; this atom-economic and step-efficient transformation was 
enabled by a bulky gold catalyst, Me4tBuXPhosAuNTf2 and bulky electron-deficient 
pyridine N-oxides derived from Hantzsch esters; (3) Au-catalyzed novel indole 
synthesis via a key [3,3] sigmatropic rearrangement; 2-alkylindoles were produced 
xi 
 
with high regioselectivity and efficiency from easily accessed N-arylhydroxylamines 
under mild conditions; an improved approach involved cooperative dual catalysis of 
Zn and Au was developed; much broader substrate scope, shorter reaction time and 
good to excellent yields were achieved with good control of regioselectivity.  
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1. Homogeneous Gold Catalysis via Carbophilic Activation 
1.1. Introduction 
One of the exciting thrusts in organic synthesis in the past two decades is 
homogeneous gold catalysis.[1-7] As early as in 1976, Thomas et al.[8] reported the first 
homogeneous gold-catalyzed reaction: hydration of alkynes promoted by chloroauric 
acid; fifteen years later, a similar transformation catalyzed by NaAuCl4 was reported 
by Utimoto et al.;[9] surprisingly, not much attention was attracted to this area until 
1998, when Teles’ group described an analogous reaction catalyzed by a cationic Au(I) 
species instead of Au(III), providing ketones, enol ethers and ketals for different 
substrates (Scheme 1).[10] Demonstrating a mild and efficient method to build up C–O 
bond, this article marked the beginning of a rising tide of homogeneous gold catalysis.  
 
Scheme 1. Gold-Catalyzed Hydration and Alcohol Addition to Alkynes 
 
 
Some of the key advantages to employing gold as a catalyst rapidly became clear. 
First, as a soft Lewis acid, gold presents extremely great reactivity in terms of 
activating π bonds, including alkynes, allenes and alkenes. Second, due to it oxidative 
2 
 
stability, gold-catalyzed reactions are typically performed under ambient conditions, 
without precautions against oxygen or moisture. Third, as an environmentally benign 
alternative to conventional stoichiometric π-acids, such as Hg.[11,12] gold is often 
tolerant to many functional groups and protecting groups that would otherwise be 
detrimental.  
 
1.2. Modes of Reactivity in Homogeneous Gold Catalysis 
The cationic Au-complexes are susceptible to a wide spectrum of nucleophilic 
attacks as the initial step (Scheme 2) and it is well established that in this step, the 
nucleophile and gold add to the alkynes/allenes in a trans manner. The subsequent 
versatile transformations such as isomerization, rearrangement, and cross-coupling 
allow rapid access to various synthetically useful molecules and building blocks.  
 
Scheme 2. Initial Nucleophilic anti-Attack 
 
 
In gold-catalyzed reactions, ligands play a crucial role in terms of stabilizing the 
cationic gold center. They can significantly modulate the catalytic reactivity of the 
metal center. The high efficiency, excellent chemo-, regio- and stereoselectivity 
demonstrated in reactions largely relies upon choosing the appropriate ligands. A 
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recent review summarized the ligand effects in homogeneous gold catalysis.[13] 
Currently, the popular Au(I) and Au(III) catalysts employed in laboratories worldwide 
are illustrated in Figure 1.  
 
Figure 1. Common Gold Catalysts 
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In early 2004, Toste et al.[14] reported a gold(I)-catalyzed Conia-ene reaction of 
α-ketoesters with tethered alkynes to give β-vinylated ketones in good to excellent 
yields. No reaction occurs with diester substrates and poor reactivity is observed with 
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internal alkynes. The authors proposed a mechanism involving the attack of 
1,3-dicarbonyl nucleophiles on a Au(I) activated alkyne, which is supported by 
deuterium labeling experiments. At the same time, the trans-manner of addition to 
alkynes was also demonstrated (Scheme 3-A). Using the terminally deuterated 
α-ketoester 1-1, the authors observed only one isomer 1-2, indicating that the 
nucleophile attacks the gold-alkyne complex in a trans-manner.  
 
Scheme 3. Evidence of Nucleophilic anti-attack to Gold-activated Alkynes 
 
 
Eight months later, Hashmi et al.[15] accomplished a Au(III)-catalyzed synthesis 
of 2,5-disubstituted oxazoles synthesized from the corresponding propargyl 
carboxamides. In this work, the anti-addition was also supported. Only one single 
diastereomer 1-4 was observed during the conversion of deuterated amide 1-3, which 
means the activation of the alkyne and the subsequent addition of the oxygen 
nucleophile is strictly stereospecific (Scheme 3-B). This suggests that the 
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carbonyl-oxygen stereoselectively attacks the Au-coordinated alkyne from the 
backside and the intermediate, aurated enolether species, is then stereospecifically 
proto-demetalated to yield oxazole 1-4.  
 
Figure 2. General Reaction Patterns of Gold Catalysis 
 
 
After the initial anti-attack, the intermediate 1-5 is ready to further go through 
α or β proto-deauration/functionalization to deliver different products. In terms of 
the reaction happening at α position, when the substrate is alkyne or allene, as the 
Au-C(sp2) bond in intermediate 1-5A or 1-5D is labile and possesses weak 
nucleophilicity, alkenyl gold can be protonated or react with an electrophile (E+) in 
a manner similar to vinylsilane, thus leading to bifunctionalized alkenes 1-6 or 1-8 
under mild reaction conditions; when the substrate is alkene, normally the 
Au-C(sp3) bond (1-5B) goes through proto-deauration and affords the adduct 1-7. 
In terms of the β approach, for the substrate of alkyne and allene, Au of 1-5A or 
1-5D donates electrons back from its filled d-orbital, forming a reactive carbenoid 
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1-9 or 1-11 respectively with the electrophile picked up at β position; for the allene 
substrate with a leaving present at β position, 1-5C would generate functionalized 
olefin 1-10 as the final product. 
The diverse range of transformations that have resulted from the π-acid activation 
of alkynes, allenes and alkenes discussed in the following sections. Based on the 
considerations and processes discussed above, subsequent transformations are best 
considered by grouping them according to the substrate type and nucleophilic 
component of the reaction.  
 
1.3. Gold-Catalyzed Reactions of Alkynes 
1.3.1. Simple Nucleophilic Addition to Alkynes 
The simple nucleophiles could be hydroxyl group, free amino group, carboxylic 
acid, amide, and carbamate, etc. Valuable functional structures including ketone, 
acetal, enol ethers or enol esters, imines, enamine and enamide can be accessed.[1,2] 
1.3.1.1. C–O Bond Formation 
In 2005, Liu et al.[16,17] reported a butenolide synthesis via a gold-catalyzed 
cascade cyclization/oxidative cleavage reactions of (Z)-enynols with molecular 
oxygen. The dihydrofuran 1-13 was initially formed from direct cyclization of 
substrate 1-12, in the presence of molecular oxygen, underwent gold-catalyzed 
aerobic oxidation to give the corresponding butenolide 1-14 (Scheme 4).  
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Scheme 4. Synthesis of Butenolides 
 
 
Geneˆt et al.[18] reported the AuCl-catalyzed transformation of substrates 1-15 to 
afford vinyl lactones 1-16 in good to excellent yields (Scheme 5). Remarkably, AuCl3 
is also able to catalyze this intramolecular addition of carboxylic acids to alkynes 
which leads to lactones. 
 
Scheme 5. Lactones from Intramolecular Acid Addition 
 
 
Larock et al.[19] used α-alkynyl enones 1-17 as substrates that undergo tandem 
intramolecular carbonyl addition, followed by intermolecular nucleophilic attack to 
generate highly substituted furan compounds 1-18. Notably, a variety of nucleophiles 
add successfully, including alcohols, anilines, 1,3-diketones, indoles, and even arenes 
(Scheme 6). 
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Scheme 6. Synthesis of Highly Substituted Furans from Alkynyl Enones 
 
 
A benzylic ether group is also suitable as a nucleophile towards gold-activated 
alkynes. Toste et al.[20] were able to convert benzyl methyl ethers 1-19 to indenyl 
methyl ethers 1-20 in moderate to excellent yields (Scheme 7). Crossover experiments 
with deuterated substrates indicated an alkyne activation to deliver intermediate 
1-19A. Even a chirality transfer was observed, indicating a “memory effect” in the 
intermediate. 
 
Scheme 7. Synthesis of Indenyl Ethers by Gold(I)-Catalyzed Intramolecular 
Carboalkoxylation of Alkynes 
 
 
1.3.1.2. C–N Bond Formation 
Utimoto et al.[21] investigated the intramolecular hydroamination reaction of 
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alkynes under mild and neutral conditions, where sodium tetrachloroaurate catalysts 
were superior for the 6-exo-dig cyclization compared to Pd(II) catalysts. After the 
initial enamine formation, a subsequent tautomerization led to the thermodynamically 
more stable imine 1-21 as the final product. The first intermolecular reactions of 
alkynes and anilines were reported by Tanaka et al.[22] in 2003. The reactions were 
performed under solvent-free conditions (Scheme 8). With catalyst loadings as little 
as 0.01 mol % of (Ph3P)AuMe and 0.05 mol % of H3PW12O40 as acidic promoter, a 
TON of 9000 could be achieved for 4-bromo and 4-cyanoaniline. Aryl, alkyl, and 
dialkyl acetylenes reacted, and aliphatic amines could not be used as nucleophilic 
partners potentially due to their much stronger basicity.   
 
Scheme 8. Au-Catalyzed Hydroamination of Alkynes 
 
 
1.3.1.3. C–F Bond Formation 
While the first gold-catalyzed hydrochlorination of alkynes was reported as early 
as 1976, [23] it was not until 2007 that the first hydrofluorination of alkynes was 
realized through gold catalysis.[24] Sadighi et al. found that (NHC)gold(I) fluoride 
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reversibly added to internal alkynes, demonstrating the first gold-mediated C–F bond 
formation. Replacing fluoride ion with the less coordinating BF4 ion enables catalysis 
with Et3N·3HF as a source of HF to give good yields of vinyl fluorides 1-17. 
Additions across the alkyne are always in an anti-fashion, giving a mixture of 
regioisomers which depends on the electronic nature of R1/R2. It should be noted that 
KHSO4 additive and catalytic amount of PhNMe2·HOTf remarkably increase the 
reaction yields (Scheme 9). 
 
Scheme 9. Hydrofluorination of Internal Alkynes 
 
 
1.3.1.4. C–S Bond Formation 
C–S bond formation is one of the fundamental transformations in organic 
synthesis. Nakumura et al. successfully employed Pd, Pt, and Au salts in the 
cyclization-isomerization of o-alkynylanilines as well as o-alkynylphenols, given that 
a suitable migratory group is available (e.g., allyl, acyl, etc.), but the corresponding 
cyclizations for o-alkynylthiophenols are not feasible for Pd due to catalyst poisoning. 
However, AuCl and AuCl3 were found out to be ideal for promoting the cyclization,[25] 
which is the first protocol for directly synthesizing 2,3-disubstituted benzothiophenes. 
Although the reaction is sensitive to the electronic requirements of the migrating 
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group, it is remarkably tolerant of the sterics of the substrate. The reaction conditions 
are mild and all yields are good to excellent (Scheme 10). 
 
Scheme 10. Synthesis of 2,3-disubstituted benzothiophenes by Gold Catalysis 
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Due to its coordinating feature and reducing property, thiol is not a good 
nucleophilic partner for direct intermolecular addition to alkynes via gold catalysis. 
Early this year, Shi et al.[26] showed an alternative method to build up C–S bond by 
the synthesis of vinyl sulfones 1-18 from sulfinic acids and terminal alkynes making 
use of a combination of a triazole BrettPhosAu(I) complex and gallium triflate 
(Scheme 11). Moderate to excellent yields were achieved under mild conditions. 
Alkyl and aryl acetylenes reacted, but internal alkynes were not suitable for this 
methodology due to their relatively low reactivity compared with terminal alkynes. 
 
Scheme 11. Gold-Catalyzed Intermolecular C–S Bond Formation 
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1.3.1.5. C–C Bond Formation 
The intermolecular hydroarylation of alkynes was investigated by Reetz and 
Sommer in 2003.[27] For phenylacetylene, a combination of AuCl3 and AgSbF6 was 
optimal, leading to 1,1-disubstituted alkenes (Scheme 12); for ethyl propiolate, gold(I) 
catalysts gave best performance, giving 1,2-disubstituted derivatives.  
 
Scheme 12. Intermolecular Hydroarylation of Alkynes 
 
 
The corresponding intramolecular versions were reported by Echavarren [28] in 
2005. One year later, with indoles in 1-29 as the intramolecular nucleophilic partner, 
Ferrer and Echavarren[29] obtained up to eight-membered ring fused indole derivatives 
1-30. These are formed by a 7-endo-dig cyclization followed by a ring expansion 
(1,2-shift) and not by a direct 8-endo-dig cyclization (Scheme 13). 
In 2006, Toste et al.[30] were able to utilize silyl enol ethers as the nucleophile to 
realize the intramolecular addition to alkynes. The reaction allows for the 
diastereoselective synthesis of a variety of bicyclic frameworks containing all-carbon 
quaternary centers. Taken together, the gold(I)-catalyzed 5-exo-dig, 5-endo-dig, and 
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5-endo-trig pentannulation reactions provide access to cyclopentenes with control of 
the double bond position. The synthetic utility of these reactions was demonstrated by 
an efficient total synthesis of (+)-lycopladine A (8 steps, 17% overall yield).  
 
Scheme 13. Gold-Catalyzed Intramolecular Reaction of Indoles with Alkynes 
 
 
Scheme 14. Cyclization of Silyl Enol Ethers 
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1.3.2. Rearrangement of Propargylic Carboxylates 
Propargylic carboxylates are versatile substrates that have been studied 
comprehensively in gold catalysis, allowing access to a variety of functional 
structures. With more and more experimental evidence, two divergent initial pathways 
in gold-catalyzed reactions of propargylic carboxylates have been proposed: 
3,3-rearrangement and 1,2-acyloxy migration (Scheme 15).  
 
Scheme 15. Rearrangement of Propargyl Carboxylates 
 
 
An initial 6-endo-dig cyclization of the ester carbonyl group results in the 
formation of a six-membered, gold-containing oxocarbenium intermediate 1-33A, 
which can undergo ring opening to form carboxyallene 1-33B or 1-33B’ via further 
activation of gold on the allene motif. In the case of 1,2-acyloxy migration, an initial 
5-exo-dig cyclization of the ester carbonyl group to the gold-activated alkyne leads to 
the formation of alkenyl gold carbene 1-33C upon heterolytic fragmentation of the 
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original ester bond. The reaction outcome drastically depends on the reaction 
pathways, which is mostly controlled by the substitution patterns on the propargyl 
moiety: in general, sterically and/or electronically unbiased substrates undergo 
reactions via 3,3-rearrangement, while electronically and/or sterically biased 
substrates prefer 1,2-acyl migrations. 
Our group reported a cascade reaction of sequential 3,3-rearrangement and [2 + 2] 
cycloaddition in 2005.[31] When indole-3-acetate 1-34 was treated with Ph3PAuSbF6 
(1 mol %), highly functionalized tetracyclic indole-derived cyclobutane 1-35 was 
formed highly diastereoselectively in excellent yield (Scheme 16).  
 
Scheme 16. Gold-Catalyzed Formation of Tetracyclic Cyclobutanes 
 
 
Activation of the alkyne motif in propargylic ester 1-34 by [Au(PPh3)]+ promotes 
a 3,3-rearrangement of the indole-3-acetoxy group, which leads to the formation of 
allenylic ester 1-34A. The allene moiety of 1-34A is further activated by the cationic 
Au(I) complex, resulting in the formation of oxonium 1-34B. Cyclobutane 4 with an 
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exocyclic E-double bond is then formed via cyclization of the oxonium group in 
1-34B to the 3-position of the indole ring, followed by intramolecular trapping of the 
iminium with the alkenylgold(I).  
An unprecedented Au-catalyzed homogeneous oxidative cross-coupling of 
propargylic acetates and arylboronic acids was developed by our group[32] in 2009, 
offering a one-step synthesis of α-arylenones. This cross-coupling reaction reveals for 
the first time the synthetic potential of incorporating a Au(I)/Au(III) catalytic cycle in 
homogeneous gold catalysis. As shown in Scheme 17, tandem gold-catalyzed 
3,3-rearrangement of the propargylic acetate 1-38 and further Au activation of the 
thus-formed allene moiety generates the oxocarbenium 1-38A, which can be readily 
hydrolyzed into the intermediate 1-38B. By using Selectfluor as a uniquely effective 
oxidant, the Au(I) center can be oxidized into Au(III) in the intermediate 1-38C. 
Transmetallation from phenylboronic acid to 1-38C then provides the Au(III) 
complex 1-38D, which undergoes reductive elimination to yield the cross-coupling 
product 1-39. The enone dimer side product is due to a competing transmetallation by 
Au(I) intermediate 1-38B and the enone 87 is due to competitive protodeauration of 
1-38B. 
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Scheme 17. Au-catalyzed Homogeneous Oxidative Cross-coupling of Propargylic 
Acetates and Arylboronic Acids 
 
 
Scheme 18. Gold-Catalyzed 1,2-Acyloxy Migration of Propargyl Carboxylate and 
Subsequent Intermolecular [4+3] Annulation 
 
 
An example of Au-catalyzed 1,2-acyloxy migration of propargyl carboxylate 
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followed by [4+3] annulation was reported by Toste and co-workers.[ 33 ] The 
propargyl benzoate 1-36 has a gem-dimethyl group at the propargyl position but none 
at the alkyne terminus. As a result of this drastic steric difference, it undergoes 
1,2-benzoxy migration selectively to form the gold carbene 1-36A, which is a 
Fischer-type carbene and electrophilic. The subsequent stepwise annulation with the 
enimine affords the azepine product 1-37 in a synthetically useful yield. 
In 2010, with the help with Dr. Biao Lu, I  accomplished an efficient synthesis 
of (1Z, 3E)-1-bromo/chloro-2-carboxy-1,3-dienes 1-41 from terminally halogenated 
propargyl carboxylates 1-40 (Scheme 19).[ 34 ] The reaction were highly 
diastereoselective, high yielding and typically finished in 10 – 30 min.  
 
Scheme 19. Synthesis of (1Z, 3E)-1-Bromo/Chloro-2-Carboxy-1,3-Dienes  
 
 
Attaching a Br or Cl group at the alkyne terminus could efficiently promote its 
participation selectively in gold-catalyzed 1,2-acyloxy migra tion, generating carbene 
intermediate 1-40A and its resonance form 1-40B, which undergoes deprotonation 
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and protodeauration to afford the final diene product 1-41. A chlorodiene product was 
suitable for the Diels-Alder reaction, and bromodiene products readily participated in 
transition metal-catalyzed cross-coupling reactions, including Kumada, Suzuki and 
Sonogashira reaction, offering efficient and flexible access to a much broader scope 
of functionalized dienes. 
 
1.3.3. Gold-Catalyzed Cycloisomerization of Enynes 
1.3.3.1. 1,6-Enynes 
Enynes are highly versatile substrates for gold catalysis. The pioneer work by 
Hashmi et al.[35] on homogeneous gold-catalyzed reactions of enynes offers an 
excellent example of the potent coupling between alkynes and alkenes. As shown in 
Scheme 20, the alkynylfuran 1-42 can be considered as a specially functionalized 
1,6-enyne. In the presence of AuCl3 at the ambient temperature, it undergoes cascade 
transformations, yielding the synthetically useful highly substituted phenol 1-43. The 
first step upon gold coordination is the reaction between the ‘en’ from the furan ring 
and the ‘yn’ moiety, leading to a reactive gold carbene intermediate 1-42A, which 
undergo a series of skeleton rearrangements, eventually leading to the aromatized 
phenol product 1-43.  
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Scheme 20. Synthesis of Polysubstituted Phenols from Enyne 
 
 
In 2004, Echavarren and co-workers published a seminal study which 
demonstrated that Au-based catalysts (2 mol % of PPh3AuCl with AgSbF6) were very 
effective for accomplishing a series of 1,6-enyne cycloisomerizations (Scheme 21).[36] 
There are two pathways for this reaction: one pathway was similar to that observed 
for Pt-based catalysts, which was initiated by a 5-exo-dig cyclization, followed by 
propanation and then generated highly reactive gold carbene intermediate 1-44B, 
leading to the final diene product 1-45. Notably, the reaction proceeded at room 
temperature, indicating a significantly more reactive nature of the gold catalyst 
compared to the Pt counterpart. The other pathway started from a 6-endo-dig 
cyclization, forming alkenyl gold intermediate 1-44C, which generated another 
carbene intermediate 1-44D by propanation. The subsequent 1,2-hydrogen migration 
afforded cyclopropane 1-46, while diene 1-47 resulted from further skeleton 
reorganization.  
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Scheme 21. Skeletal Rearrangement of 1,6-enynes 
 
By engaging a ketone tethered on the alkene side, Echavarren reported that this 
enyne cycloisomerization could provide a rapid access to a tricyclic skeleton in a 
[2+2+2] cycloaddition of ketoenynes.[37] Mechanistically, an initial enyne cyclization 
of 1-48 promoted by gold leads to the cyclopropyl gold carbene 1-48A, which is then 
attacked by the proximal carbonyl group to give the intermediate 1-48B. The 
following stereoselective cyclization of the alkenylgold moiety on the oxocarbenium 
in 1-48B thereby yields the tricyclic product 1-49. Notably, this [2+2+2] 
cycloaddition is highly diastereoselective, and the newly formed chiral centers in 1-49 
are controlled by the chiral propargyl carbon center and the double bond geometry. 
This chemistry was later applied to the first total syntheses of (+)-orientalol F by the 
same author (Scheme 22).[38] 
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Scheme 22. Enynone Cycloisomerization en Route to the Total Synthesis of 
(+)-Orientalol F. 
 
 
1.3.3.2. 1,5-Enynes 
Besides 1,6-enynes, 1,5-enynes are also extensively studied in gold catalysis. The 
early independent reports by Fürstner et al.[39] and Malacria et al.[40] established that 
cycloisomerizations of this type of enynes proceed with an initial formation of the 
metal carbene 1-50A in the presence of either LAu(I) or PtCl2. This carbene can 
undergo either 1,2-C–H insertion to eventually afford isomeric bicyclic ketones 1-51 
if R group is H, or a 1,2-acyloxy migration to yield enol esters 1-52 when R group is 
carbonyl. (Scheme 23). Fürstner has applied this chemistry in the total synthesis of 
sesquiterpenes such as (-)-α-cubebene and (-)-cubebol.[41]  
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Scheme 23. Cycloisomerizations of 1,5-enynes 
 
1.3.4. Reactions of ortho-Substituted Arylalkynes 
Arylalkynes with nucleophilic groups ortho to the C–C triple bond often serve as 
‘privileged’ substrates for gold catalysis due to the forced proximity of reacting 
partners and often beneficiary conjugation between them. In a pioneer work by 
Yamamoto in 2004,[42] a carbonyl group is used as the ortho nucleophilic group, and 
its cyclization to the proximal gold-activated alkyne generates the benzo[c]pyrylium 
salt 1-53A, which acts as a reactive and electron-deficient diene and undergoes [4+2] 
cycloaddition with phenylacetylene readily. The thus-formed intermediate 1-53B 
rearranges readily to yield the synthetically useful naphthyl ketone 1-54 in an 
excellent yield (Scheme 24). 
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Scheme 24. AuBr3-Catalyzed Benzannulation Reaction. 
 
 
In their continued study using ortho-tethered nitrone as the internal oxidant, Shin 
et al.[ 43 ] reported the coupling of this intramolecular redox process with a 
pinacol-Mannich-Michael cascade in 2010.  
 
Scheme 25. Stereoselective Gold-catalyzed Redox-pinacol-Mannich-Michael 
Cascade Reaction. 
 
 
As shown in Scheme 25, an initial attack at the gold-activated C–C triple bond by 
the tethered nitrone generates the alkenylgold 1-55A, which can fragment the N-O 
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bond, and generate a reactive α-oxo gold carbene intermediate 1-55B. With a tertiary 
alcohol proximate to the electrophilic carbene center, a pinacol-type rearrangement 
occurs immediately, leading to the β-diketone 1-55C. Notably, this type of pinacol 
rearrangement was previous realized by our group in 2007.[44] Subsequent tandem 
Mannich reaction and Michael addition yields a complex tetracycle 1-56 in a good 
yield and with a good diastereoselectivity. 
 
1.3.5. Gold Vinylidene and Related Intermediates 
Vinylidenes complexes of various metals, such as Ru, Rh and W, are versatile 
intermediates that mediate the formation of various carbon-heteroatom and 
carbon-carbon bonds in a range of powerful catalytic reactions. However, little has 
been known about gold vinylidenes till recently. In 2011, our group reported the first 
case of gold vinylidene formation from cycloisomerization of benzene-1,2-diynes 
(Scheme 26).[45] Based on both mechanistic studies and theoretical calculations, we 
proposed the following mechanism: firstly, the N-oxide acts as a base to extract the 
proton from the terminal alkyne active by BrettPhosAu(I), affording alkynylgold 
complex 1-57-Au1; while likely the reversed process, i.e., protodeauration, occurs, 
the presence of a base should help shift the equilibrium toward 1-57-Au1. Another 
cationic gold(I) can then activate the other C–C triple bond of 1-57-Au1; followed by 
a 5-endo-dig cyclization, a gold vinylidene intermediate 1-57-Au2 would be 
generated. This novel species, in contrast to its Ru or Rh counterparts, is highly 
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reactive and undergo a facile C–H insertion, leading to 1-58-Au; the subsequent 
protodeauration affords the observed tricyclic indenes product 1-58. Three month 
later, Hashmi and co-workers reported very similar work independently.[46]  
 
Scheme 26. First Example of Gold Vinylidene Formation from Endiynes 
 
 
Later, Hashmi and co-workers explored a serious of diyne compound and 
reported some interesting results.[47-49] One terminal and one aryl-substituted alkyne 
1-62 afforded dibenzopentalene compound 1-63 in moderate yield via the gold 
vinylidene pathway, which offers a straightforward and relatively efficient access 
towards this class of molecules which are of interest in the context of materials 
science.[50] However, the substrate scope is very limited: only those substrates with 
electron-donating/neutral substituted group on the phenyl ring were shown to work, 
and an interesting benzo[4,5]pentaleno[1,2-b]thiophene 1-63a can be obtained in only 
20% isolated yield (Scheme 27-A).  
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Interestingly, for thiophene fused diyne substrates 1-64, the tricyclic pentalene 
compound, which was supposed to be formed from the gold vinylidene intermediate, 
was not observed by the authors; instead, indanothiophenes 1-65 were afforded in 
good efficiency through σ, π-dual activation and a 6-endo diyne cyclization when a 
dual-activation IPrAu(I) based catalyst was utilized (Scheme 27-B). Efficient 
synthesis of fluorenothiophenes was also demonstrated in this work, which makes this 
chemistry more interesting.  
 
Scheme 27. Different Pathways for Different Substrates 
 
 
After our group successfully generated gold vinylidene from benzene-dialkyne 
substrates via a 5-endo-dig cyclization, no success was achieved in terms of switching 
to the 6-endo-dig pathway for the same substrates. As a result, cis-enediyne, another 
type of substrate, was then tested. Pleasantly, the C–H insertion product, substituted 
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benzene 1-67, was indeed generated and Mor-DalPhosAuNTf2 served as the best 
catalyst. The reaction was initiated by 6-endo-dig cyclization to generate 
α-auronaphthyl cation 1-66-Au2 after gold acetylide 1-66-Au1 was formed. Moreover, 
cation 1-66-Au2 rearranges to its more stable structural isomer 1-66-Au4 through a 
low-energy-barrier gold migration, the transition state of which is in the form of an 
aryne-coordinated gold complex 1-66-Au3. In the next step, the resonance form of 
1-66-Au4 then generate gold carbene intermediate 1-67-Au, which leads to the final 
product 1-67 upon carbene C(sp3)-H insertion.  
 
Scheme 28. Gold-Catalyzed Cyclizations of cis-Enediynes 
 
 
The difference between the pathways of benzene-dialkynes and cis-enediynes can 
be explained by considering the difference in gained aromatic stabilization: when the 
substrate is benzene-dialkyne, the additional resonance energy gained upon the 
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6-endo-dig cyclization is 28 kcal/mol (64 kcal/mol for naphthalene and 36 kcal/mol 
for benzene).[51] However, when the substrate is cis-enediynes, the aromaticity gained 
by the newly formed benzene ring would be 8 kcal/mol greater (36 kcal/mol). Our 
DFT calculations confirmed this idea, which was also agreed by the work of Hashmi 
et al. reported early this year.[52] 
 
Scheme 29. Synthesis of Vinyl Sulfonates via Gold Vinylidene Complexes 
 
 
Very recently, Hashmi et al.[53] utilized terminal alkynes that bear sulfonate 
leaving groups at an appropriate distance to generate gold vinylidene and afford vinyl 
sulfonates as the final products (Scheme 29). The alkyne 1-68 was converted a gold 
acetylide 1-68-Au1 in the presence of a propynyl gold(I) precatalyst, after which a 
cyclization takes place and generates a gold vinylidene complex forming a tight 
contact ion pair with the sulfonate group (i.e., 1-68-Au2), and the following 
recombination of the two parts eventually delivers vinyl sulfonates 1-69. A new type 
of carbene ligand, NHC(15) seemed to perform slightly better than biaryl phosphine 
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ligand XPhos (81% vs 79% with 2.5 mol % Au catalyst loading). In spite of the low to 
moderate yields and limited substrate scope, it’s still a novel way to generate gold 
vinylidene with only one alkyne group and solo gold activation. 
 
1.4. Gold-Catalyzed Reactions of Allenes 
Allenes are highly valuable synthetic precursors in preparative organic chemistry 
because of their ability to undergo a variety of transformations. Because of their soft 
and carbophilic character, gold catalysts are particularly well suited for the selective 
activation of allenes in the presence of other reactive functionalities.  
In 2007, an interesting catalytic system reported by Toste et al.[ 54 ] takes 
advantage of a chiral counterion, which was introduced into the catalyst by a silver 
phosphate salt (Scheme 30). Thus, treatment of γ- or δ-allenols 1-70 with catalytic 
amounts of an achiral gold precatalyst dppm(AuCl)2 and the chiral silver salt afforded 
heterocycles 1-71 with high yield and excellent enantioselectivity in most cases. For 
the terminal allene (R = H), the enantiomeric excess could be improved from 80 to 92% 
by using a chiral gold catalyst together with the chiral silver salt. Application of this 
method to allenic carboxylic acids afforded chiral γ-lactones with up to 82% ee. 
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Scheme 30. Chiral Counterion in the Enantioselective Cycloisomerization of 
Allenols 
 
 
n R yield (%) ee (%) 
1 -(CH2)4- 90 97 
1 Me 91 95 
2 Me 81 90 
2 H 96 80 
 
In 2010, Toste and co-workers expanded the scope of gold-catalyzed 
intramolecular exo-selective hydroaminations to allenic hydrazines 1-70 and 
hydroxylamines 1-72.[55] The former substrates afforded pyrazolidines 1-71 in the 
presence of Segphos-Au complex Au*-1, whereas the binap-gold catalyst Au*-2 gave 
the best results in the cyclization of the hydroxylamine derivatives to isoxazolidines 
1-73 (Scheme 31). Moderate to excellent yields and enantioselectivities were obtained 
in most cases, and the methodology was also applied to the synthesis of chiral 
tetrahydrooxazines. 
Despite the propensity for thiols to bind to gold, which would be expected to 
nullify its ability to act as a catalytic candidate, in 2006 Krause et al.[56] found that an 
intramolecular hydrothiolation of allenes could take place. This is the first example of 
gold-catalyzed C–S bond formation and the authors posited that the gold-thiol 
complex should be the preferred species in situ with the perfect chirality transfer 
observed. Besides AuCl, AuI is also efficient in some cases (Scheme 32). 
32 
 
Scheme 31. Cycloisomerization of Allenic Hydrazines and Hydroxylamines 
 
 
Scheme 32. Intramolecular Thiol Addition to Allenes 
 
 
1.5. Gold-Catalyzed Reaction of Allenes 
Alkene activation has attracted lots of attention in the past ten years and much 
progress has been made in this research area. In this segment, gold-catalyzed addition 
of carbon- and heteroatom-based nucleophiles to inactivated alkenes are widely 
recognized as “capricious” transformations due to alkyne and allene counterparts. 
However, tremendous developments have been made over the past few years. 
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1.5.1. Nucleophilic Addition Reactions 
1.5.1.1. C–O Bond Formation 
He et al.[57] first demonstrated that Au(I) promoted the hydroamination of alkenes 
in 2006. With 5% Ph3PAuOTf at 85 °C, both inter- and intramolecular additions of 
tosylamide occur in good to excellent yields (Scheme 33). A mechanistic analysis 
confirmed that a trans-addition mechanism was operative. As a control experiment, 
they also studied the 31P NMR of Ph3PAuOTf at 85 °C and found that the PPh3Au+ 
species does not interact with TsNH2 and indeed interacts with norbornene or 
cyclohexene.  
 
Scheme 33. Hydroamination of Alkenes 
 
 
1.5.1.2. C–N Bond Formation 
In 2005, He and co-workers first reported the intermolecular addition of both 
phenols and carboxylic acids to simple olefins with Ph3PAuOTf.[58,59] Some terminal 
olefins eventually migrate to an internal position to give mixed products, but further 
migration does not take place. Allylic benzenes, however, do not migrate to more 
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stable styrenes. Different functional groups are tolerated (Scheme 34). One year later, 
the same group reported the same transformation but catalyzed by HOTf at room 
temperature with good to excellent yields. 
 
Scheme 34. Phenol and Carboxylic Acid Additions to Alkenes 
 
 
1.5.1.3. C–C Bond Formation 
Li et al.[60] reported a gold(III)-catalyzed intermolecular addition of 1,3-diketones 
to olefins in 2004. Because of the high Lewis acidity of the AuCl3/3AuOTf catalyst 
system, substrates like dimethyl malonate and β-ketoesters decomposed and did not 
undergo the reaction.  
There is no detectable diastereoselectivity with the gold(III) system at room 
temperature. Shortly after, they found by lowering the reaction temperature to 0 °C, 
dienes, trienes, and cyclic enol ethers also react with diketones to give moderate to 
good yields.[61] Sterically hindered dienes give lower yields (Scheme 35).  
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Scheme 35. Intermolecular Addition of 1,3-Diketones to Olefins 
 
 
Reports of direct hydroarylation of simple olefins by gold are rare. In 2007 Liu et 
al.[62] found that AuCl3/3AgOTf can catalyze addition of N-protected indoles to vinyl 
arenes and trisubstituted olefins using the DNA-encoding and DNA-programed 
assembly of substrate pairs. Notably most reactions above could also be catalyzed by 
a catalytic amount of strong acids like HOTf (Scheme 36). 
 
Scheme 36. Hydroarylation of Alkenes 
 
 
Li et al.[63] reported that the same catalyst system, AuCl3/3AgOTf, catalyzes an 
efficient annulation of phenols and dienes to give various benzofuran products 
(Scheme 37). Cationic Ph3PAuOTf shows no product formation, perhaps due to 
36 
 
degradation of dienes accelerated by cationic gold(I). The authors proposed that the 
intermolecular Friedel-Craft reaction occurs first and then the subsequent 
intramolecular addition of the phenol O-H bond leads to the final benzofuran 
products. 
 
Scheme 37. Annulation of Phenols and Dienes 
 
 
1.5.1.4. C–S Bond Formation 
In 2007, He et al.[64] found that Ph3PAuBF4 to be a highly active catalyst for the 
addition of a wide variety of sulfur nucleophiles to conjugated dienes. A number of 
functional groups are tolerated including NO2, OMe and even free OH. While free 
NH2 is not tolerated, it can be protected as Cbz to permit the addition to occur. 
Unfortunately, attempts to add simple thiols to simple olefins failed, even at 100 °C 
(Scheme 38). 
 
Scheme 38. Thiol Addition to Dienes 
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1.5.2. Allylic Substitution Reactions 
From a synthetic, environmental and economic point of view, it’s highly desirable 
to use simple allylic alcohols as alkylating reagents in place of more activated 
analogues (i.e. halides, acetates, carbonates and phosphates), since the only 
side-product is water. Late transition metal catalysts proved to be efficient in 
addressing the poor reactivity of these substrates.[65] Due to the ability of gold 
complexes to act as both σ- and π-acids, gold catalysis gained an exceptional role in 
the activation of allylic alcohols.  
In 2011, Ess and Aponick reported a mechanistic study on the intramolecular 
hydroalkoxylation of hydroxy allylic alcohols 1-74, pointing out the key role of 
intramolecular hydrogen bonding interactions for both reactivity and stereoselectivity. 
Anti-addition followed by anti-elimination was energetically favored by DFT 
calculation.[66]   
 
Scheme 39. Mechanistic Investigation on the Intramolecular Au(I)-catalyzed 
Hydroalkoxylation of Allylic Alcohols 
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Interestingly and also importantly, a strong hydrogen bond was established during 
the catalytic cycle between the hydroxy groups. The H-bond turned out to be a key 
interaction for the high reactivity of 1-74 toward cyclization, leading to an 
intramolecular proton transfer resulting into an intermediate with better leaving group 
1-74A. Furthermore, as the H-bond was conserved during the entire process of the 
reaction, it also determined the E geometry of the newly formed C–C double bond 
(Scheme 39).  
The importance of the H-bond network in gold-catalyzed reactions of allylic 
alcohols is also highlighted by the intramolecular enantioselective allylic alkylation of 
indoles, which was documented by Bandini and Miscione.[ 67 , 68 ] Combined 
experimental and computational studies revealed the presence of a complex H-bond 
network between the indole ring, the counterion OTf− and the leaving group OH along 
all the reaction profile (Scheme 40). Multiple functions were recognized in these 
interactions. Firstly, all the strong H-bonds conferred a constrained conformation to 
the substrates (U-fold) placing the two reacting partners in close proximity (1-76A). 
Secondly, after the initial nucleophilic attack of the indole ring, the counterion, 
trifluoromethanesulfonate, facilitated the elimination of water from 1-76C by 
shuttling one proton atom from the indolyl ring to the leaving hydroxy group. This 
proposed catalytic cycle also accounted for the observed stereochemistry of the 
product 1-77 (R) when the chiral gold complex (R)-DTBM-MeO-biphep was 
employed. 
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Scheme 40. Intramolecular Enantioselective Au(I)-Catalyzed Alkylation of 
Indoles with Allylic Alcohols. 
 
 
In early 2012, Widenhoefer et al.[69] were able to demonstrate an enantioselective 
dehydrative amination of allylic alcohols with carbamates, emphasizing what an 
essential role the H-bond network played in this type of allylic substitution reactions, 
once again. Pyrrolidines and piperidines 1-79 were obtained with enantiomeric 
excesses up to 94% by using a chiral gold complex based on (S)-DTBM-MeO-biphep 
(Scheme 41-A).  
Mechanistic investigation suggested that the configuration of the newly formed 
stereocenter was completely controlled by the catalyst. On the contrary, studies on 
stereochemically defined secondary allylic alcohols revealed that the configuration of 
the allylic carbon atom affected the configuration of the newly formed C–C double 
bond. The E configuration of the carbon-carbon double bond from the starting 
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material turned out to be essential to achieve high enantioselectivity. Also in this case, 
it’s worthy to mention that a mechanism consisting of an initial anti-aminoauration 
followed by anti-elimination accounted for the observed experimental results 
(Scheme 41-B).  
 
Scheme 41. Intramolecular Enantioselective Dehydrative Amination of Allylic 
Alcohols Catalyzed by Chiral Au(I)-complexes. 
 
 
Metal catalyzed electrophilic activation of isolated alkenes is often considered 
one of the most challenging metal-assisted nucleophilic manipulations of inactivated 
unsaturated hydrocarbons by far. Relative inertness of C=C with respect to alkynes or 
allenes leads to this trend. In this scenario Au(I) and Au(III) catalysis is playing a 
major role leading to tremendous developments  
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2. A General Ligand Design for Gold Catalysis Allowing 
Ligand-Directed anti Nucleophilic Attack to Alkynes 
2.1. Introduction and Design 
Numerous powerful synthetic methodologies, allowing efficient and rapid access 
to a broad series of functional structures and compounds, have been developed based 
on an initial anti nucleophilic attack at the LAu(I) coordinated C–C triple bond. 
However, most homogeneous gold catalyses require 1–5 mol % catalytic loading, 
which means it’s highly unlikely for these reactions to be applicable in medium or large 
scale applications due to the expensive nature of metal gold, not mentioning the 
industrial scale processes.  
The above general shortcoming in gold catalysis is mainly due to the low turnover 
numbers (TONs) of the catalysts: Au(I) complexes based on phosphine ligands offers 
good reactivities but generally short life time, while Au(I) complexes based on NHC 
ligands are typically more stable due to its stronger coordination nature than phosphine 
ligands but less reactive at the price of stability. To overcome this limitation, we need 
substantially improve the TONs of the catalysts and hence dramatically lowering their 
loadings. To realize this target, two solutions might come to play: 1) higher temperature 
with NHC-based catalyst to increase turnover frequency (TOF); 2) designed 
(phosphine) ligands to achieve higher TOF and longer lifetime. 
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2009, Nolan et al.[1] reported the first example of gold catalysis at part-per-million 
catalytic loadings: [(NHC)Au(I)]-catalyzed alkyne hydration. Due to the high thermal 
stability of IPrAu(I), the reactions could be heated to 120 °C for long time so that only 
ppm catalyst loading was required to convert alkynes to ketones in good to excellent 
yields (Scheme 42). However, there are a few questions marks and limitations 
remaining for this chemistry: large excess of AgSbF6 was needed in most cases, which 
also potentially catalyzed this reaction, but no control reaction was done; the tolerance 
of functional groups or protecting groups was not demonstrated and the regioselectivity 
for internal alkynes were bad (2.2:1 to 4.4:1). Clearly higher temperature with 
NHC-based catalyst was able to increase TON, but suffer from the bad selectivity and 
relatively harsh conditions at the same time. 
 
Scheme 42. [(NHC)Au(I)]-Catalyzed Alkyne Hydration at PPM Catalyst 
Loadings 
 
 
Ligand tuning[2] is a well-practiced strategy in transition metal catalysis to achieve 
high catalyst TONs, but little success has been reported in this regard in homogeneous 
gold catalysis. Recently LaVallo et al.[3] reported a new type of gold catalyst to be very 
efficient when catalyzing hydroamination of alkynes with primary amines; the highest 
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turnover number observed for hydroamination with this catalyst exceeded a stunning 
95, 000. This single-component zwitterionic gold complex formed by the coordination 
of a phosphine ligand bearing an inert and noncoordinating carborane substituent, 
CB11Cl11−, to an Au(I) ion (Scheme 43).  
The authors postulate that the proximity of the anionic CB11Cl11- group to the Au 
center may lead to electrostatic stabilization of the positively charged reaction 
intermediates.[3] Analogously, the charge on the carborane substituent may also act as 
an electrostatic tether to prevent phosphine dissociation and subsequent catalyst 
decomposition. 
 
Scheme 43. Hydroamination of Alkynes with Primary Anilines 
 
 
Those two simple and typical but also classical and useful transformations are both 
based on an initial coordination of a C–C triple bond to a LAu(I), a cationic gold(I) 
species with one coordinating ligand, and a subsequent anti attack by a nucleophile at 
the alkyne (Figure 3-A). Due to the linear nature of the L-Au-alkyne complex and the 
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anti approach of the nucleophilic attack, it is highly challenging to introduce bonding 
interaction between the ligand and the nucleophile due to apparent spatial constrain. As 
a result, it’s not surprising that there is no reported reaction of this nature before this 
work. Even though in the research of enantioselective gold catalysis,[4,5] ligands and/or 
counter anions to the metal center could impose a chiral environment in the 
approaching path of nucleophiles (often with allene and allylic alcohol substrates), the 
controls are unvaryingly from the sterics and offer little, if not to the opposite effect, 
rate acceleration or efficiency improvement. 
 
Figure 3. A Novel Ligand Design for Highly Efficient Gold Catalysis  
(A) anti attack at gold(I)-activated alkyne by a nucleophile  
(B) a general concept to achieve quasi-intramolecular, ligand directed nucleophilic 
attack  
(C) a design based on biphenyl-2-ylphosphine framework 
 
 
It is envisioned that a ligand with a rigid and extending framework could project a 
functional directing group farther enough to reach to the approach nucleophile (Figure 
3-B).[6] The functional group could be designed in such a way that it could have 
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attractive interaction with the nucleophile and hence be capable of directing its attack at 
the gold-activated triple bond. The rigidity of the backbone would minimize the 
entropy cost for organizing transition states, and the directing group should be flexible 
enough to accommodate a broad substrate scope. This strategy is expected to facilitate 
the initial nucleophilic attack drastically by converting it from an intermolecular 
process to a quasi-intramolecular event and may also accelerate subsequent 
transformations. As a result, higher catalyst TONs and hence more efficient catalysis 
could be expected.  
Bulky and electron-rich biphenyl-2-ylphosphines belong to a privileged class of 
phosphorus-based ligands that are developed by Buchwald’s group[7-9] for various 
versatile Pd catalyzed cross-coupling reactions.[10,11] Lately, these ligands have been 
borrowed to apply in gold catalysis with much success,[12-19] but modification of them 
for gold catalysis is rare.[20] Perhaps due to the nature of Pd catalysis, the lower half of 
the bottom phenyl ring of these ligands (i.e., C3’, C4’ and C5’) has seldom been 
substituted with functional groups. The only exceptions are a 3’-sulfonate ligand 
derived from SPhos and a 4’-sulfonate ligand based on XPhos for the purpose of 
increasing catalyst aqueous solubility so that the coupling reactions could be performed 
in water, a very green solvent.[21] In contrast to square planar Pd(II) complexes, 
bis-coordinated gold(I) complexes exhibit linear structures, which stands a ligand 
design philosophy different from that for Pd catalysis. In the context of 
biphenylphosphine ligands (Figure 3-C), by fixing the P-C2 rotation using bulky 
substituents on the phosphorus, the linear P-Au-alkyne axis should be parallel to and 
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bisect the pendant phenyl ring, thus forcing the Au-coordinated alkyne to stay right on 
the top of the lower half of that pendant ring. We think that if these remote positions on 
that part of the phenyl ring, with the activated alkyne lying above, were to be 
functionalized with H-bond acceptors, these functional groups could extend further 
enough to direct certain neutral nucleophiles via H-bonding interactions and/or proton 
stabilization to attack the activated alkyne in a quisi-intramolecular anti approach. 
Those directing groups can not only act as bases to speed up the process of the initial 
nucleophilic attacks, but also serve as the proton-supplier to accelerate the course of 
proton-deauration after the attack. In this manner the design concept shown in Figure 
3-B could be implemented.  
To put this concept into practice, I designed and synthesized a series of 
2-biphenyldi-(1-adamentyl)phosphine ligands L1 – L10 (Figure 4) with either C3’ or 
C4’ functionalized. They can be readily synthesized via consecutive cross-coupling 
reactions and then followed by coupling of di(1-adamentyl)phosphine (Ad2PH). Its 
ease of installation does make Ad2P very temping at the first place,[22] but more 
importantly, its electron-rich nature makes the corresponding Au complex more stable, 
and the steric bulkiness of the Ad groups would protect the Au from the intermolecular 
deactivation. As a result, it helps to sustain the catalyst for longer life time to realize a 
high TOF. 
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Figure 4. 2-Biphenyldi-(1-adamentyl)phosphine Ligands L1 – L10 
 
2.2. Au-Catalyzed Ligand-directed Nucleophilic Additions to Alkynes 
with Part-Per-Million Catalyst Loading  
The addition of a carboxylic acid to an alkyne is chosen as the model reaction to 
exam our design and this reaction was firstly reported by Kim[23] in 2010. Interestingly, 
PPh3AuCl/AgPF6 catalyst afforded the Markovnikov addition products, whereas 
PPh3AuCl/AgOTf catalyst gave the more stable isomerized products via the 
Markovnikov products (Scheme 44). TONs of this transformation was up to 18, and the 
best catalyst TON (i.e., 124) of this type of reaction was achieved via Ru catalysis.[24] 
Notably, the products enol esters are versatile substrates of broad synthetic utilities; 
they possess not only mildly activated acyl groups which make themselves better 
acylation reagents than alkyl esters, but also relatively stable enol motifs that would 
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afford α-functionalized ketones.  
 
Scheme 44. Gold(I)-Catalyzed Addition of Carboxylic Acids to Alkynes 
 
 
 
2.2.1. Conditions Study 
 Benzoic acid and 1-dodecyne were used to optimize the reaction conditions 
because their non-volatile property makes it easier to detect the reaction products. I 
started the screening with 1 mol % Au catalyst at 40 °C using DCE as the solvent and 
the concentration of limiting benzoic acid was 0.5 M.  
As shown in Table 1, with IPrAuNTf2, a catalyst only different by the counter 
anion from the previously reported ppm-level IPrAuCl/AgSbF6 for alkyne hydration in 
1,4-dioxane/H2O, [1] there was only trace amount of the desired 2-dodecenyl benzoate 
1a detected after 8 hours and most starting materials remained unreacted (entry 1). 
Gold catalysts based on biphenyl monophosphine ligands JohnPhos and bulkier 
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BrettPhos gave similarly low reactivity too (entries 2 and 3). Mor-DalPhosAuNTf2 
with a P,N-type ligand which showed interesting ability in terms of stabilizing α-gold 
carbene,[25] did not provide any promising result for this reaction, neither did simple 
Ph3PAuNTf2, as expected (entries 4 and 5).  
While a basic dimethylamino group at the 4’ position in the case of the ligand L1 
did not offer any improvement (entry 6) , its regioisomer L4 with the substituent at the 
3’ position led to some notably improvement (entry 7), hinting that substitution at C3’ 
might be better than at C4’ for the reaction. Although L2 and L5 with relatively neutral 
ethyl ester group at 3’ or 4’ positions only gave trace products (entries 8 and 9), with 
piperidin-1-ylcarbonyl as the functional group at either the 4’ or the 3’ position in the 
case of ligand L3 or L6, respectively, a much more efficient reaction with an observed 
catalyst TON of 80 was realized, suggesting that an amide is a suitable functional 
directing group for promoting the acid addition to the alkyne (entries 10 and 11). By 
lowering down the gold catalyst loading to 0.11%, the TONs reached 609 for L3 (entry 
12) and 827 for L6 (entry 13), which are much better than the Ru case. [24] Again, ligand 
with directing group at C3’ seemed to be better than at C4’ position, which was 
consistent with the phenomena observed from L1 and L4. TON was further increased 
to 1681 (entry 14) by further decreasing the loading of the better gold complex L6AuCl 
to 200 ppm with slightly more concentrated reaction condition (1 M).  
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Table 1. Screening Various Ligands and Optimizing Reaction Conditions. 
 
entry [Au] solvent, temperature, conc. time 
NMR yielda 
2-1a TON 2-2a
1 IPrAuNTf2 (1%) DCE, 40 °C, 0.5 M 8 h 0.5% 0.5 0 
2 JohnPhosAuNTf2 (1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
3 BrettPhosAuNTf2 (1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
4 Ph3PAuNTf2 (1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
5 Mor-DalPhosAuNTf2 (1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
6 L1AuCl/AgNTf2 (1.1%/1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
7 L4AuCl/AgNTf2 (1.1%/1%) DCE, 40 °C, 0.5 M 8 h 6% 5 0 
8 L2AuCl/AgNTf2 (1.1%/1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
9 L5AuCl/AgNTf2 (1.1%/1%) DCE, 40 °C, 0.5 M 8 h trace - 0 
10 L3AuCl/AgNTf2 (1.1%/1%) DCE, 40 °C, 0.5 M 8 h 89% 80 7% 
11 L6AuCl/AgNTf2 (1.1%/1%) DCE, 40 °C, 0.5 M 8 h 89% 80 7% 
12 L3AuCl/AgNTf2 (0.11%/0.1%) DCE, 40 °C, 0.5 M 8 h 67% 609 0 
13 L6AuCl/AgNTf2 (0.11%/0.1%) DCE, 40 °C, 0.5 M 8 h 91% 827 2% 
14 L6AuCl/AgNTf2 (220/200 ppm) DCE, 40 °C, 1 M 12 h 37% 1681 0 
15 L7AuCl/AgNTf2 (220/200 ppm) DCE, 40 °C, 1 M 12 h 27% 1227 0 
16 L8AuCl/AgNTf2 (220/200 ppm) DCE, 40 °C, 1 M 12 h 35% 1590 0 
17 L9AuCl/AgNTf2 (220/200 ppm) DCE, 40 °C, 1 M 12 h 36% 1636 0 
18 L10AuCl/AgNTf2 (220/200 ppm) DCE, 40 °C, 1 M 12 h 43% 1954 0 
19 L10AuNTf2 (200 ppm) DCE, 40 °C, 1 M 12 h 47% 2350 0 
20 L10AuNTf2 (50 ppm)/NaBARF (0.12%) DCE, 80 °C, 2 M 12 h 85% 17000 0 
21 L10AuNTf2 (50 ppm)/NaBARF (0.12%) PhCl, 80 °C, 2 M 12 h 93% 18600 0 
22 L10AuNTf2 (40 ppm)/NaBARF (0.12%) PhF, 80 °C, 2 M 12 h 97% 24250 0 
23 L10AuNTf2 (25 ppm)/NaBARF (0.12%) PhF, 80 °C, 2 M 12 h 86% 34400 0 
24 L10AuCl (50 ppm)/NaBARF (0.12%) PhF, 80 °C, 2 M 12 h 68% 13600 0 
25 JohnPhosAuNTf2(500 ppm)/ NaBARF (0.12%) PhF, 80 °C, 2 M 12 h 2% 40 0 
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a The NMR yield is calculated by assuming that the triplet at around 0.9 ppm corresponds to the 
terminal methyl groups of all compounds derived from 2-dodecyne. NaBARF, sodium 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate; DCE, 1,2-dichloroethane. 
 
With little success in terms of other functional groups at the 3’ position, the 
reaction optimization was then focused on modifying the amide N-substituents of L6. A 
family of ligands with different amide N-substituent, morpholine (L7), 
N,N-diethylamine (L8), N,N-diisopropyl amine (L9) and pyrrolidine (L10) were 
prepared to compare the efficiency; the results are shown in entries 15-19. L10 turned 
out to be the most efficacious ligand, and L10AuNTf2 afforded a TON of 2350 for 200 
ppm loading, which was slightly higher than the combination of L10AuCl/AgNTf2.  
 
Table 2. C=O Stretching Wavelengths of Carbonyls in Ligands and Catalysts. 
 
 
 
 
 
A qualitative inverse correlation between the reaction yields and the wavenumbers 
of the amide carbonyl stretch band (C=O) of both the ligands and the corresponding 
gold complexes (Table 2) is revealed. The lower C=O is, the more basic the carbonyl 
L C=O (L) C=O (LAuCl) TON 
L7 N(CH2)2O 1639 1634 1350 
L8 NEt2 1635 1629 1750 
L9 NiPr2 1634 1628 1800 
L6 N(CH2)5 1630 1625 1850 
L10 N(CH2)4 1628 1620 2150 
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oxygen of the amide group is and hence the stronger H-bond acceptor it is. Therefore, 
the tendency of the reaction yields positively correlate to the H-bond acceptor capacity 
of the amide carbonyl oxygens. This qualitative trend is consistent with the ligand 
design that demands the remote functional group to recruit the nucleophile via 
H-bonding.  
However, the reaction couldn’t go to completion with 200 ppm L10AuNTf2 even 
longer reaction time and higher temperature was provided. We suspected that the gold 
catalyst was deactivated or trapped by some coordinating anionic impurities possibly 
from the solvent. The crude product was analyzed and the results supported our 
speculation: no L10AuNTf2 was detected after the reaction but a major peak of 
L10AuCl was observed in both 31PNMR and ESI+. The chloride could come from the 
leak of the solvent, 1,2-dichloroethane, under thermal condition after long reaction 
time.  
Neat condition was then tried, however the result was even worse; it seemed that 
the solvent was necessary and possibly helped the hydrogen-bonding formation. Then 
different additives were tried to scavenge the Au catalyst, including AgNTf2, AgOTf, 
AgSbF6, NaOTf, KPF6 and NaBARF (sodium tetrakis[3,5- 
bis(trifluoromethyl)phenyl]borate. While silver salts tended to produce more benzoic 
anhydride 2-2a which might indicate silver activates enol motif of the product toward 
the attack from benzoic acid, NaOTf and KPF6 didn’t help the reaction potentially due 
to their low solubility in relatively non-polar organic solvent. Much to our delight, 
NaBARF reactivated the catalyst without producing any side-products: 50 ppm 
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L10AuNTf2 plus 0.12 mol % NaBARF gave the desired product 2-dodecenyl benzoate 
2-1a in 85% yield and the TON was increased to 17000 (entry 20) at 80 °C under a little 
bit more concentrated condition (2 M).  
Different solvents were also screened; none of the polar solvents (THF, 
1,4-dioxane, ethyl acetate or acetone) gave promising result. Chlorobenzene (TON of 
18600) performed a little bit better than 1,2-dichloroethane, but not as well as 
fluorobenzene, which achieved a TON of 24250 with almost full conversion (entries 21 
and 22). Further decreasing the catalytic loading to 25 ppm allowed the TON to 
increase to 34400 (entry 23), but unfortunately the reaction couldn’t go any further after 
12 more hours. Interestingly, when L10AuCl was used instead of L10AuNTf2, the 
TON was only 13600 (entry 24); presumably that’s because the BARF ion is extremely 
weakly coordinating counterion so that the lifetime of the corresponding Au catalyst 
was significantly shorter than L10AuNTf2. As a result, the overall efficiency of 
L10AuCl/NaBARF was less than L10AuNTf2/NaBARF in spite of a higher reactivity. 
In comparison, under the same conditions a catalyst TON of 40 was reached for 
JohnPhosAuNTf2 (entry 25). By considering that t-butyl and 1-adamantyl have similar 
steric bulk, the rate acceleration of 860 fold by L10AuNTf2 over JohnPhosAuNTf2 can 
be attributed to the mere incorporation of the remote 3’-amide group. The structure of 
the ligand L10 is confirmed by the X-ray diffraction study of its gold complex 
L10AuCl. Thanks to Zhixun Wang for growing this single crystal. 
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Figure 5. The ORTEP Drawing of L10AuCl at 50% Ellipsoid Probability 
 
 
2.2.2. The Reaction Scope with Ultra-Low Catalyst Loadings 
With the low sub-micromolar catalysis realized, its applicability to other carboxylic 
acids was first examined using 1-hexyne or 1-dodecyne as the alkyne partner. As 
shown in Table 3, various acids possessing a diverse range of functional groups were 
allowed, mostly resulting in nearly quantitative yields while with a catalyst loading of 
100 ppm or less. For benzoic acids, substituents could be electron-withdrawing groups 
(3,5-dimehtyl/2-1b, 2-methyl/2-1c, 3-methoxyl/2-1d) and electron-donating groups 
(3-Bromo/2-1e, 2-Chloro-4-Nitro/2-1f, 2,6-dichloro/2-1g, 3-B(Pin)/2-1h) without 
affecting the reaction efficiency. Thiophene-2-carboxylic acid, enoic acids and 
dienoic acid (i.e., 2-1j, 2-1k, 2-1i, 2-1l) all proceeded very smoothly to give 
corresponding enol esters.  
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Table 3. Reactions of Various Acids with 1-Hexyne or 1-Dodecyne a 
 
   
2-1b, 99%  
(65 ppm Au)  
 
2-1c, 99% 
(60 ppm Au) 
 
2-1d, 99% 
(100 ppm Au) 
 
2-1e, 99% 
(75 ppm Au) 
 
    
2-1f, 99% 
(75 ppm Au) 
 
2-1g, 99% 
(50 ppm Au) 
 
2-1h, 99% 
(150 ppm Au) 
 
2-1i, 99% 
(50 ppm Au) 
 
    
2-1j, 97% 
(100 ppm Au) 
 
2-1k, 96% 
(100 ppm Au) 
 
2-1l, 99% 
(65 ppm Au) 
 
2-1m, 99% 
(75 ppm Au) 
 
    
2-1n, 99% 
(100 ppm Au) 
 
2-1o, 98% 
(80 ppm Au) 
 
2-1p, 99%  
(10 ppm Au, 60 °C) 
 
2-1q, 99% 
(20 ppm Au) 
 
    
2-1r, 99% 
(75 ppm Au) 
2-1s, 99% 
(100 ppm Au) 
2-1t, 80% 
(600 ppm Au) 
2-1u, 99% 
(150 ppm Au) 
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a Reactions run under N2 in oven dried vial; isolated yield; NaBARF, sodium 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate. 
 
For alkyl carboxylic acids, cyclopropanecarboxylic acid, sterics-demanding 
1-adamentanecarboxylic acid, acidity-sensitive vinyl acetic acid and 2-phenoxyacetic 
acid (i.e., 2-1m, 2-1n, 2-1o, 2-1s) reacted very well. While trichloroacetic acid (2-1q) 
only required 20 ppm catalyst to finish the reaction, more acidic trifluoroacetic acid 
only necessitated 10 ppm catalyst for full conversion (2-1p), giving a catalyst TON of 
at least 99,000. The reaction of phenylglyoxylic acid gave satisfying result too (2-1r). 
Whereas the reaction of N-Boc proline leading to 2-1t require higher catalyst loading, 
the reaction of N-phthalimide phenylalanine afforded 2-1u in 99% yield with only 150 
ppm Au catalyst.  
Relatively basic N,N-dimethyl aniline motif could be also tolerated with slightly 
more gold catalyst loading, but picolinic acid did not work at all. This is a common 
limitation in Au catalysis: substrates containing basic pyridine motif are often not 
suitable for most reactions. At the same, methanesulfonic acid gave very complicated 
results. 
 
Figure 6. Other Acid Substrates 
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Table 4. Reactions of Various Alkynes with Benzoic Acid a 
 
Ph O
O
   
2-1v, 99% (100 ppm Au)  
 
 
2-1w, 95%, (300 ppm Au) 
no NaBARF, 40 °C 
 
2-1x, 98%, (120 ppm Au) 
 
 
   
2-1y, 89%, (150 ppm Au) 
 
 
2-1z, 97%, (1500 ppm Au) 
2 equiv. alkyne, 60 °C 
 
2-1aa, 99%, (1500 ppm 
Au) 
 
 
 
2-1ab, 85%, (500 ppm Au) 
2.8:1 
2-1ac, 98%, (150 ppm Au) 
  
a Reactions run under N2 in oven dried vial; isolated yield; NaBARF, sodium 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate. 
 
The scope of different alkynes was then probed using simple benzoic acid. As 
shown in  
Table 4, terminal alkynes with different functionalities and protecting groups (Cl, 
OTIPS, OBn) were all suitable substrates and the reaction yields were mostly near to 
quantitative (i.e., 2-1v, 2-1w, 2-1x, 2-1y). Notably in the case of 6-chloro-1-hexyne, 
NaBARF does not help the reaction, possibly due to the potential interaction between 
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the chloro group and sodium ion of NaBARF. In the cases of an enyne (i.e., 1z) and 
non-activated internal alkynes (i.e., 1aa and 1ab), the catalyst loadings were relatively 
high, likely due to lower reactivities of these substrates in comparison to aliphatic 
terminal alkynes; on the other hand, the activated internal alkyne ethyl 
3-phenylpropiolate reacted pretty well to give 2-1ac in 98% yield.  
In the early stage of this research, I found out an interesting outcome: when 
propargyl alcohol was subjected to the reaction condition, the reaction did not stopped 
at the point of initial formation of enol ester, and went to further giving α-benzoyloxy 
ketone 2-3 as the final product. 
 
Scheme 45. Propargyl Alcohol as the Substrate 
 
 
2.2.3. Discussion 
This dramatic increase of catalyst TON in this gold catalyzed reaction using the 
remotely amide-functionalized L10 as ligand can be attributed to the H-bonding 
between the basic amide group on the ligand and the approaching carboxylic acid. This 
interaction not only allows the reaction to happen in a quasi-intramolecular fashion and 
hence decrease the entropy loss in the transition state, but also materializes a general 
base catalysis by basic amide moiety, via which the nucleophilicity of the acid is 
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enhanced. Moreover, the protonated amide motif after the initial attack should serve as 
an intramolecular proton source for the subsequent rapid protodeauration and therefore 
accelerate turnover frequency of the catalyst.  
To authenticate this rationale and, hence, to offer theoretical support to our 
original design, density functional theory (DFT) [26,27] studies were performed with 
GAUSSIAN09 program and PBE1PBE[ 28 , 29 ] method by Dr. Yuxue Li. In the 
calculation, the ligand L10, one molecule of benzoic acid and one molecule of 
propyne were used; moreover, 6-31+G** basis set was used for the reactants, the 
NTf2- anion and the 3’-(pyrrolidin-l-ylcarbonyl) group, 6-311+G** basis set was used 
for P, 6-31G* basis set was used for other atoms in the ligand, and the SDD basis set 
with an Effective Core Potential (ECP)[30] was used for Au. Geometry optimization 
was performed in dichloroethane using the SMD[31] method. Harmonic vibration 
frequency calculations were carried out and each of the optimized transition states has 
one imaginary frequency.  
We proposed that, in the catalytic reaction with JohnPhos as the ligand, the NTf2 - 
counter anion will activate the benzoic acid and assist the proton transfer process. 
[32-34] However, in the catalytic reaction with L10 the amide group is a better 
alternative to the NTf2 - anion. To facilitate the comparison of these two scenarios, a 
reaction pathway using L10 as the ligand but without involving its 3’-amide group 
was used to mimic the case of JohnPhos.  
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Figure 7. The Optimized NTf2 - Anion Activated Transition State TS-NTf2 and 
Amide Group Activated Transition State TS-Amide. (The selected bond lengths 
are in angstroms, the relative energies Esol and free energies Gsol (in italic, 298K) 
in dichloroethane are in kcal/mol.) 
 
 
As shown in Figure 7, in the transition state TS-NTf2, the NTf2 - anion stabilize 
the proton of the benzoic acid while its carbonyl oxygen attacks the C2 of propyne; 
notably, the amide group is a bystander. In TS-Amide, the amide group stabilizes the 
proton, and the NTf2 - anion is far away from the reaction center, binding to the 
system via weak hydrogen bonds. The TS-Amide is 2.1 kcal/mol more favorable in 
free energy than TS-NTf2, consistent with the experimental observation that L10 is a 
better ligand than JohnPhos. In addition, in TS-Amide NTf2 - does not participate in 
the reaction and hence needs not to be bound. [34] Such a binding in TS-Amide causes 
rigid body translational and rotational entropy loss, which was estimated to be 3.6~4.8 
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kcal/mol for the binding of small molecules to protein.[35] Based on this estimation, 
TS-Amide should be more than 5 kcal/mol more favorable than TS-NTf2, which is in 
line with the observed 860 fold increase of the TONs as the estimated energy barrier 
difference is around 4.7 kcal/mol if the TON difference is treated as the rate 
difference. These theoretical studies corroborate that the basic amide group and the 
intramolecular nature of the reaction are critical for the much improved TONs. 
 
2.2.4. Scope of Nucleophiles and Synthetic Applications 
Besides carboxylic acids, the remote amide group in L10 can also facilitate 
nucleophilic attack by H2O, resulting in substantially accelerated hydration of alkynes. 
As shown in Table 5, when the reaction was performed in toluene, a non-polar solvent 
which probably helps the formation of the H-bonding between the reacting partners, 
with only 2.5 equivalents of H2O existing in the reaction, L10 turned out to be a much 
more effective ligand than the non-functionalized 2-biphenyphosphine ligand 
JohnPhos and the NHC ligand IPr; the same trend was observed with methanol serving 
as the solvent, and notably without optimization the hydration was easily accomplished 
with 100 ppm of L10AuNTf2 and a catalyst TON of at least 10,000. Remarkably 
IPrAu(I), which was utilized in hydration of alkynes with ppm catalyst loading at very 
high temperature (120 °C), presented much lower activity at lower temperature (80 °C).  
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Table 5. Gold-Catalyzed Hydration of Alkyne  
 
a NMR yields using diethyl phthalate as the internal reference 
 
To further validate the generality of this ligand with remote amide group, 
hydroamination of alkynes with aniline was performed. As shown in Scheme 46, using 
L10AuNTf2 as the catalyst, its turnover number with phenylacetylene as the substrate 
reached 8500, a nevertheless pleasing number even though lower than that (i.e., 22000) 
achieved by the best catalyst developed by LaVallo;[3] however, with 1-dodecyne as the 
substrate, L10AuNTf2 was a much better catalyst than the one by LaVallo as its TON 
reached 3900 while a TON of 435 is reported in the latter case with a similar 1-hexyne 
as the substrate. These results achieved from both hydration and hydroamination of 
alkynes again highlight the essential role of the remote amide group, and more 
importantly suggest that the design principle is general and flexible enough to be 
applicable to other transformations.  
 
catalyst 
yielda/TON 
R = n-decyl, [Au] (500 ppm), 
toluene (0.25 x n mL), 5 h 
R = n-butyl, [Au] (100 ppm), 
MeOH (0.3 x n mL), 6 h 
JohnPhosAuNTf2 8%/160 44%/4400 
IPrAuNTf2 9%/180 69%/6900 
L10AuNTf2 38%/760 100%/10000 
68 
 
Scheme 46. Gold-Catalyzed Hydroamination of Alkynes 
NH2
Ph (1.2 equiv)
(1.2 equiv)Me
9
L10AuNTf2 (100 ppm)NaBARF (0.16 %)
80 °C, DCE (2 M), 18 h
Ph N
PhMe
85% yield
TON: 8500
Ph N
Me Me9
39% yield
TON: 3900
 
 
The synthetic utility of this chemistry is firstly exemplified by a two-step, high 
yielding synthesis of amides (Scheme 47-A), where the gold catalysis offered mild 
activation of carboxylic acids in a highly efficient manner. For the most part, 
amide-forming reactions involve “activating” the carboxylic acid and the best known 
method is the Schotten-Baumann reaction, which need convert the acids to acid 
chlorides first; toxic and corrosive thionyl chloride or oxalyl chloride is required. In the 
second step, more than one equivalent base has to be used to quench the hydrochloric 
acid generated during the reaction. None of above is following the principles of green 
chemistry, which is becoming more and more important in the future development of 
society. The other well-known way, DCC coupling, however, often suffered from the 
one equivalent waste produced during the process, which also increase the difficulty of 
isolation at the same time. Now I could start from carboxylic acids, generating enol 
esters very efficiently with ultra-low catalyst loading without purification in many 
cases, and then react with amines to afford corresponding amides with non-toxic, 
volatile and easily removed ketone as the only by-product. Moreover, the fact that the 
above two-step, one-pot reaction can be run in high concentration (2M for the first step 
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and no solvent for the second step), which significantly decreases the usage of organic 
solvents, also makes this synthetic sequence more interesting and attractive. 
 
Scheme 47. Application in Amide and Ester Synthesis a 
 
a Isolated yields. NaBARF, sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate; DCE, 
1,2-dichloroethane. 
 
In addition to amide synthesis, I wondered whether esters could be synthesized in 
the same way. Much to my delight, the above two-step/one-pot synthetic route also 
applied well to the synthesis of ester: with little optimization, the corresponding ethyl 
ester was formed in 84% overall yield. 5 mol % Lewis acid Sc(OTf)3 was necessitated 
for the second step and ten equivalents of ethanol needed to be used to obtain decent 
yield (Scheme 47-B). Again, this synthetic sequence stands a green and mild way to 
couple carboxylic acid and alcohol.  
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2.2.5. Conclusion 
In summary, a novel ligand design that could dramatically improve the turnover 
frequency of gold catalysis has been successfully realized based on the privileged 
biphenylphosphine platform. It engages functional groups at the remote 3’ position to 
direct and promote the anti attack of natural nucleophiles to the gold-activated alkynes, 
which is unprecedented in homogeneous gold catalysis, especially considering the 
spatial challenge of using ligand to reach anti-approaching nucleophile in a linear 
L-Au-alkyne centroid structure. With a basic, H-bond accepting 
(pyrrolidin-1-yl)carbonyl group at the 3’ position, the gold(I) complex derived from the 
biphenylphosphine ligand becomes highly efficient in catalyzing acid addition to 
alkynes, with its TON up to 99,000. DFT calculations support the role of the amide 
moiety in directing the attack of carboxylic acid via H-bonding. Further applications of 
this catalyst to hydration and hydroamination of alkynes likewise realized high catalyst 
TONs, therefore confirming the general applicability of this ligand design. We 
anticipated that this design and the general principle of engaging bonding interactions 
between ligand and reactants could be employed to substantially improve an array of 
other gold catalyses, thereby promoting the application of gold chemistry in industrial 
scale processes, and might also be useful for improving catalysis by other transition 
metals. 
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2.3. Other Ligand-Promoted Interesting Transformations 
During the process of ligand design, I also prepared the following ligands (Figure 
8) and some of them do provide very exciting activities.  
 
Figure 8. Other New Interesting Ligands 
 
 
2.3.1. Acid Addition: Results of L11/L12Au(I)  
It’s known that bulky NHC ligand IPr provides incredible thermal stability for 
gold catalyst, so L11, a new type of carbene ligand with remote 3’-amide as the 
directing group, was prepared to achieve both stability and reactivity. Although a 
TON of 700 (Table 6, entry 1)was obtained for L11Au(I) for catalyzing acid addition 
to the alkyne, which was much better compared with IPr (TON of 0.5 at 40 °C), the 
catalyst is still not as good as L10Au(I) presumably due to the following two 
reactions: 1) carbene ligand is more electron-rich, which makes the corresponding 
gold catalyst less cationic and reactive; 2) the liner carbene-Au-alkyne axis is aligning 
far away from instead of paralleling to the pendant phenyl ring of L11Au(I), as a 
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result of which, the Au-activated alkyne might be more difficult to reach when the 
amide directs the acid to attack.  
Compared with JohnPhosAu(I), which gave trace product under same condition, 
L12Au(I) afforded 23% yield with a TON of 23 (Table 6, entry 2), further confirming 
the directing effect of the functional group on the ortho phenyl ring, although the 
position of the carbonyl group on L12 was probably not ideal. 
 
Table 6. Other Ligand Effect for Acid Addition 
 
entry [Au] solvent, temperature, conc. time 
NMR yield a 
1a TON 2a 
1 L11AuCl/AgNTf2 (0.11%/0.1%) DCE, 80 ˚C, 1 M 19 h 70% 700 3% 
2 L12AuCl/AgNTf2 (1.1%/1%) DCE, 40 ˚C, 0.5 M 6 h 23% 23 38%
a The NMR yield is calculated by assuming that the triplet at around 0.9 ppm corresponds to the 
terminal methyl groups of all compounds derived from 2-dodecyne. 
 
2.3.2. Alcohol Addition 
Alkenyl ethers are versatile building blocks in organic synthesis and they are 
supposed be easy to obtain by the alcohol addition to alkyne under gold catalysis. 
However, as Teles et al.[36] reported in 1998, after the first alcohol addition, it was 
rather difficult to stop the reaction at the alkenyl ether stage and hence the second 
alcohol came to attack, gives the ketal as the final product. Again, by ligand design, a 
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breakthrough has been made in this area (Scheme 48). L13 features a sulfonate 
functional group at 5’ position, and the methoxy group at 2’ position is for the easy 
installation and basicity enhancement of the sulfonate group. Its corresponding gold 
catalyst afforded the desired alkenyl methyl ether 2-4 in 86% NMR yield with 0.55 
mol % loading after 3 h when 6-dodecyne was the substrate. Once the alkyne 
switched to terminal alkyne, unfortunately, ketal was the only product ever observed 
and quantitative yield was obtained at room temperature after 1 h even excess alkyne 
was used. It means more engineering work needs to be done about L13.  
 
Scheme 48. Ligand Controlled Alcohol Addition to Alkyne 
 
 
2.3.3. Alkyne Isomerization 
Zhixun Wang recently found out that terminal alkyne 2-5 could isomerize to give 
55% allene 2-6, 12% internal alkyne 2-6’ with 19% staring material left when 
3’-amino L4Au(I) was used in the reaction (Scheme 49-A). To increase the acidity of 
Au and basicity of amino group, I prepared L14, the enhanced version of L4. The 
structure of the ligand L14 is confirmed by the X-ray diffraction study of its gold 
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complex L14AuCl (Figure 9), whose single crystal was grown in a mixture solvents of 
methylene chloride and acetonitrile. 
 
Scheme 49. Ligand Promoted Gold Catalyzed Alkyne Isomerization 
Ph
Me L14AuCl/NaBARF (2/10 mol %) Ph MePhCF3, 60 °C, 12 h
2-8, 89% yield
•
Me+
L4AuCl/NaBARF
(5/10 mol %)
2-5 2-6, 55% 2-6', 12%
BnO BnODCE, 60 °C, 12 h
BnO +  2-5
19%
A
B
2-7  
 
Figure 9. The ORTEP Drawing of L14AuCl at 50% Ellipsoid Probability 
 
 
By using L14AuCl and NaBARF, we found out aryl internal alkynes 2-7 easily 
isomerized to afford 1,3-diene 2-8 in 89% isolated yield, which is very impressive. To 
explain this unusual reactivity, we proposed a mechanism in Figure 10 using 2-7 as the 
substrate: the coordination of alkyne 2-7 to L14Au+, as shown in the structure 2-7A, 
would force one of the propargylic hydrogen (shown in bold and colored) close to the 
basic aniline nitrogen and moreover, the C–H bond more or less parallel to π* and 
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hence perpendicular to the Au-alkyne centroid; With the concerted ‘pull’ by cationic 
gold and ‘push’ by the ideally aligned nitrogen, propargylic deprotonation would occur 
even with such a weak base (pKa in DMSO ~ 4). The resulting allenylgold intermediate 
2-7B could undergo ipso-protodeauration to deliver the gold allene complex 2-7C. It is 
notable that the aniline nitrogen serves as an intramolecular proton shuttle in these two 
steps. If the allene substituents could stabilize a developing carbocation, it is 
conceivable that an equilibrium between 2-7C and a gold-substituted allylic cation (i.e., 
2-7D) would be established. The latter structure would place a C–H bond, which is α to 
the allyl cation moiety (shown in bold and colored), near the aniline nitrogen once 
again. A consequential intramolecular deprotonation would then afford the dienylgold 
complex 2-7E, which could undergo internal ipso-protodeauration to afford the diene 
product 2-8 and regenerate the catalyst L14Au+.  
During the mechanistic study, I found out an interesting phenomenon: when the 
substrate is allene, by using different catalysts, it could isomerize to different dienes 
(Scheme 50). When 3’-amino L14Au(I) was used, allene 2-9 was converted to 
terminal diene 2-10 in very high yield even at room temperature after 4.5 h, while 
4’-amino L1Au(I) provided a different product, internal diene 2-11 in 20% yield with 
70% starting material left after the same reaction time. More mechanistic study is on 
the way in our lab. 
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Figure 10. Proposed Mechanism for Alkyne Isomerization 
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Scheme 50. Ligand Effect on Allene Isomerization 
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2.4. Experimental Section 
General. Ethyl acetate (ACS grade), hexanes (ACS grade), diethyl ether (ACS grade), 
were purchased from Fisher Scientific and used without further purification. 
Anhydrous 1,2-dichloroethane were bought from Acros and used directly. 
Fluorobenzene was purchased from Synquest Labs, Inc and distilled over P2O5 before 
use. Most commercially available carboxylic acids below 99.5% purify were 
recrystallized from distilled Fluorobenzene, and all commercially available alkynes 
were distilled over NaBH4 before use. NaBARF was purchased from Synquest Labs 
and dried by heating to 100 °C under high vacuum for overnight. Reactions were 
monitored by thin layer chromatography (TLC) using Silicycle precoated silica gel 
plates. Flash column chromatography was performed over Silicycle silica gel 
(230-400 mesh). 1H NMR and 13C NMR spectra were recorded on a Varian 500/600 
MHz Unity plus spectrometer and a Varian 400 MHz spectrometer using residue 
solvent peaks as internal standards (CDCl3, 1H: 7.26 ppm; 13C: 77.00 ppm). Infrared 
spectra were recorded with a Perkin Elmer FT-IR spectrum 2000 spectrometer and are 
reported in reciprocal centimeter (cm-1). Mass spectra were recorded Micromass 
QTOF2 Quadrupole/Time-of-Flight Tandem mass spectrometer by electrospray 
method. 
 
General Procedure A: Synthesis of Ligands and Catalysts 
As shown in Scheme 51, to a dispersion of 10 mmol 3-iodobenzoic acid (1 equiv) 
in 50 mL dry CH2Cl2 was added 25 mmol oxalyl chloride (2.5 equiv) and three drops 
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of DMF, and the mixture was stirred for 2 - 4 h at room temperature. The reaction 
mixture was evaporated under reduced pressure and dried under vacuum to yield 
3-iodobenzoyl chloride, which was dissolved in 50 mL dry CH2Cl2 again and cooled 
in an ice bath. A 10 mL CH2Cl2 solution containing 15 mmol amine (1.5 equiv) and 
20 mmol Et3N (2 equiv) was then added and the reaction mixture was stirred at room 
temperature under a nitrogen atmosphere. After 1 h, the solution was treated with 50 
mL water and 100 mL DCM, and the organic phase was separated, dried, evaporated, 
and then purified by column chromatography to yield compound L-A in 90 - 95% 
yield.  
 
Scheme 51. General Procedure for Synthesis of Ligands and Catalysts a 
 
a DMF, N, N-dimethylformamide; DCM, dichloromethane; Dippf, 
bis(diisopropylphosphinyl)ferrocene; Tol, toluene; DMS, dimethylsulfide. 
 
A mixture of 8 mmol L-A (1 equiv), 8.8 mmol 2-bromophenylboronic acid (1.1 
equiv) and 24 mmol Et3N (3 equiv) in 40 mL DMF was stirred and bubbled with N2 
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gas for 15 minutes, and then 0.4 mmol Pd(PPh3)4 (5 mol %) was added; the reaction 
mixture was heated at 90 °C for 4 - 8 h under nitrogen atmosphere. Once TLC 
indicated A was completely consumed, the reaction was diluted with 500 mL Et2O 
and washed with water to remove DMF. Then the organic layer was dried over 
MgSO4, filtrated, evaporated, and then purified by column chromatography to yield 
product L-B in 85 - 92% yield. 
Under nitrogen atmosphere 2 mmol L-B (1 equiv), 0.1 mmol Pd(OAc)2 (5 
mol%), 0.12 mmol DiPPF (1,1'-bis(diisopropylphosphino)ferrocene, 6 mol%), 2.4 
mmol NaOt-Bu (1.2 equiv) and 5 mL dry Toluene were added to a flamed dried 
Schlenk flask and the resulting suspension was stirred until apparently homogeneous 
(around 15 min). Added 2.2 mmol di(1-adamantyl)phosphine (1.1 equiv), the flask 
was heated at 110 °C in oil bath for 12 h, which then was cooled to room temperature, 
and purified by column chromatography without work-up to yield the final ligand L 
in 60 – 80% yield. 
To a suspension of 1 mmol ligand L in 5 mL anhydrous DCM was added 
chloro(dimethylsulfide)gold(I) (294.5 mg, 1 mmol). The mixture was stirred for 30 
min at room temperature and the solvent was evaporated off under reduced pressure 
to give the desired gold complex LAuCl in quantitative yield. 
To a solution of 0.8 mmol ligand L in 4 mL anhydrous DCM was added Silver 
bis(trifluoromethanesulfonyl)imide (309 mg, 0.8 mmol). The mixture was stirred for 
20 min at room temperature and the precipitating silver chloride was filtered. The 
solvent was evaporated off under reduced pressure to give the desired gold complex 
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LAuNTf2 in quantitative yield. 
 
General Procedure B: Preparation of Enol Esters 
R OH
O
R1
L10AuNTf2
NaBArF,PhF (2 M), 
80 C, 12 - 24 h
+ R O
O
R1
2-1
R2
H
R2
v 
In a sealed 1 dr reaction vial equipped with a magnetic stirring bar, 3 mmol 
carboxylic acids (1 equiv), 4.4 mmol 1-hexyne (1.45 equiv) or 3.6 mmol other 
alkynes (1.2 equiv) and 3.1 mg NaBARF (1200 ppm) were added to 0.6 mL 
fluorobenzene. L10AuNTf2 (50 μL of a 3.09 mg/mL solution in PhF, 0.150 μmol, 50 
ppm) was added to the above vial and then the reaction mixture was heated at 80 ºC 
for 12 - 24 h. Once the reaction finished by TLC, it was concentrated and left on the 
high vacuum pump for overnight to give the NMR pure product. If crude NMR was 
not pure, the residue was further purified through silica gel flash chromatography to 
give the desired product. 
 
General Procedure C: One-pot Sequence Preparation of Amides  
 
In a sealed 1 dr reaction vial equipped with a magnetic stirring bar, 3 mmol 
carboxylic acids (1 equiv), 4.4 mmol 1-hexyne (1.45 equiv) and 3.1 mg NaBARF 
(1200 ppm) were added to 0.6 mL fluorobenzene. L10AuNTf2 (50 μL of a 3.09 
mg/mL solution in PhF, 0.150 μmol, 50 ppm or 100 μL, 100 ppm) was added to the 
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above vial and then the reaction mixture was heated at 80 ºC for 12 - 18 h. Once the 
reaction finished by TLC, it was concentrated and left on the high vacuum pump for 
overnight to give the crude product, followed by adding 3.6 mmol amine (1.2 equiv) 
and stirring at 100 ºC for 6 - 24 h. Once the reaction completed by TLC, the mixture 
was purified through silica gel flash chromatography (eluents: ethyl acetate: hexanes 
= 1: 3) to give the desired product. 
 
L1 
Scheme 52 Synthesis of Aniline Ligand L1 
 
4-Bromo-N,N-dimethylaniline L1b was prepared according to the literature 
procedure[ 37 ] and biaryl compound L1c was obtained by using same literature 
procedure.[38] Ligand L1 was then synthesized in 67% yield through general procedure 
A, step 3. 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 7.6 Hz, 1H), 7.35 (t, J = 7.3 Hz, 
1H), 7.31 – 7.23 (m, 2H), 7.13 (d, J = 8.4 Hz, 2H), 6.75 – 6.70 (m, 2H), 3.00 (s, 6H), 
1.90 (q, J = 12.2 Hz, 18H), 1.66 (s, 12H). 13C NMR (125 MHz, CDCl3) δ 152.00 (d, J = 
32.1 Hz), 148.83, 136.62 (d, J = 2.9 Hz), 133.19 (d, J = 26.3 Hz), 132.23 (d, J = 7.1 Hz), 
131.29 (d, J = 3.9 Hz), 131.06 (d, J = 6.0 Hz), 128.08, 124.62, 111.21, 41.88 (d, J = 13.1 
Hz), 40.52, 37.28 (d, J = 25.9 Hz), 36.97, 28.86 (d, J = 8.5 Hz). 31P NMR (162 MHz, 
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CDCl3) δ 22.35 IR (neat): 3047, 2902, 2847, 1612, 1522, 1450, 1343, 1301, 1224, 
1194, 1166, 1047, 970, 947, 814, 768, 743; HRMS ESI (m/z): [MH]+ calcd. for 
C34H45NP, 498.3290; found, 498.3280. 
L1AuCl 
 
Au complex L1AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (600 MHz, CDCl3) 7.83 (t, J = 7.5 Hz, 1H), 7.46 (dt, J 
= 23.5, 7.6 Hz, 2H), 7.36 – 7.29 (m, 1H), 6.97 (d, J = 8.1 Hz, 2H), 6.87 (s, 2H), 3.05 
(s, 6H), 2.24 – 2.05 (m, 12H), 1.98 (s, 6H), 1.67 (s, 12H). 13C NMR (150 MHz, CDCl3) 
δ 151.06, 134.35, 133.85 (d, J = 7.7 Hz), 130.27, 129.90, 129.66 (d, J = 7.8 Hz), 
125.94 (d, J = 6.5 Hz), 124.12 (d, J = 45.1 Hz), 113.37 (d, J = 61.3 Hz), 42.45 (d, J = 
23.5 Hz), 42.09 (d, J = 2.5 Hz), 36.25, 28.57 (d, J = 9.8 Hz). 31P NMR (162 MHz, 
CDCl3) δ 62.87. IR (neat): 2904, 2849, 2798, 1611, 1523, 1448, 1347, 1301, 1223, 
1166, 1126, 1045, 972, 913, 815, 773, 744; HRMS ESI (m/z): [MNa]+ calcd. for 
C34H45AuClNPNa, 752.2463; found, 752.2448. 
L3 
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Ligand L3 was synthesized through general procedure A. 1H NMR (500 MHz, CDCl3) 
δ 7.89 (d, J = 7.5 Hz, 1H), 7.40 – 7.31 (m, 4H), 7.26 (t, J = 3.9 Hz, 3H), 7.22 (ddd, J 
= 7.3, 4.0, 1.7 Hz, 1H), 3.72 (bs, 2H), 3.47 (bs, 2H), 1.85 (q, J = 12.7 Hz, 18H), 1.67 
(m, 18 H). 13C NMR (125 MHz, CDCl3) δ 170.57, 150.98 (d, J = 32.7 Hz), 145.27 (d, 
J = 6.9 Hz), 136.62 (d, J = 2.6 Hz), 133.78, 133.11 (d, J = 29.0 Hz), 130.68 (d, J = 4.1 
Hz), 130.50 (d, J = 6.2 Hz), 128.19, 125.94, 125.53, 48.84, 43.26, 41.80 (d, J = 13.0 
Hz), 37.34 (d, J = 26.2 Hz), 36.89, 28.78 (d, J = 8.6 Hz), 26.53, 25.72, 24.67. 31P 
NMR (162 MHz, CDCl3) δ 20.64. IR (neat): 2911, 2861, 1627, 1443, 1347, 1274, 
1157, 1023, 751; HRMS ESI (m/z): [MNa]+ calcd. for C38H48NOPNa, 588.3371; 
found, 588.3395. 
L3AuCl 
 
Au complex L3AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (600 MHz, CDCl3) δ 7.89 – 7.84 (m, 1H), 7.50 (d, J = 
7.7 Hz, 4H), 7.16 (t, J = 7.5 Hz, 3H), 4.05 – 3.60 (m, 4H), 2.26 – 2.09 (m, 12H), 2.01 
(s, 6H), 1.69 (s, 18H). 13C NMR (125 MHz, CDCl3) δ 169.85, 150.07 (d, J = 13.0 Hz), 
143.89 (d, J = 6.3 Hz), 136.25, 134.36 (d, J = 2.3 Hz), 133.94 (d, J = 7.5 Hz), 130.48 
(d, J = 2.3 Hz), 129.68, 127.68, 126.44 (d, J = 6.4 Hz), 123.03 (d, J = 43.5 Hz), 49.77, 
43.41, 42.66 (d, J = 23.9 Hz), 42.13 (d, J = 2.5 Hz) , 36.23, 28.57 (d, J = 9.8 Hz), 
36.97, 25.78, 24.74. 31P NMR (162 MHz, CDCl3) δ 62.19. IR (neat): 2911, 2851, 
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1627, 1443, 1347, 1274, 1157, 1023, 751; HRMS ESI (m/z): [MNa]+ calcd. for 
38H48AuClNNaOP, 820.2725; found, 820.2709. 
L4 
 
1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.40 – 7.27 (m, 3H), 7.24 – 
7.18 (m, 1H), 6.74 – 6.67 (m, 1H), 6.62 – 6.55 (m, 2H), 2.95 (s, 6H), 1.90 (q, J = 12.2 
Hz, 18H), 1.65 (s, 12H).). 13C NMR (125 MHz, CDCl3) δ 152.63 (d, J = 32.5 Hz), 
149.27, 144.77 (d, J = 7.5 Hz), 136.45 (J = 3.8 Hz), 133.10 (d, J = 26.3 Hz), 130.41 (d, 
J = 6.2 Hz), 127.96, 127.70, 125.08, 119.16 (d, J = 3.0 Hz), 115.72 (d, J = 3.6 Hz), 
110.65, 42.00, 41.95 (d, J = 13.1 Hz), 37.18 (d, J = 26.0 Hz), 36.98, 28.87 (d, J = 8.5 
Hz). 31P NMR (162 MHz, CDCl3) δ 22.26. IR (neat): 2901, 2847, 1602, 1584, 1498, 
1449, 1343, 1301, 1047, 991, 955, 762, 743; HRMS ESI (m/z): [MNa]+ calcd. for 
C34H44NPNa, 520.3109; found, 520.3088. 
L4AuCl 
 
Au complex L4AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (600 MHz, CDCl3) δ 7.84 (t, J = 7.6 Hz, 1H), 7.48 (dt, 
J = 21.5, 7.4 Hz, 2H), 7.37 – 7.33 (m, 1H), 7.28 (bs, 1H), 6.93 (bs, 1H), 6.60 – 6.30 
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(m, 2H), 3.01 (s, 6H), 2.27 – 2.05 (m, 12H), 1.98 (d, J = 21.1 Hz, 6H), 1.67 (d, J = 
20.9 Hz, 12H).13C NMR (125 MHz, CDCl3) δ 151.42, 142.81, 134.24 (d, J = 2.3 Hz), 
133.12 (d, J = 7.3 Hz), 130.17, 129.14, 125.95 (d, J = 6.2 Hz), 123.90, 123.55, 117.48, 
113.95, 112.69, 42.31 (d, J = 45.5, 45 Hz), 42.14 (dd, J = 45.5, 2.7 Hz), 40.84, 36.28 
(d, J = 8.2 Hz), 28.58 (dd, J1 = J2 = 9.9 Hz). 31P NMR (162 MHz, CDCl3) δ 62.61. IR 
(neat): 2904, 2849, 2803, 1600, 1585, 1500, 1450, 1431, 1355, 1344, 1301, 1260, 
1178, 1163, 1124, 1045, 990, 972, 842, 770, 733; HRMS ESI (m/z): [MNa]+ calcd. for 
C34H44AuClNPNa, 754.2463; found, 754.2451. 
L6 
 
Ligand L6 was synthesized through general procedure A. 1H NMR (500 MHz, CDCl3) 
δ 7.91 – 7.84 (m, 1H), 7.41 – 7.31 (m, 4H), 7.29 (ddd, J = 7.3, 2.6, 1.6 Hz, 1H), 7.26 – 
7.23 (m, 1H), 7.20 (d, J = 1.6 Hz, 1H), 3.71 (s, 2H), 3.47 (s, 2H), 1.85 (q, J = 11.9 Hz, 
18H), 1.69 – 1.39 (m, 18H).13C NMR (125 MHz, CDCl3) δ 170.52, 150.92 (d, J = 32.3 
Hz), 143.70 (d, J = 7.1 Hz), 136.53 (d, J = 2.6 Hz), 135.31, 132.92 (d, J = 27.9 Hz), 
132.10 (d, J = 4.7 Hz), 130.58 (d, J = 6.1 Hz), 128.41 (d, J = 3.1 Hz), 128.37 (d, J = 1.1 
Hz), 127.29, 125.65, 125.02, 48.95, 43.12, 41.89 (d, J = 12.9 Hz), 37.41 (d, J = 25.5 
Hz), 36.91, 28.79 (d, J = 8.6 Hz), 26.68, 25.62, 24.63. 31P NMR (162 MHz, CDCl3) δ 
21.12. IR (neat): 2901, 2847, 1630, 1443, 1343, 1300, 1265, 1228, 1110, 1026, 1002, 
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970, 907, 826, 809, 765, 731; HRMS ESI (m/z): [MNa]+ calcd. for C38H48NOPNa, 
588.3371; found, 588.3361. 
L6AuCl 
 
Au complex L6AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (600 MHz, CDCl3) δ 7.88 – 7.82 (m, 1H), 7.55 (d, J = 
7.8 Hz, 1H), 7.52 – 7.45 (m, 3H), 7.31 – 7.27 (m, 1H), 7.14 (d, J = 7.6 Hz, 1H), 7.11 
(s, 1H), 3.86 – 3.53 (m, 4H), 2.28 – 1.91 (m, 18H), 1.84 – 1.42 (m, 18H). 13C NMR 
(125 MHz, CDCl3) δ 170.05, 149.81 (d, J = 12.9 Hz), 142.54 (d, J = 6.6 Hz), 136.66, 
134.29, 134.27, 133.57 (d, J = 7.3 Hz), 130.50 (d, J = 2.2 Hz), 130.35, 129.05, 127.38, 
126.70, 126.53 (d, J = 6.6 Hz), 123.49 (d, J = 43.9 Hz), 49.33, 43.16, 42.61 (J = 37.5 
Hz, 23.8 Hz), 42.16 (dd, J = 55.0, 2.6 Hz) 36.25, 36.23, 36.22, 28.54 (dd, J = 15.1, 9.8 
Hz),26.78, 25.75, 24.66. 31P NMR (162 MHz, CDCl3) δ 62.26. IR (neat): 2906, 2851, 
2231, 1625, 1444, 1344, 1301, 1253, 1228, 1109, 1042, 1002, 972, 915, 852, 804, 772, 
729; HRMS ESI (m/z): [MNa]+ calcd. C38H48AuClNNaOP, 820.2725; found, 
820.2717. 
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L7 
 
Ligand L7 was synthesized through general procedure A. 1H NMR (500 MHz, CDCl3) 
δ 1H NMR (500 MHz, CDCl3) δ 7.88 (dd, J = 5.2, 3.7 Hz, 1H), 7.45 – 7.33 (m, 4H), 
7.31 – 7.27 (m, 1H), 7.25 – 7.19 (m, 2H), 3.86 – 3.39 (m, 8H), 1.84 (dd, J = 29.2, 9.6 
Hz, 18H), 1.64 (q, J = 12.6 Hz, 12H). 13C NMR (125 MHz, CDCl3) δ 170.64, 150.66 
(d, J = 32.2 Hz), 143.89 (d, J = 7.1 Hz), 136.54 (d, J = 2.7 Hz), 134.04, 132.87 (d, J = 
27.6 Hz), 132.44 (d, J = 4.1 Hz), 130.54 (d, J = 6.1 Hz), 128.71 (d, J = 3.8 Hz), 
128.44 (d, J = 1.1 Hz), 127.62, 125.81, 125.33, 67.02, 48.51, 42.48, 41.92 (d, J = 12.8 
Hz), 37.43 (d, J = 25.2 Hz), 36.89, 28.76 (d, J = 8.6 Hz). 31P NMR (162 MHz, CDCl3) 
δ 21.17. IR (neat): 2902, 2848, 1639, 1450, 1301, 1273, 1166, 1115, 1018, 807, 743; 
HRMS ESI (m/z): [MNa]+ calcd. for C37H46NO2PNa, 590.3164; found, 590.3174. 
L7AuCl 
 
Au complex L7AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (600 MHz, CDCl3) δ 7.88 – 7.84 (m, 1H), 7.57 (d, J = 
7.8 Hz, 1H), 7.54 – 7.46 (m, 3H), 7.30 – 7.26 (m, 1H), 7.18 – 7.10 (m, 2H), 4.03 – 
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3.48 (m, 8H), 2.27 – 2.13 (m, 6H), 2.04 (dd, J = 44.5, 13.8 Hz, 12H), 1.75 – 1.59 (m, 
12H). 13C NMR (150 MHz, CDCl3) δ 170.11, 149.56 (d, J = 12.9 Hz), 142.81 (d, J = 
6.4 Hz), 135.49, 134.32, 133.53 (d, J = 7.3 Hz), 130.82, 130.57 (d, J = 2.1 Hz), 
129.11, 127.69, 127.07, 126.66 (d, J = 6.6 Hz), 123.48 (d, J = 43.8 Hz), 67.55, 66.88, 
48.80, 48.67, 42.65 (dd, J = 30.6, 23.7 Hz), 42.19 (d, J = 45.5 Hz), 36.23 (d, J = 8.0 
Hz), 28.52 (dd, J = 16.5, 9.8 Hz). 31P NMR (162 MHz, CDCl3) δ 62.31. IR (neat): 
2908, 2851, 1738, 1634, 1460, 1347, 1302, 1264, 1157, 1114, 1045, 799, 748; HRMS 
ESI (m/z): [MNa]+ calcd. for C37H46AuClNNaO2P, 822.2518; found, 822.2507. 
L8 
 
Ligand L8 was synthesized through general procedure A. 1H NMR (500 MHz, CDCl3) 
δ 7.88 (d, J = 7.5 Hz, 1H), 7.41 – 7.33 (m, 3H), 7.33 – 7.25 (m, 3H), 7.22 (s, 1H), 3.49 
(m, 4H), 1.96 – 1.78 (m, 18H), 1.70 – 1.52 (m, 12H), 1.36 – 0.98 (m, 6H). 13C NMR 
(125 MHz, CDCl3) δ 171.46, 150.89 (d, J = 32.1 Hz), 143.63 (d, J = 7.0 Hz), 136.54 (d, 
J = 2.6 Hz), 135.91, 132.90 (d, J = 28.0 Hz), 131.67 (d, J = 4.4 Hz), 130.56 (d, J = 6.1 
Hz), 128.50 (d, J = 3.9 Hz), 128.40 (d, J = 1.0 Hz), 127.23, 125.63, 124.31, 43.36, 41.88 
(d, J = 12.9 Hz), 39.12, 37.39 (d, J = 25.7 Hz), 36.89, 28.76 (d, J = 8.6 Hz), 14.28, 
12.97. 31P NMR (162 MHz, CDCl3) δ 21.01. IR (neat): 2902, 2847, 1635, 1449, 1345, 
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1303, 1218, 1100, 970, 767, 731; HRMS ESI (m/z): [MNa]+ calcd. for C37H48NOPNa, 
576.3371; found, 576.3395. 
L8AuCl 
 
Au complex L8AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (500 MHz, CDCl3) δ 7.90 – 7.79 (m, 1H), 7.54 – 7.44 
(m, 4H), 7.32 (dd, J = 9.1, 4.3 Hz, 1H), 7.16 (d, J = 7.4 Hz, 1H), 7.11 (s, 1H), 3.84 – 
3.29 (m, 4H), 2.34 – 2.16 (m, 6H), 2.16 – 1.93 (m, 12H), 1.78 – 1.52 (m, 12H), 1.18 
(dt, J = 45.6, 7.0 Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 171.17, 149.86 (d, J = 12.6 
Hz), 142.68 (d, J = 6.3 Hz), 137.60, 134.29 (d, J = 2.3 Hz), 133.71 (d, J = 7.4 Hz), 
130.53 (d, J = 2.3 Hz), 130.23, 129.01, 127.00, 126.51 (d, J = 6.6 Hz), 126.00, 123.46 
(d, J = 43.8 Hz), 43.62, 42.61 (dd, J = 46.3, 23.6 Hz), 42.18 (dd, J = 60.1, 2.6 Hz) 
39.13, 36.24, 28.54 (dd, J = 17.8, 9.8 Hz) 14.54, 12.86. 31P NMR (162 MHz, CDCl3) 
δ 62.36. IR (neat): 2908, 2851, 1629, 1451, 1346, 1302, 1159, 1071, 1046, 771, 747; 
HRMS ESI (m/z): [MNa]+ calcd. for C37H48AuClNNaOP, 808.2725; found, 808.2700. 
L9 
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Ligand L9 was synthesized through general procedure A. 1H NMR (500 MHz, CDCl3) 
δ 7.89 (d, J = 7.5 Hz, 1H), 7.41 – 7.31 (m, 3H), 7.31 – 7.26 (m, 2H), 7.22 (dt, J = 7.4, 1.4 
Hz, 1H), 7.17 (t, J = 1.5 Hz, 1H), 4.2 – 3.2  (m, 2H), 1.94 – 1.78 (m, 18H), 1.70 – 1.59 
(m, 12H), 1.59 – 0.9 (m, 12H). 13C NMR (125 MHz, CDCl3) δ 171.24, 151.01 (d, J = 
32.1 Hz), 143.90 (d, J = 6.9 Hz), 137.85, 136.58 (d, J = 2.7 Hz), 132.76 (d, J = 27.9 Hz), 
131.57 (d, J = 5.3 Hz), 130.78 (d, J = 6.2 Hz), 128.38 (d, J = 1.1 Hz), 127.43 (d, J = 2.6 
Hz), 126.95, 125.54, 123.40, 50.72, 45.91, 41.89 (d, J = 12.9 Hz), 37.41 (d, J = 25.6 
Hz), 36.90, 28.80 (d, J = 8.6 Hz), 20.79. 31P NMR (162 MHz, CDCl3) δ 21.17. IR 
(neat): 2905, 2849, 1738, 1634, 1445, 1373, 1340, 1212, 1158, 1041, 768; HRMS ESI 
(m/z): [MNa]+ calcd. for C39H52NOPNa, 604.3684; found, 604.3694. 
L9AuCl 
 
Au complex L9AuCl was obtained in quantitative yield according to general 
procedure A, step 4. 1H NMR (600 MHz, CDCl3) δ 7.84 (t, J = 7.9 Hz, 1H), 7.50 (q, J 
= 6.0, 4.2 Hz, 2H), 7.47 – 7.41 (m, 2H), 7.31 (t, J = 5.1 Hz, 1H), 7.12 (d, J = 7.0 Hz, 
1H), 7.02 (s, 1H), 4.53 (bs, 1H), 3.49 (bs, 1H), 2.29 – 2.18 (m, 6H), 2.14 – 2.00 (m, 
12H), 1.96 (s, 3H), 1.77 – 1.45 (m, 15H), 1.30 – 1.19 (m, 3H), 1.08 – 0.96 (m, 3H). 
13C NMR (150 MHz, CDCl3) δ 170.95, 149.94 (d, J = 13.1 Hz), 142.76 (d, J = 6.5 
Hz), 139.05, 134.25, 133.68 (d, J = 7.3 Hz), 130.45, 129.59, 129.10, 126.46 (d, J = 
6.5 Hz), 126.31, 124.97, 123.46 (d, J = 43.9 Hz), 51.38, 45.92, 42.53 (d, J = 93.5 Hz, 
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23.6 Hz), 42.17 (d, J = 82.5 Hz), 36.24, 28.54 (dd, J = 27.1, 9.8 Hz), 21.07, 20.67, 
20.53. 31P NMR (162 MHz, CDCl3) δ 62.37. IR (neat): 2917, 2850, 1736, 1628, 1577, 
1540, 1448, 1373, 1343, 1301, 1211, 1105, 1019, 973, 772, 747, 710; HRMS ESI 
(m/z): [MNa]+ calcd. for C39H52AuClNNaOP, 836.3038; found, 836.3021. 
L10 
 
Ligand L10 was synthesized through general procedure A. 1H NMR (500 MHz, 
CDCl3) δ 7.91 – 7.85 (m, 1H), 7.48 (dt, J = 7.6, 1.4 Hz, 1H), 7.42 – 7.31 (m, 4H), 7.29 
(d, J = 7.6 Hz, 1H), 7.25 – 7.21 (m, 1H), 3.65 (t, J = 7.0 Hz, 2H), 3.53 (t, J = 6.6 Hz, 
2H), 2.00 – 1.78 (m, 22H), 1.72 – 1.55 (m, 12H). 13C NMR (125 MHz, CDCl3) δ 
169.91, 150.94 (d, J = 32.3 Hz), 143.51 (d, J = 7.0 Hz), 136.52 (d, J = 2.7 Hz), 136.01, 
132.93 (d, J = 27.7 Hz), 132.33 (d, J = 4.3 Hz), 130.60 (d, J = 6.1 Hz), 128.90 (d, J = 3.6 
Hz), 128.35 (d, J = 1.1 Hz), 127.25, 125.65, 125.31, 49.90, 46.04, 41.89 (d, J = 12.9 
Hz), 37.35 (d, J = 25.5 Hz), 36.90, 28.78 (d, J = 8.6 Hz), 26.40, 24.54. 31P NMR (162 
MHz, CDCl3) δ 22.10. IR (neat): 2901, 2847, 1628, 1424, 1342, 1301, 1253, 1162, 
1047, 971, 921, 808, 767, 730; HRMS ESI (m/z): [MNa]+ calcd. for C37H46NOPNa, 
574.3215; found, 574.3214. 
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L10AuCl 
 
L10AuCl was synthesized through general procedure A, step 4. 1H NMR (500 MHz, 
CDCl3) δ 7.85 (t, J = 8.1 Hz, 1H), 7.69 (d, J = 7.8 Hz, 1H), 7.54 – 7.42 (m, 3H), 7.29 (d, 
J = 18.1 Hz, 2H), 7.16 (d, J = 7.6 Hz, 1H), 3.93 – 3.53 (m, 4H), 2.30 – 1.79 (m, 22H), 
1.73 – 1.59 (m, 12H). 13C NMR (125 MHz, CDCl3) δ 169.23, 149.83 (d, J = 13.0 Hz), 
142.46 (d, J = 6.4 Hz), 136.92, 134.28 (d, J = 2.4 Hz), 133.66 (d, J = 7.4 Hz), 130.94, 
130.51 (d, J = 2.4 Hz), 128.61, 128.14, 127.22, 126.54 (d, J = 6.5 Hz), 123.52 (d, J = 
43.7 Hz), 50.16, 46.42, 42.58 (dd, J = 23.7, 11.7 Hz), 42.16 (dd, J = 28.6, 2.6 Hz), 
36.23, 28.54 (dd, J = 9.9, 7.1 Hz), 26.57, 24.43. 31P NMR (162 MHz, CDCl3) δ 62.32. 
IR (neat): 2906, 2851, 2232, 1620, 1598, 1575, 1442, 1344, 1301, 1259, 1198, 1104, 
1045, 972, 914, 806, 772, 730; HRMS ESI (m/z): [MNa]+ calcd. for 
C37H46AuClNNaOP, 806.2569; found, 806.2565. 
L10AuNTf2 
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L10AuNTf2 was synthesized through general procedure A, step 5. 1H NMR (600 
MHz, CDCl3) δ 7.91 – 7.85 (m, 1H), 7.68 (d, J = 7.7 Hz, 1H), 7.62 – 7.53 (m, 3H), 
7.35 (bs, 1H), 7.30 (d, J = 7.3 Hz, 1H), 7.24 (bs, 1H), 3.72 – 3.40 (m, 4H), 2.24 – 1.82 
(m, 22H), 1.76 – 1.53 (m, 12H).13C NMR (150 MHz, CDCl3) δ 169.75, 148.81 (d, J = 
10.6 Hz), 142.12, 136.21, 134.06, 133.59 (d, J = 7.4 Hz), 131.69, 131.29, 128.88, 
127.66 (d, J = 87.8 Hz), 127.11 (d, J = 7.4 Hz), 121.30 (d, J = 44.7 Hz), 119.62 (dd, J 
= 324 Hz), 50.24, 46.92, 43.08 (d, J = 24.6 Hz), 42.14 (d, J = 38.5 Hz), 36.03, 28.48 
(dd, J = 12.3, 10.2 Hz), 26.20, 24.24. 31P NMR (162 MHz, CDCl3) δ 61.10. IR (neat): 
2908, 2853, 1622, 1596, 1575, 1451, 1354, 1229, 1196, 1138, 1061; HRMS ESI+ 
(m/z): [M-NTf2]+ calcd. for C37H46NOAuP, 748.2983; found, 748.2975; ESI- (m/z) 
[M-L8Au]- calcd. For C2NO4S2F6, 279.9173; found, 279.9159. 
L14 
 
1H NMR (CDCl3, 600 MHz, δ): δ 7.93 (d, J = 8.0 Hz, 1H), 7.54 (dd, J = 8.1, 2.0 Hz, 
1H), 7.50 (t, J = 2.5 Hz, 1H), 6.93 (dd, J = 8.6, 3.0 Hz, 1H), 6.80 (d, J = 8.8 Hz, 1H), 
6.67 (d, J = 2.9 Hz, 1H), 3.67 (s, 3H), 3.10 – 2.91 (m, 4H). 2.00 – 1.87 (m, 9H), 1.87 
-1.75 (m, 9H), 1.75 – 1.57 (m, 16H), 1.56 – 1.50 (m, 2H). 13C{1H} NMR (CDCl3, 150 
MHz, δ): 150.23, 149.08 (d, J = 35.1 Hz), 145.42, 139.49 (d, J = 30.6 Hz), 136.42 (d, J 
= 2.9 Hz), 131.52 (d, J =7.2 Hz), 130.00 (q, J = 32.2 Hz), 127.30 – 127.10 (m), 124.25 
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(q, J = 272.3 Hz), 123.00 (d, J = 2.1 Hz), 121.68 (d, J = 3.8 Hz), 117.26, 54.93, 52.30, 
41.81 (dd, J = 66.9 Hz, 13.1 Hz), 37.12 (dd, J = 126 Hz, 26 Hz), 36.95 (d, J = 15.4 Hz), 
28.85 (dd, J = 30 Hz, 8.6 Hz), 26.10, 24.23. 31P NMR (CDCl3, 162 MHz, δ): 19.89. 19F 
NMR (CDCl3, 376 MHz, δ): -66.69. MS ESI (m/z): [MH]+ calcd. for C39H50F3NOP, 
636.36; found, 636.33. 
L14AuCl 
 
1H NMR (CDCl3, 600 MHz, δ): 7.96 (t, J = 7.4 Hz, 1H), 7.69 (d, J = 8.2 Hz, 1H), 7.53 (t, 
J = 2.6 Hz, 1H), 7.15 (bs, 1H), 6.88 (d, J = 9.0 Hz, 1H), 6.54 (bs, 1H), 3.65 (s, 3H), 3.10 
(s, 2H), 2.21 – 2.08 (m, 12H), 2.00 (s, 6H), 1.71 – 1.61 (m, 18H), 1.53 (t, J = 6.3 Hz, 
2H). 13C{1H} NMR (CDCl3, 150 MHz, δ): 149.98, 148.66, 146.04, 134.59 (d, J = 2.6 
Hz), 132.16 (q, J = 32.8 Hz), 130.30 - 130.00 (m), 129.61, 129.34, 123.47 (d, J = 273.1 
Hz), 122.46, 120.85, 118.91, 112.50, 55.23, 51.94, 42.61 (dd, J = 28.1, 22.9 Hz), 42.15 
(dd, J = 32.1, 2.8 Hz), 36.24 (dd, J = 5.5, 1.6 Hz), 28.59 (dd, J = 23.9, 9.9 Hz), 25.82, 
24.16. 31P NMR (CDCl3, 162 MHz, δ): 57.59. 19F NMR (CDCl3, 376 MHz, δ): -67.23. 
MS ESI (m/z): [MH]+ calcd. for C39H50AuClF3NOP, 868.29; found, 868.30. 
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2-1a 
 
857 mg Compound 2-1a was obtained in 99% yield according to general procedure B 
after chromatography (eluents: ethyl acetate: hexanes = 1: 30).1H NMR (CDCl3, 600 
MHz, δ): 7.96 (t, J = 7.4 Hz, 1H), 7.69 (d, J = 8.2 Hz, 1H), 7.53 (t, J = 2.6 Hz, 1H), 7.15 
(bs, 1H), 6.88 (d, J = 9.0 Hz, 1H), 6.54 (bs, 1H), 3.65 (s, 3H), 3.10 (s, 2H), 2.21 – 2.08 
(m, 12H), 2.00 (s, 6H), 1.71 – 1.61 (m, 18H), 1.53 (t, J = 6.3 Hz, 2H). 13C{1H} NMR 
(CDCl3, 150 MHz, δ): 149.98, 148.66, 146.04, 134.59 (d, J = 2.6 Hz), 132.16 (q, J = 
32.8 Hz), 130.30 - 130.00 (m), 129.61, 129.34, 123.47 (d, J = 273.1 Hz), 122.46, 
120.85, 118.91, 112.50, 55.23, 51.94, 42.61 (dd, J = 28.1, 22.9 Hz), 42.15 (dd, J = 32.1, 
2.8 Hz), 36.24 (dd, J = 5.5, 1.6 Hz), 28.59 (dd, J = 23.9, 9.9 Hz), 25.82, 24.16. 31P NMR 
(CDCl3, 162 MHz, δ): 57.59. 19F NMR (CDCl3, 376 MHz, δ): -67.23. MS ESI (m/z): 
[MH]+ calcd. for C39H50AuClF3NOP, 868.29; found, 868.30. 
2-1b 
 
693 mg Compound 2-1b was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 7.70 (s, 2H), 7.23 (s, 1H), 
4.83 (d, J = 0.5 Hz, 2H), 2.38 (d, J = 0.5 Hz, 6H), 2.35 (t, J = 7.5 Hz, 2H), 1.59 – 1.48 
(m, 2H), 1.45 – 1.34 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
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165.07, 156.88, 138.09, 134.88, 129.73, 127.58, 101.16, 33.10, 28.64, 22.11, 21.11, 
13.81. IR (neat): 3116, 2958, 2931, 2873, 2864, 1732, 1667, 1610, 1466, 1382, 1204, 
867, 761; HRMS ESI (m/z): [MNa]+ calcd. for C15H20O2Na, 255.1361; found, 
255.1342. 
2-1c 
 
652 mg Compound 2-1c was obtained in 99% yield according to general procedure B 
without chromatography.  1H NMR (600 MHz, CDCl3) δ 8.05 – 7.92 (m, 1H), 7.43 
(td, J = 7.5, 1.3 Hz, 1H), 7.34 – 7.16 (m, 2H), 4.84 (dd, J = 6.1, 1.2 Hz, 2H), 2.64 (s, 
3H), 2.35 (t, J = 7.5 Hz, 2H), 1.63 – 1.47 (m, 2H), 1.46 – 1.34 (m, 2H), 0.93 (t, J = 7.3 
Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 165.49, 156.79, 140.81, 132.31, 131.79, 
130.86, 129.01, 125.75, 101.23, 33.15, 28.66, 22.10, 21.79, 13.82. IR (neat): 3072, 
2957, 2932, 2873, 2864, 1735, 1666, 1603, 1458, 1383, 1294, 865, 737; HRMS ESI 
(m/z): [MNa]+ calcd. for C14H18O2Na, 241.1204; found, 241.1199. 
2-1d 
 
698 mg Compound 2-1d was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (600 MHz, CDCl3) δ 7.71 – 7.64 (m, 1H), 7.59 (dd, 
J = 2.5, 1.5 Hz, 1H), 7.36 (dd, J = 10.3, 5.6 Hz, 1H), 7.12 (ddd, J = 8.2, 2.7, 0.8 Hz, 
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1H), 4.84 (dd, J = 15.3, 1.4 Hz, 2H), 3.85 (s, 3H), 2.34 (t, J = 7.8 Hz, 2H), 1.57 – 1.46 
(m, 2H), 1.45 – 1.31 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 
164.55, 159.55, 156.75, 131.14, 129.40, 122.24, 119.71, 114.25, 101.22, 55.36, 33.06, 
28.61, 22.05, 13.78. IR (neat): 3078, 2957, 2932, 2873, 2864, 1735, 1666, 1586, 1488, 
1466, 1432, 1278, 1213, 869, 750; HRMS ESI (m/z): [MNa]+ calcd. for C14H18O3Na, 
257.1154; found, 257.1151. 
2-1e 
 
845 mg Compound 2-1e was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 8.21 (t, J = 1.8 Hz, 1H), 8.05 
– 7.94 (m, 1H), 7.70 (ddd, J = 8.0, 2.0, 1.1 Hz, 1H), 7.34 (dd, J = 9.9, 5.9 Hz, 1H), 
4.84 (dt, J = 3.7, 1.5 Hz, 2H), 2.33 (t, J = 7.5, 2H), 1.51 (tdd, J = 8.4, 7.3, 5.1 Hz, 2H), 
1.38 (dq, J = 14.4, 7.3 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) 
δ 163.36, 156.61, 136.15, 132.82, 131.81, 129.98, 128.43, 122.49, 101.47, 33.00, 
28.59, 22.06, 13.78. IR (neat): 3070, 2959, 2932, 2873, 2864, 1737, 1668, 1571, 1468, 
1423, 1291, 1251, 1233, 1173, 1116, 1067, 869, 806, 742; HRMS ESI (m/z): [MNa]+ 
calcd. for C13H15BrO2Na, 305.0153; found, 305.0144. 
2-1f 
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847 mg Compound 2-1f was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 8.31 (d, J = 2.2 Hz, 1H), 8.17 
(dd, J = 8.6, 2.2 Hz, 1H), 8.08 – 7.93 (m, 1H), 5.16 – 4.67 (m, 2H), 2.34 (t, J = 7.6 Hz, 
2H), 1.57 – 1.47 (m, 2H), 1.38 (dq, J = 14.4, 7.3 Hz, 3H), 0.91 (t, J = 7.3 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ 162.18, 156.36, 149.49, 135.48, 134.90, 132.12, 126.00, 
121.45, 101.90, 32.80, 32.80, 28.47, 28.47, 21.97, 21.97, 13.73, 13.73. IR (neat): 
3041, 2959, 2931, 2873, 2864, 1745, 1668, 1590, 1528, 1467, 1388, 1348, 1280, 1220, 
1127, 1042, 860, 764, 732; HRMS ESI (m/z): [MNa]+ calcd. for C13H14ClNO4Na, 
306.0509; found, 306.0508. 
2-1g 
 
816 mg Compound 2-1g was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.25 (m, 3H), 4.97 (d, 
J = 1.9 Hz, 1H), 4.88 (q, J = 1.3 Hz, 1H), 2.41 – 2.34 (m, 2H), 1.62 – 1.52 (m, 2H), 
1.45 – 1.35 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) 162.82, 
156.55, 133.28, 131.80, 130.98, 127.85, 101.94, 32.86, 28.42, 22.02, 13.79. IR (neat): 
3087, 2959, 2933, 2874, 1756, 1670, 1586, 1565, 1434, 1381, 1272, 1225, 1196 1166, 
1139, 1082, 1053, 931, 881, 802, 780, 746; HRMS ESI (m/z): [MNa]+ calcd. for 
C13H14Cl2O2Na, 295.0269; found, 295.0256. 
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2-1h 
 
987 mg Compound 2-1h was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 8.52 (d, J = 18.9 Hz, 1H), 
8.16 (dt, J = 7.8, 1.5 Hz, 1H), 8.01 (d, J = 7.4 Hz, 1H), 7.46 (dd, J = 9.3, 5.9 Hz, 1H), 
4.93 – 4.71 (m, 2H), 2.35 (dd, J = 23.6, 16.1 Hz, 2H), 1.57 – 1.44 (m, 2H), 1.43 – 
1.26 (m, 16H), 0.91 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 164.76, 
156.84, 139.45, 136.05, 132.53, 129.26, 127.80, 101.17, 84.04, 43.36, 33.04, 28.58, 
24.79, 22.07, 13.77. IR (neat): 3065, 2979, 2960, 2933, 2874, 1735, 1667, 1606, 1422, 
1362, 1327, 1248, 1222, 1144, 965, 857, 753; HRMS ESI (m/z): [MNa]+ calcd. for 
C18H27BO4Na, 353.1900; found, 353.1887. 
2-1i 
 
627 mg Compound 2-1i was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 7.94 – 7.80 (m, 1H), 7.68 – 
7.51 (m, 1H), 7.19 – 7.05 (m, 1H), 4.87 (d, J = 1.3 Hz, 1H), 4.81 (s, 1H), 2.32 (t, J = 
7.5 Hz, 2H), 1.70 – 1.48 (m, 2H), 1.45 – 1.25 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ 160.16, 156.34, 134.03, 133.30, 132.92, 127.80, 101.38, 
33.08, 28.55, 22.02, 13.77. IR (neat): 3116, 2956, 2932, 2873, 2864, 1725, 1667, 
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1524, 1417, 1254, 1071, 864,744; HRMS ESI (m/z): [MNa]+ calcd. for C11H14O4SNa, 
233.0612; found, 233.0605. 
2-1j 
 
814 mg Compound 2-1j was obtained in 97% yield according to general procedure B 
after chromatography (eluents: ethyl acetate: hexanes = 1: 30). 1H NMR (500 MHz, 
CDCl3) δ 7.03 (dt, J = 15.6, 6.9 Hz, 1H), 5.85 (dt, J = 15.4, 1.5 Hz, 1H), 4.72 (d, J = 
2.5 Hz, 2H), 2.25 – 2.15 (m, 4H), 1.55 – 1.42 (m, 4H), 1.33 – 1.21 (m, 14H), 0.94 (t, J 
= 7.3 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H) .13C NMR (125 MHz, CDCl3) δ 164.68, 156.58, 
150.64, 120.88, 100.85, 100.84, 34.26, 33.37, 31.87, 29.55, 29.51, 29.34, 29.29, 28.97, 
26.44, 22.65, 21.18, 14.06, 13.63. IR (neat): 3056, 2956, 2928, 2856, 1737, 1654, 
1466, 1379, 1319, 1218, 1158, 1120, 983, 866; HRMS ESI (m/z): [MNa]+ calcd. for 
C18H32O2Na, 303.2300; found, 303.2307. 
2-1k 
 
766 mg Compound 2-1k was obtained in 96% yield according to general procedure B 
after chromatography (eluents: ethyl acetate: hexanes = 1: 30). 1H NMR (500 MHz, 
CDCl3) δ 6.92 (dddd, J = 8.4, 7.1, 5.8, 1.4 Hz, 1H), 4.78 – 4.58 (m, 2H), 2.23 (t, J = 
7.5 Hz, 2H), 1.87 – 1.84 (m, 3H), 1.81 (dd, J = 7.1, 1.0 Hz, 3H), 1.49 – 1.41 (m, 2H), 
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1.34 (dq, J = 14.3, 7.1 Hz, 2H), 0.89 (t, J = 7.3 Hz, 2H). 13C NMR (125 MHz, CDCl3) 
δ 166.17, 156.88, 138.35, 128.39, 100.72, 33.07, 28.63, 22.06, 14.43, 13.79, 12.02. IR 
(neat): 3118, 2957, 2927, 2856, 1720, 1666, 1654, 1467, 1380, 1342, 1264, 1225, 
1145, 1124, 1068, 868, 729; HRMS ESI (m/z): [MNa]+ calcd. for C17H30NaO2, 
289.2144; found, 289.2138. 
2-1l 
 
580 mg Compound 2-1l was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.20 (m, 1H), 6.30 – 
6.06 (m, 2H), 5.79 (dd, J = 19.5, 15.7 Hz, 1H), 4.78 – 4.67 (m, 2H), 2.23 (t, J = 7.5, 
2H), 1.86 (d, J = 5.8 Hz, 3H), 1.50 – 1.40 (m, 2H), 1.34 (dq, J = 14.3, 7.1 Hz, 2H), 
0.89 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 165.33, 156.60, 146.12, 
140.06, 129.68, 118.37, 100.85, 33.10, 28.57, 22.07, 18.65, 13.79. IR (neat): 3029, 
2960, 2930, 2874, 2864, 1728, 1646, 1617, 1329, 1228, 1177, 1128, 1000, 867; 
HRMS ESI (m/z): [MNa]+ calcd. for C12H18NaO2, 217.1204; found, 217.1205. 
2-1m 
 
748 mg Compound 2-1m was obtained in 99% yield according to general procedure B 
after chromatography (eluents: ethyl acetate: hexanes = 1: 30).  1H NMR (500 MHz, 
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CDCl3) δ 4.69 (d, J = 2.8 Hz, 2H), 2.18 (t, J = 7.6 Hz, 2H), 1.65 (qd, J = 6.8, 5.6, 2.7 
Hz, 1H), 1.45 (p, J = 7.4 Hz, 2H), 1.27 (d, J = 12.5 Hz, 15H), 1.08 – 1.02 (m, 2H), 
0.93 – 0.89 (m, 2H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 173.00, 
156.63, 100.78, 33.29, 31.87, 29.56, 29.51, 29.35, 29.30, 28.96, 28.96, 26.42, 22.65, 
14.07, 12.93, 8.74. HRMS ESI (m/z): [MNa]+ calcd. for C11H14O4SNa, 275.1987; 
found, 275.1971. 
2-1n 
 
778 mg Compound 2-1n was obtained in 99% yield according to general procedure B 
after chromatography (eluents: ethyl acetate: hexanes = 1: 30). 1H NMR (600 MHz, 
CDCl3) δ 4.68 (d, J = 1.0 Hz, 1H), 4.64 (s, 1H), 2.19 (t, J = 7.2 Hz, 2H), 2.03 (s, 3H), 
1.93 (d, J = 2.9 Hz, 6H), 1.78 – 1.67 (m, 6H), 1.48 – 1.38 (m, 2H), 1.34 (dq, J = 14.3, 
7.1 Hz, 2H), 0.90 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 175.59, 156.65, 
100.46, 40.76, 38.64, 36.35, 32.82, 28.44, 27.82, 21.94, 13.71. IR (neat): 3115, 2957, 
2933, 2908, 2864, 1743, 1666, 1454, 1212, 1181, 1065, 865, 736; HRMS ESI (m/z): 
[MNa]+ calcd. for C17H26O2Na, 285.1830; found, 285.1821. 
2-1o 
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742 mg Compound 2-1o was obtained in 98% yield according to general procedure B 
after chromatography (eluents: ethyl acetate: hexanes = 1: 30). 1H NMR (500 MHz, 
CDCl3) δ 5.94 (ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 5.25 – 5.08 (m, 2H), 4.71 (s, 3H), 
3.16 (d, J = 7.0 Hz, 2H), 2.21 – 2.15 (m, 2H), 1.44 (p, J = 7.4 Hz, 2H), 1.35 – 1.20 (d, 
J = 11.8 Hz, 14H), 0.87 (t, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 169.54, 
156.52, 129.83, 118.81, 101.02, 39.12, 33.21, 33.21, 31.86, 29.54, 29.49, 29.33, 29.28, 
28.92, 26.36, 22.64, 14.05. IR (neat): 3118, 3085, 2957, 2927, 2856, 1757, 1667, 
1645, 1330, 1292, 1223, 1447, 1147, 992, 976, 921, 869; HRMS ESI (m/z): [MNa]+ 
calcd. for C16H28O2Na, 275.1987; found, 275.1971. 
2-1p 
 
832 mg Compound 2-1p was obtained in 99% yield according to general procedure B 
(60 °C) after chromatography (eluents: hexanes). 1H NMR (500 MHz, CDCl3) δ 4.95 
(d, J = 2.7 Hz, 1H), 4.91 – 4.85 (m, 1H), 2.27 (t, J = 7.6 Hz, 2H), 1.49 (p, J = 7.5 Hz, 
2H), 1.38 – 1.20 (m, 14H), 0.88 (t, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
155.71, 155.40 (q, J = 42.5 Hz), 114.50 (q, J = 283.75 Hz), 102.43, 32.63, 31.91, 
29.56, 29.48, 29.32, 29.27, 29.27, 28.79, 26.11, 22.69, 14.05. 19F NMR (376 MHz, 
CDCl3) δ -75.09. IR (neat): 2929, 2886, 2858, 1798, 1675, 1468, 1360, 1228, 1172, 
1142, 879, 771. HRMS FI (m/z): [M]+ calcd. for C14H23F3O2, 280.1650; found, 
280.1665. 
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2-1q 
 
978 mg Compound 2-1q was obtained in 99% yield according to general procedure B 
after chromatography (eluents: hexanes). 1H NMR (500 MHz, CDCl3 δ 4.93 (d, J = 
0.8 Hz, 1H), 4.87 (d, J = 3.2 Hz, 1H), 2.30 (t, J = 7.6 Hz, 2H), 1.52 (p, J = 7.5 Hz, 
2H), 1.36 – 1.20 (m, 14H), 0.87 (t, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
159.84, 156.69, 102.00, 89.78, 32.50, 32.50, 31.88, 29.54, 29.46, 29.30, 29.26, 28.79, 
28.78, 26.16, 22.66, 14.08. IR (neat): 3121, 2957, 2928, 2856, 1779, 1673, 1467, 
1379, 1201, 1107, 961, 878, 823; HRMS ESI (m/z): [MNa]+ calcd. for C14H23Cl3O2Na, 
351.0661; found, 351.0650. 
2-1r 
 
693 mg Compound 2-1r was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (600 MHz, CDCl3) δ 8.10 – 7.95 (m, 2H), 7.67 (t, 
J = 7.4 Hz, 1H), 7.52 (t, J = 7.8 Hz, 2H), 5.00 – 4.84 (m, 2H), 2.34 (t, J = 7.6 Hz, 2H), 
1.52 (dt, J = 15.3, 7.5 Hz, 2H), 1.45 – 1.31 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C 
NMR (150 MHz, CDCl3) δ 185.48, 161.70, 156.04, 135.00, 132.25, 129.95, 128.92, 
102.10, 32.82, 28.33, 21.94, 13.72. IR (neat): 3066, 2960, 2934, 2874, 2864, 1752, 
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1691, 1598, 1452, 1322, 1193, 1168, 987, 878, 746; HRMS ESI (m/z): [MNa]+ calcd. 
for C14H16O3Na, 255.0997; found, 255.0988. 
2-1s 
 
698 mg Compound 2-1s was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.01 (t, 
J = 7.4 Hz, 1H), 6.96 – 6.92 (m, 2H), 4.80 (d, J = 1.8 Hz, 1H), 4.77 (d, J = 1.6 Hz, 
1H), 4.70 (s, 2H), 2.23 (t, J = 7.5 Hz, 2H), 1.42 (tt, J = 8.3, 6.9 Hz, 2H), 1.38 – 1.28 
(m, 2H), 0.90 (t, J = 7.2 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 166.95, 157.56, 
155.89, 129.42, 129.41, 121.66, 114.48, 114.46, 101.31, 65.08, 32.79, 28.30, 21.86, 
13.62. IR (neat): 3067, 2959, 2933, 2873, 2864, 1777, 1652, 1668, 1601, 1590, 1497, 
1459, 1458, 1438, 1379, 1162, 1108, 963, 876, 753; HRMS ESI (m/z): [MNa]+ calcd. 
for C14H18O3Na, 257.1154; found, 257.1144. 
2-1t 
 
712 mg Compound 2-1t was obtained in 80% yield according to general procedure B 
(600 ppm L10AuNTf2, 2500 ppm NaBARF) after chromatography (eluents: ethyl 
acetate: hexanes = 1: 2). 1H NMR (500 MHz, CDCl3) δ 4.79 – 4.59 (m, 2H), 4.33 (dd, 
J = 8.6, 3.6 Hz, 1H), 4.26 (dd, J = 8.7, 4.0 Hz, 1H), 3.59 – 3.31 (m, 2H), 2.34 – 2.13 
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(m, 3H), 2.07 – 1.78 (m, 3H), 1.46 – 1.42 (m, 4H), 1.40 (d, J = 6.5 Hz, 6H), 1.36 – 
1.26 (m, 2H), 0.92 – 0.81 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 171.11 , 156.47 , 
156.29 , 154.20 , 153.66 , 100.78 , 79.92 , 79.66 , 59.00 , 58.91 , 46.44 , 46.26 , 32.91 , 
32.80 , 30.89 , 29.87 , 28.44 , 28.37 , 28.31 , 28.25 , 24.28 , 23.46 , 21.94 , 13.71. IR 
(neat): 3116, 2976, 2961, 2934, 2876, 1763, 1705, 1396, 1152, 1088, 957, 871, 773; 
HRMS ESI (m/z): [MNa]+ calcd. for C16H27NO4Na, 320.1838; found, 320.1834. 
2-1u 
 
1128 mg Compound 2-1u was obtained in 99% yield according to general procedure 
B without chromatography. 1H NMR (500 MHz, CDCl3) δ 7.78 (dd, J = 5.4, 3.1 Hz, 
2H), 7.68 (dd, J = 5.5, 3.0 Hz, 2H), 7.22 – 7.10 (m, 5H), 5.23 (dd, J = 11.3, 5.2 Hz, 
1H), 4.78 (d, J = 1.8 Hz, 1H), 4.75 (d, J = 1.7 Hz, 1H), 3.68 – 3.51 (m, 2H), 2.21 (td, 
J = 7.5, 4.5 Hz, 2H), 1.40 (qd, J = 8.1, 7.5, 5.6 Hz, 2H), 1.35 – 1.24 (m, 2H), 0.86 (t, J 
= 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 167.26, 167.08, 156.45, 136.51, 134.08, 
131.50, 128.82, 128.51, 126.84, 123.42, 101.49, 53.24, 34.65, 32.73, 28.40, 21.94, 
13.73. IR (neat): 3065, 2958, 2933, 2873, 2865, 1778, 1759, 1718, 1669, 1607, 1498, 
1468, 1288, 1222, 1170, 1105, 1000, 961, 915, 876, 720; HRMS ESI (m/z): [MNa]+ 
calcd. for C23H23NO4Na, 400.1525; found, 400.1515. 
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2-1v 
 
686 mg Compound 2-1v was obtained in 99% yield according to general procedure B 
without chromatography. 1H NMR (600 MHz, CDCl3) δ 8.16 – 8.03 (m, 2H), 7.59 (t, 
J = 7.4 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 4.91 – 4.76 (m, 2H), 2.25 (td, J = 10.7, 3.0 
Hz, 1H), 1.99 (t, J = 10.5 Hz, 2H), 1.87 – 1.73 (m, 2H), 1.72 – 1.64 (m, 2H), 1.34 – 
1.13 (m, 6H).13C NMR (150 MHz, CDCl3) δ 164.82, 160.66, 133.17, 129.94, 129.87, 
128.40, 99.61, 41.80, 30.62, 26.05, 25.94. IR (neat): 3064, 2930, 2855, 1733, 1661, 
1601, 1451, 1314, 1271, 1240, 1194, 1169, 1133, 1092, 1068, 1026, 872, 705; HRMS 
ESI (m/z): [MNa]+ calcd. for C15H18NO2Na, 253.1208; found, 253.1204. 
2-1w 
Ph O
O
Cl
95% 
(300 ppm Au)
no NaBARF  
678 mg Compound 2-1w was obtained in 95% yield when 1,2-dichloroethane was 
used as a solvent instead of PhF. (0.5 M, 300 ppm L10AuNTf, no NaBARF) after 
chromatography (eluents: ethyl acetate: hexanes = 1: 30). 1H NMR (600 MHz, CDCl3) 
δ 8.09 (t, J = 8.4 Hz, 2H), 7.67 – 7.53 (m, 1H), 7.47 (t, J = 7.7 Hz, 2H), 4.88 (d, J = 
21.0 Hz, 2H), 3.63 – 3.48 (m, 2H), 2.39 (t, J = 7.5 Hz, 2H), 1.88 (qd, J = 14.9, 6.9 Hz, 
2H), 1.76 – 1.63 (m, 2H). 13C NMR (150 MHz, CDCl3) δ 164.68, 155.79, 133.33, 
129.88, 129.69, 128.45, 101.96, 44.64, 32.64, 31.70, 23.72. IR (neat): 3064, 2955, 
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2870, 2847, 1730, 1667, 1602, 1492, 1452, 1272, 1026, 875, 801, 746; HRMS ESI 
(m/z): [MNa]+ calcd. for C13H15ClO2Na, 261.0658; found, 261.0654. 
2-1x 
 
1023 mg Compound 2-1x was obtained in 98% yield according to general procedure 
B (2500 ppm NaBARF) after chromatography (eluents: ethyl acetate: hexanes = 1: 
50). 1H NMR (500 MHz, CDCl3) δ 8.13 – 8.01 (m, 2H), 7.69 – 7.52 (m, 1H), 7.50 – 
7.37 (m, 2H), 5.00 – 4.84 (m, 2H), 3.89 (td, J = 6.6, 0.8 Hz, 2H), 2.69 – 2.51 (m, 2H), 
1.17 – 0.97 (m, 21H). 13C NMR (125 MHz, CDCl3) δ 164.74, 153.83, 133.27, 129.92, 
128.41, 103.97 – 103.59 (m), 103.15, 99.07, 60.64, 37.38, 17.96, 11.95. IR (neat): 
3064, 2944, 2893, 2867, 1736, 1670, 1602, 1464, 1384, 1268, 1233, 1175, 1092, 1069, 
1026, 882, 706; HRMS ESI (m/z): [MNa]+ calcd. for C20H32NaO3Si, 371.2018; found, 
371.2020. 
2-1y 
 
828 mg Compound 2-1y was obtained in 89% yield according to general procedure B 
(2500 ppm NaBARF) after chromatography (eluents: ethyl acetate: hexanes = 1: 20). 
1H NMR (500 MHz, CDCl3) δ 8.15 – 7.97 (m, 2H), 7.63 – 7.54 (m, 1H), 7.47 (t, J = 
7.8 Hz, 2H), 7.38 – 7.17 (m, 5H), 4.89 (d, J = 1.6 Hz, 1H), 4.87 – 4.85 (m, 1H), 4.51 
(s, 2H), 3.51 (t, J = 6.1 Hz, 2H), 2.38 (t, J = 7.2 Hz, 2H), 1.77 – 1.51 (m, 4H). 13C 
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NMR (125 MHz, CDCl3) δ 164.69, 156.34, 138.51, 133.23, 129.88, 129.81, 128.41, 
128.29, 127.54, 127.44, 101.59, 72.82, 69.88, 33.19, 29.02, 23.22. IR (neat): 3185, 
2962, 2935, 2873, 2876, 1761, 1674, 1250, 1217, 847, 833; HRMS ESI (m/z): [MNa]+ 
calcd. for C20H22O3Na, 333.1467; found, 333.1453. 
2-1z 
 
547 mg Compound 2-1z was obtained in 97% yield according to general procedure B 
(2 equiv 2-methylbut-1-en-3-yne, 5000 ppm NaBARF, 60 °C) after chromatography 
(eluents: ethyl acetate: hexanes = 1: 20).1H NMR (500 MHz, CDCl3) δ 8.16 (dtd, J = 
8.1, 2.1, 1.3 Hz, 1H), 7.67 – 7.57 (m, 1H), 7.55 – 7.42 (m, 1H), 5.32 – 5.14 (m, 2H), 
5.04 (ddd, J = 7.9, 2.9, 1.5 Hz, 2H), 2.01 (d, J = 0.7 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 165.13 – 164.49 (m), 154.09 – 153.24 (m), 136.63, 133.45, 130.04, 129.68 
– 129.31 (m), 128.54, 113.92, 103.60, 19.46. IR (neat): 3063, 2976, 2954, 2928, 2902, 
2855, 1738, 1603, 1452, 1263, 1152, 1090, 1068, 1026, 887, 707; HRMS EI (m/z): 
[M]+ calcd. for C12H12O2, 188.0837; found, 188.0835. 
2-1aa 
 
855 mg Compound 2-1aa was obtained in 99% yield according to general procedure 
B (5000 ppm NaBARF) after chromatography (eluents: ethyl acetate: hexanes = 1: 
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30). 1H NMR (500 MHz, CDCl3) δ 8.12 (dt, J = 8.4, 1.6 Hz, 2H), 7.83 – 7.54 (m, 1H), 
7.54 – 7.40 (m, 2H), 5.11 (t, J = 7.3 Hz, 1H), 2.41 – 2.19 (m, 2H), 1.97 (q, J = 7.3 Hz, 
2H), 1.57 – 1.45 (m, 2H), 1.43 – 1.16 (m, 10H), 0.98 – 0.74 (m, 6H). 13C NMR (125 
MHz, CDCl3) δ 164.39, 148.58, 133.10, 129.91, 129.87, 128.40, 116.53, 33.43, 31.36, 
31.23, 28.77, 26.37, 25.31, 22.41, 22.40, 13.98, 13.96. IR (neat): 3064, 2957, 2930, 
2872, 2859, 1733, 1452, 1259, 1089, 1068, 1026, 708; HRMS ESI (m/z): [MNa]+ 
calcd. for C19H28O2Na, 311.1987; found, 311.1977. 
1ab + 1ab’ 
 
755 mg Compounds 2-1ab and 2-1ab’ were obtained in 85% yield (2.8:1) according 
to general procedure B (2500 ppm NaBArF4) after chromatography (eluents: ethyl 
acetate: hexanes = 1: 15). 1H NMR (500 MHz, CDCl3) δ 8.15 – 8.07 (m, 2H), 7.64 – 
7.58 (m, 1H), 7.52 – 7.46 (m, 2H), 7.38 – 7.26 (m, 5H), 5.31 (qd, J = 6.8, 0.9 Hz, 
0.25H), 5.25 – 5.19 (m, 0.73H), 4.54 (s, 0.52H), 4.51 (s, 1.55H), 3.65 (td, J = 6.6, 1.1 
Hz, 0.53H), 3.50 (td, J = 6.8, 1.1 Hz, 1.56H), 2.70 – 2.61 (m, 0.52H), 2.41 – 2.30 (m, 
1.57H), 2.07 – 1.99 (m, 2.35H), 1.59 (dd, J = 6.8, 1.2 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 164.32, 164.25, 146.42, 146.26, 138.34, 138.23, 133.24, 133.21, 129.91, 
129.89, 129.65, 129.60, 128.41, 128.27, 127.60, 127.57, 127.47, 127.46, 113.45, 
112.85, 72.86, 72.75, 69.24, 67.26, 34.22, 26.19, 19.63, 10.81. HRMS ESI (m/z): 
[MNa]+ calcd. for C19H20O3Na, 319.1310; found, 319.1313. 
 
111 
 
2-1ac 
 
870 mg Compound 2-1ac was obtained in 98% yield according to general procedure 
B after chromatography (eluents: ethyl acetate: hexanes = 1: 4). This compound is 
known and the spectrum are consistent with literature data.[1] 1H NMR (500 MHz, 
CDCl3) δ 8.23 (dd, J = 8.3, 1.2 Hz, 2H), 7.72 – 7.59 (m, 3H), 7.53 (dd, J = 10.8, 4.8 
Hz, 2H), 7.47 – 7.34 (m, 3H), 6.38 (s, 1H), 4.13 (q, J = 7.1 Hz, 2H), 1.15 (t, J = 7.1 
Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 164.08, 163.82, 157.83, 133.70, 133.45, 
130.95, 130.37, 129.11, 128.84, 128.64, 125.95, 106.84, 60.38, 14.05. IR (neat): 2918, 
2951, 1742, 1714, 1636, 1449, 1279, 1234, 1157, 1080, 1064, 1023, 765; HRMS ESI 
(m/z): [MNa]+ calcd. for C18H16O4Na, 319.0946; found, 319.0943. 
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3. Rapid Access to Chroman-3-Ones via Gold-Catalyzed 
Oxidation of Propargyl Aryl Ethers 
3.1. Introduction 
Metal-promoted dediazotizations of diazo carbonyl compounds are the most 
reliable strategy to access α-oxo metal carbenes/carbenoids, which are versatile 
intermediates that can go through various synthetically challenging but also highly 
valuable transformations, such as C–H insertion, ylide formation, and 
cyclopropanation reactions.[1] Of particular synthetic importance are those methods 
based on Rh catalysis, which allow enantioselective transformations with chiral 
coordinating ligands utilized. Unfortunately, this strategy is largely limited by the 
hazardous nature of the diazo carbonyl substrates, due to the highly energetic diazo 
moiety and hence the toxicity and potential of explosion. Consequently, although 
large scale processes have been executed with engineering ingenuity,[ 2 , 3 ] these 
reactions are still recommended to perform in small scales to avoid possible safety 
related issues. Moreover, the preparations of these precursors typically require robust 
reagents, hence putting further strain on operational safety, and often entail 
multiple-step synthetic sequence unless the methylene group is fairly acidic.[1] As a 
result, the development of safe surrogates of diazo carbonyl compounds while 
maintaining the ease of accessing the corresponding metal carbenes would address 
this incapacitating issue and provide extensive benefit to synthetic practices.  
Even though diazo carbonyl compounds have been used to access α-oxo gold 
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carbene/carbenoid,[4-8] we believe the same intermediate could be generated from a C–
C triple bond instead of an energetic diazo moiety by a strategy involving an external 
oxidant (Scheme 53). Therefore, the hazardous α-diazo carbonyl compounds in 
principle could be replaced with readily available and most benign alkynes, at least in 
the jurisdiction of gold catalysis. Due to the largely unexplored reactivities of α-oxo 
gold carbenes and their ease of efficient access enabled by this oxidative strategy, 
many other research groups were drawn to the synthetic potential of the approach as 
well after our group explored some versatile reactivities of these carbene 
intermediates.  
 
Scheme 53. Generation of α-Oxo Gold Carbenes via Alkynes Oxidation: Alkynes 
as Surrogates of α-Diazo Carbonyl Compounds 
O
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O Z
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In 2010, our group reported the first example of accessing α-oxo gold carbenes 
via intermolecular oxidation of terminal alkynes under mild reaction conditions 
(Scheme 54).[9] By using pyridine N-oxide as the external oxidant, homopropargylic 
alcohols was facilely converted to α-oxo gold carbene intermediate under gold 
117 
 
catalysis, which was then trapped by intramolecular O-H group, yielding the products 
dihydrofuran-3-ones 3-1a in good yields. Significantly, the intermolecular approach 
makes alkynes equivalent to hazardous α-diazo ketones and, moreover, offers much 
synthetic flexibility. Half year later, our group successfully utilized the same strategy 
to oxidize propargyl alcohols to oxetan-3-ones 3-1b, a highly valuable substrate for 
drug discovery (Scheme 54).[10] The facile formation of the strained oxetane ring 
provides strong support for the intermediacy of α-oxo gold carbenes. 
 
Scheme 54. Intramolecular O-H Insertion by α-Oxo Gold Carbene   
 
 
In 2011, the same approach was applied to a one-step synthesis of azetidin-3-ones 
from propargylic amides (Scheme 55).[11] The chiral Bus (tert-Butylsulfonyl) was 
chosen to be the protecting group of amine because it’s easy to access and allows 
highly stereoselective construction of the stereogenic propargylic position according 
to Ellman's chemistry.[ 12 ] Using bulky ligand BrettPhos and bulky 2,6- 
dibromopyridine N-oxide, azetidin-3-ones 3-2 were facilely obtained in overall >50% 
yield with >98% ee after a four-step sequence from Bus imines. This reaction permits 
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an expedient access to various chiral azetidin-3-ones and tolerates sensitive functional 
groups such as azido and NHBoc due to the exceedingly mild conditions 
 
Scheme 55. Access to Azetidin-3-ones by Au-Catalyzed Oxidation Reactions 
 
 
At the same time, a gold-catalyzed intermolecular oxidations of internal alkynes 
was also accomplished by our group with high regioselectivities using 
8-alkylquinoline N-oxides as oxidants.[13] For the sterically biased internal alkyne 
substrate 3-3, the combination of IPrAuNTf2 and 8-isopropylquinoline N-oxide led to 
selective formation of enone 3-5 over its isomer 3-5’, which are formed upon 1,2-C–
H insertions by the isomeric α-oxo gold carbenes 3-4 and 3-4’, respectively (Scheme 
56). The regioselectivity is ascribed to the preferred approach of the oxidant to the 
less hindered end of the C–C triple bond. For the first time, synthetically versatile 
α,β-unsaturated ketones are obtained directly from alkyne moieties in good to 
excellent yields and with excellent E-selectivities. This reaction allows 
α,β-unsaturated carbonyl compounds to be masked as relatively stable and readily 
available alkynes, thus offering a practical solution to compatibility issues with these 
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functional groups likely encountered in the syntheses of complex structures. 
 
Scheme 56. Formation of Enones by Au-Catalyzed Oxidation of Alkynes 
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3.2. The Design of Accessing Chroman-3-ones by α-Oxo Gold 
Carbenes  
After the α-oxo gold carbenes were successfully trapped by O-H and N-H bonds, 
we started to wonder if C–H bond insertion would occur in the same manner. By this 
strategy, we were hoping to access to chroman-3-ones rapidly because it’s an 
important structural motif and its derivatives have served as key intermediates in the 
total synthesis of natural products such as miroestrol,[14] (+)-myristinin A,[15] and 
afzelechin,[16] as well as in accessing a range of bioactive chromans for managing 
various diseases including hypertension,[ 17 ] HIV,[16] sexual dysfunction,[ 18 ] and 
melanoma.[19]  
In their 1991 review,[20] Danan and Kirkiacharian concluded that there was a lack 
of efficient synthetic methods for this structure. Little progress[21] has been made 
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since then, which makes the twenty-years-old statement still remain essentially true to 
date. Perpetually, these compounds are prepared through multistep routes [20,22] from 
basic chemicals (i.e., phenol). For example, a typical route was reported by Corey et 
al. (Scheme 57-A): starting from a basic condensation of salicylaldehyde with 
acrylonitrile to form 2H-chromene-3-carbonitrile under refluxing conditions, followed 
by basic hydrolysis, acidification and formation of acyl azide, the subsequent Curtius 
rearrangement and acidic hydrolysis of the resulting vinyl isocyanate afforded the 
corresponding chroman-3-one.[14,22,23] While the overall yield could be as high as 
60%, the step and atom economy is very low and strong acidic and basis conditions 
were unavoidable.  
 
Scheme 57 Access to Chroman-3-ones: Previous Work 
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Alternatively, a similarly long approach took advantage of copper carbene 
intermediate (Scheme 57-B): starting from phenols or naphthanols,[24] a sequence of 
O-alkylation, chlorination of carboxylic acid and diazo-substitution gave the key 
precursor, α-diazo-α’-phenoxy acetones. Treated with Cu(CF3CO2)2, the copper 
carbenoid was generated and the succeeding C–H insertion led to the final 
chroman-3-one products. However, no application of this method has been reported in 
the literature because of its limited substrate scope another clear drawback associated 
with using toxic and explosive diazomethane.[25] 
 
Scheme 58. Access to Chroman-3-ones: New Design 
 
 
To solve the above problem with a long history, we envisioned that our oxidative 
strategy to generate α-oxo gold carbene would allow replacement of 
α-diazo-α′-phenoxy acetones with readily available propargyl aryl ethers, which are 
only one-step away from phenols of easy access and often obtained in quantitative 
yields, thereby establishing a concise, safe, and potentially highly efficient itinerary to 
this class of heterocycles. Generally metal carbenes can be generated via 
dediazotization, but this Au-catalyzed alkyne oxidation strategy permits the replace of 
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toxic, potentially explosive and difficult-to-access α-diazo ketones since alkynes are 
benign and readily available.  
 
3.3. Conditions Optimizations 
3.3.1. Ligand Investigation  
On the onset, 4-tert-butylphenyl propargyl ether 3-6a was chosen as the standard 
substrate for condition optimization. Bulky electron-deficient 2,6-dibromopyridine 
N-oxide was used as the external oxidant and DCE (1,2-dichloroethane) as the solvent 
(Table 7). When either Ph3PAuNTf2 (entry 1) or the more electrophilic 
phosphite-coordinated (ArO)3PAuNTf2 (Ar = 2,4-di-tert-butylphenyl, entry 2) was 
employed as the catalyst, both reactions were sluggish. The desired chroman-3-one 
3-7a was formed in <10% yield with almost half amount of starting material left;3-4% 
α-chloro ketone 3-10a was also detected, which was probably from α-oxo gold 
carbene trapped by the halogenated solvent DCE. Notably, relatively bulky IPrAuNf2 
improve the reaction significantly, provide 45% 3-7a, 7% phenol 3-8a, 3% 
directly-cyclized 2H-chromene 3-9a and 3% 3-10a with 8% starting material 3-6a left 
after 16 h (entry 3). 
In the previous work of our group on azetidine-3-one synthesis, [11] we noticed that 
gold catalysts based on biphenylphosphine ligands were increasingly effective as the 
ligand became more and more bulky and BrettPhosAuNTf2 was the optimal catalyst. 
As expected, the same trend was observed for this reaction as well comparing 
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sterics-increasing cy-JohnPhosAuNTf2, tBuXPhosAuNTf2 and BrettPhosAuNTf2 
(entries 4-6); chroman-3-one 3-7a was formed in 65% NMR yield within only 30 min 
with BrettPhosAuNTf2 as the catalyst (entry 6). Me4tBuXPhos[26-28] is a bulkier ligand 
than BrettPhos; seeking to further improve this reaction, I made 
Me4tBuXPhosAuNTf2 and tested it out. To our delight, the yield did get improved to 
78% (entry 7) with other reaction condition unchanged. 
 
Table 7. Catalyst Optimization a 
 
 
 
 
 
 
 
a Estimated by 1H NMR using diethyl phthalate as the internal reference. b Ar is 
2,4-di-tert-butylphenyl 
 
Single crystal X-ray diffraction studies established the structure of this effective 
catalyst (Figure 11-A). In comparison with BrettPhosAuNTf2 (Figure 11-B), the 
entry catalyst time 3-6a  remained 
yield 
3-7a 3-8a 3-9a 3-10a 
1 Ph3PAuNTf2 16 h 41% 6% - -  3% 
2 (ArO)3PAuNTf2 b 16 h 58% 7% - -  4% 
3 IPrAuNTf2 16 h 8% 45% 7% 3% 3% 
4 Cy-JohnPhosAuNTf2 16 h 17% 9% 5% 2% 6% 
5 tBuXPhosAuNTf2 16 h - 27% 10% 4% 5% 
6 BrettPhosAuNTf2 0.5 h - 65% 5% 4%  3% 
7 Me4tBuXPhosAuNTf2 0.5 h - 78% 5% 8% - 
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Au1-P1-C2 angle is smaller by 5.52˚, and the distance between Au1 and C1’ is shorter 
by 0.265 Å, suggesting that Me4tBuXPhos forces Au center more toward the shielding 
pendant 2,4,6-triisopropylphenyl group and hence increase the steric crowding of the 
metal center. In a simplistic picture, the gold center in Me4tBuXPhosAuNTf2 is 
positioned in a deeper pocket than in the case of other catalysts. This crowding could 
also be reflected by its %VBur value[29,30] (61.8 based on the X-ray structure of its 
AuNTf2 complex and 60.6 on its AuCl complex[31]), which is significantly bigger than 
that of BrettPhos (53.7 %VBur based on the X-ray structure of its AuNTf2 complex[11]).  
 
Figure 11. Ortep Ellipsoid Drawing of Complexes Me4tBuXPhosAuNTf2 and 
BrettPhosAuNTf2 with 50% Probability. (The hydrogen atoms have been 
omitted for clarity. The distances shown are in Å, and the angles in degree.) 
 
 
In fact, Me4tBuXPhosAuNTf2 has a higher %VBur value than any of the LAu(I) 
complexes investigated by Clavier and Nolan. [30] As a result, side reactions with the 
corresponding gold carbene 3A via intermolecular processes might become less 
detrimental due to the enhanced difficulty of access, and the more imposing 
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2,4,6-triisopropylphenyl group might also facilitate the carbene moiety to adopt 
conformations with bending backbones that are poised to undergo productive 
intramolecular cyclization, both of which could lead to increased efficiency. 
Conspicuously, Barriault et al. [31] recently reported that 
[Me4tBuXPhosAuNCMe]+SbF6− is the best catalyst for selectively promoting 
6-endo-dig carbocyclizations of alkenyl silyl ether to alkynes over typically favored 
5-exo-dig ones. 
 
3.3.2. Counter Ion Investigation 
Counter ions play very important roles in organometallic catalysis, certainly 
including gold catalysis. After fixing the best ligand for the gold catalyst, we further 
looked into the counter ion effect for this reaction. As shown in Table 8, most counter 
ion afforded relatively satisfying results (entries 1-5), among which NTf2-, PF6-, and 
SbF6- performed similarly well. However, OTf- only gave 42% desired product 3-7a 
with 22% starting material 3-6a left (entry 6). Because PF6- and SbF6- are 
weak-coordinating counter ion, their corresponding gold catalysts are not very stable 
to store and have to be generated in situ by mixing Me4tBuXPhosAuCl and silver salt 
every time. Although both of them gave just as good results as NTf2-, to make the 
operations of running reactions easier, I chose to prepare the stable 
Me4tBuXPhosAuNTf2 first due to its ease of handling. When the counter ion was 
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changed to strong coordinating tosylate, benzoate and trifluoroacetate, no reaction 
was observed possibly due their low activities.  
 
Table 8. Counter Ion Effect a 
 
 
 
 
 
a Estimated by 1H NMR using diethyl phthalate as the internal reference. 
 
3.3.3. Oxidant Investigation  
Since no more improvement could be made by modifying gold catalysts, then I 
began to investigate the oxidants, N-oxides (Table 9). Other common oxidants 
(3,5-dichlropyridine N-oxide, 2,4-dichlropyridine N-oxide, 2,6-dichlropyridine 
N-oxide, lutidine N-oxide and 8-methylquinoline N-oxide) that we used previously 
[9,10,11] did not improve the reaction any better (entries 2-6). However, it was clear that 
hindered and electron-deficient N-oxides fared better.  
entry counter ion 3-6a  remained 
yield 
3-7a 3-9a
1 NTf2 - 78% 8% 
2 PF6 - 76% 8% 
3 BARF - 66% 10%
4 SbF6 - 78% 8% 
5 BF4 - 72% 10%
6 OTf 22% 42% 4% 
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Table 9. Oxidant Effect a 
 
 
 
 
 
 
 
 
a Estimated by 1H NMR using diethyl phthalate as the internal reference. b 1.3 equivalent. c 1.2 
equivalent. d 82% isolated yield. 
 
Consequently, I prepared pyridine N-oxides NO-7 and NO-8 by a quick sequence 
of double oxidations of the corresponding Hantzsch esters (Scheme 59). To the best of 
our knowledge, these hindered and electron-deficient N-oxides have never been used 
as oxidants before. Gratifyingly, with 1.3 equivalent of NO-7, the reaction yield was 
improved to 84% (entry 7); a slightly better yield 87% was obtained with 1.2 
equivalent of even more hindered NO-8 (entry 8).  
entry N-Oxide time 3-6a remained yield 3-7a 3-8a 3-9a 
1 NO-1 15 min - 78% 5% 8% 
2 NO-2 15 h 18% 38% 2% 1% 
3 NO-3 15 h 7% 53% - 2% 
4 NO-4 15 min - 67% 4% 6% 
5 NO-5 15 h 39% 29% - - 
6 NO-6 15 h 10 45% - 5% 
7 NO-7 b 1 h - 84% d - 2% 
8 NO-8 c 1 h - 87% - 2% 
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Scheme 59. Synthesis of N-oxides NO-7 and NO-8 a 
 
 
a TFAA=trifluoroacetic anhydride, UHP=urea hydrogen peroxide. 
Table 10. Direct Cyclization without N-Oxide a 
 
 
 
 
 
 
 
a Estimated by 1H NMR using diethyl phthalate as the internal reference 
 
In these reactions, only small amounts of benzopyran 3-9a were formed via 
competitive gold-catalyzed 6-endo-dig cyclizations. However, in the absence of 
oxidant 4a, this cyclization was rather fast and generally efficient in the presence of a 
array of gold catalysts (Table 10). These results indicated that the N-oxide, besides 
entry catalyst time yield of 3-9a
1 Ph3PAuNTf2 1 h 66% 
2 (ArO)3PAuNTf2 b 1 h 73% 
3 IPrAuNTf2 1 h 80% 
4 Cy-JohnPhosAuNTf2 1 h 64% 
5 tBuXPhosAuNTf2 1 h 76% 
6 BrettPhosAuNTf2 15 min 87% 
7 Me4tBuXPhosAuNTf2 25 min 79% 
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being the oxidant, might hinder the side reaction by changing the activity of the gold 
catalyst through, most likely, its coordination to the LAu(I).  
 
3.4. Substrates Scope  
With the best gold catalyst Me4tBuXPhosAuNTf2, and the new oxidants NO-7 and 
NO-8 as the optimal combination, I quickly explored the reaction scope with the help 
of Dr. Kegong Ji. As shown in Table 11, with the parent phenyl propargyl ether as 
substrate, unsubstituted chroman-3-one 3-7b was obtained in a decent 75% yield. An 
ortho-Me substitution on the benzene ring were inconsequential (3-7c, 78%). The 
cyclization in the case of a meta-Me (3-7d, 67%) was highly regioselective, favoring 
the less hindered position para to the Me group (12:1); an even higher regioselectivity 
was achieved with a ortho-tBu substrate (3-7e, 16:1). A second methyl substitution on 
the benzene ring did not affect much the reaction yield (3-7f, 70%). Substrates with 
differently substituted methoxy groups reacted smoothly, affording corresponding 
products in good yields (3-7g/h/i; 70 – 83%). Importantly, the regioselectivity in the 
case of a meta-methoxy group could be improved to 11:1 when the reaction was run 
at 0 °C (3-7i) without affecting the reaction efficiency much. Markedly, these 
chroman-3-ones, 3-7g/h/i, were previously prepared from more expensive 
methoxy-substituted salicylaldehydes following the aforementioned multistep 
sequence, and the overall yields were mostly less than 41 %. [22]  
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Table 11. Suberate Scope a 
 
    
3-7b, (76%, B) 
 
3-7c, (78%, B) 
 
3-7d, (67%,  
p:o=12:1, A) 
3-7e, (74%,  
p:o=16:1, A) 
    
3-7f, (70%, A) 
 
3-7g, (83%, B) 
 
3-7h, (70%, B) 
 
3-7i, (75%,  
p:o=11:1, B) b 
 
  
3-7j, (70%, A) 
 
3-7k, (86%, B) 
 
3-7l, (63%, B) 
 
3-7m, (81%, A) 
 
  
 
3-7n, (54%, B) 
 
3-7o, (50%, B) 
 
3-7p, (43%, A) 
 
3-7q, (68%, A) 
 
 
 
   
3-7r, (81%, A) 
 
3-7s, (83%, A) 
 
3-7t, (66%, A) 
 
3-7v, (50%) c 
 
  
3-7w, (35%) c 
 
3-7x, (60%,  
l:b=8:1, B) b 
3-7y, (61%,  
l:b=3.3:1, B) b 
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a The reactions were run in a vial without exclusion of air and moisture, and the substrate 
concentration was 0.05 M. Yields of isolated products are reported. b The reaction was run at 0 °C. 
c 1.1 equivalent 2,6-dibromopyridine N-oxide was used; NMR yield using diethyl phthalate as the 
internal reference. Bn=benzyl, TBS=tert-butyldimethylsilyl. l/b=linear/bent. 
 
After the reaction, one equivalent (at least) of pyridine NO-7b or NO-8b would 
be generated and sometimes its polarity was very close to the desired product 3-9. To 
make the purification easier, for most substrates we tried the both condition A and B 
at first and then chose whichever provided a less difficult purification since both 
conditions gave similarly good results.  
The functional group tolerance of this chemistry is also well-demonstrated: 
substrates with a TBS ether (3-7j), a benzyl ether (3-7k), an acetate (3-7l), and a 
secondary amide (3-7m) all reacted smoothly to give 63 – 86% yield. However, 
electron-withdrawing groups including halides (3-7n, 3-7o) and methoxycarbonyl 
(3-7p), the reactions were less efficient notwithstanding still useful considering the 
short sequences (43 – 54%). This chemistry also worked well with naphthalene 
substrates (3-7q/r, 68 – 81%), showing excellent regioselectivities. 
Aliphatic substitutions at the propargyl position, including the sterically 
demanding isopropyl group, were readily endured with substantial yield afforded 
(3-7s/t, 66 – 83%). Notably, the diazo ketone approach could not afford this type of 
2-alkyl-substituted product effectively because of a major side Buchner ring 
expansion reaction leading to norcaradiene side products. [25] However, in the case of 
a phenyl group at the propargylic position, the yield was very low (37 %, 3-7u), 
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possibly due to the sensitivity of the substrate 3-6u in the presence of the Lewis acidic 
gold complex. 
 
 
 
The cases of 3-7v and 3-7w were generated in the early stage of this research. 
Even not under the optimal conditions, the substrates substituted by para-Cl and 
ortho-Cl groups could give the desired products in moderate yields. Notably as the 
inductive effect increased for the electron-withdrawing groups, the efficiency of the 
reaction diminished comparing 3-7v (50%, para-Cl) and 3-7w (35%, ortho-Cl). With 
the bis(ether) substrate derived from p-hydroquinone, double oxidative cyclization 
occurred smoothly to afford the linear tricycle 3-7x in a respectable yield and 
selectivity (60%, 8:1). A similar reaction was achieved with the substrate derived 
from resorcinol although the regioselectivity was moderate (3-7y, 61%, 3.3:1).  
One limitation of this methodology is that internal alkyne substrate did not work 
(Scheme 60). Under the optimum conditions 3-6z proceeded to from benzopyran 3-9z 
in high yield instead of chroman-3-one 3-7z, which is disappointing but 
understandable. Both sterics and electronic property of the internal alkyne halted the 
intermolecular oxidation reaction, favoring the intramolecular 6-endo-dig cyclization. 
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Scheme 60. Reactions of Internal Alkyne Substrate  
 
 
3.5. Other Types of Substrates 
Besides aryl propargyl ether, but-3-yn-1-ylbenzene 3-11 also reacted relatively 
efficiently to afford 3,4-dihydronaphthalen-2(1H)-one 3-12 in 57% yield under the 
previous optimal conditions for the formation of chroman-3-ones (Scheme 61). 
Considering the electronic difference between those two types of substrates, potential 
improvement remained possible and ligand tuning might help. 
 
Scheme 61. Synthesis of 3,4-dihydronaphthalen-2(1H)-one 
 
 
Aryl propargyl amine 3-13 did not provide any product under the condition 
shown in Scheme 62-A, presumably due to the basicity of the nitrogen, which shut 
down the catalysis. After one equivalent of TFA (trifluoroacetic acid) was added to 
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the reaction, no desired product but quinoline 3-14 was formed in 53% yield. With a 
benzyl protecting group on the nitrogen (Scheme 62-B), 3-15 did not give any desired 
product in spite of a 60% conversion without acidic additive. Similar to 3-13, when 
one equivalent TFA was added quinoline salt 3-16 was formed in a yield 75%. The 
formation of quinolines most likely resulted from an initial gold-catalyzed 6-endo-dig 
cyclization and a subsequent oxidation by 2,6-dibromopyridine N-oxide.  
 
Scheme 62. Reactions of Aryl Propargyl Amines 
 
 
Then electron-withdrawing protecting groups were also examined, including 
acetyl, tosyl and trifluoroacetyl groups (Figure 12), but no positive results were 
obtained out of those substrates.  
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Figure 12. Other Aryl Propargyl Amines 
 
 
3.6. Summary 
In summary, one-step efficient synthesis of chroman-3-ones from readily 
available propargyl aryl ethers was documented. This gold-catalyzed oxidation 
strategy is step- and atom-economic compared with literature protocols, and should be 
able to facilitate research involving this versatile type of heterocyclic compounds. No 
toxic or explosive reagents are involved and the reaction conditions are rather mild. A 
new gold catalyst, Me4tBuXPhosAuNTf2, was prepared and fully characterized. Its 
hindered nature is revealed by X-ray diffraction studies. This study as well as the 
work of Barriault et al. suggests this cationic gold complex based on bulky 
Me4tBuXPhos can be exclusively effective and should be included in the ligand 
selection of practitioners who are interested in gold catalysis. In addition, two easily 
accessible pyridine N-oxides derived from Hantzsch esters were demonstrated to be 
highly potent oxidants; they should help enable the development of gold-catalyzed 
alkyne oxidation reactions, which permit excellent synthetic efficiency and step 
economy. 
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3.7. Experimental Section 
General Procedure A: Preparation of Propargyl Aryl Ethers 3-6 
Propargyl aryl ethers 3-6 were prepared by alkylation of the corresponding 
phenols with propargyl bromide. In a general procedure, a mixture of phenol (10 
mmol) and anhydrous potassium carbonate (30 mmol) in DMF (20 mL) was heated to 
60 ℃ for half an hour under inert atmosphere with proper stirring. The reaction 
mixture was then cooled to room temperature and propargyl bromide (12 mmol) was 
added slowly. The reaction was monitored by TLC and after completion (1 - 4 h) the 
mixture was diluted with ether and washed at least 3 times with brine. The ethers were 
purified with flash silica gel column chromatography after solvent evaporation.  
 
Preparation of N-oxides NO-7 
 
Hantzsch Ester NO-7a was prepared in 90% yield according known procedure.[32] 
A mixture of paraformaldehyde (100 mmol), ethyl acetoacetate (400 mmol), and 
ammonium acetate (200 mmol) in 200 mL of water was vigorously stirred at refluxing 
temperature for 2h. The reaction was monitored by TLC. After the reaction was 
completed, the reaction mixture was cooled to room temperature, then filtrated and 
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washed with 10mL of water twice. The obtained yellow solid product was nearly pure 
and used in the next step without further purification.  
Pyridine NO-7b was achieved in 95% yield according to the literature 
procedure.[33] To a solution of NO-7a (10 mmol) in EtOAc (100 mL), molecular 
iodine (510 mg, 2 mmol, 20 mol %) and UHP (1.9 g, 20 mmol) were added. The 
reaction mixture was stirred at rt for 1h. After that to the reaction mixtures, water (10 
mL) and solid Na2S2O5 in small portions were added to complete decolouration. The 
phases were separated and the aqueous phase was additionally extracted with EtOAc 
(10 mL). The combined organic layers were dried over Na2SO4, filtered and 
evaporated to dryness. The solid product was nearly pure and could be used directly 
in the next step. The pure pyridine might also be obtained by recrystallization from 
diisopropyl ether.  
NO-7 
 
K2CO3 (20 mmol) and UHP (10 mmol) were stirred in dry 1,4-dioxane or CHCl3 (100 
ml) for 1 h, then TFAA (10 mmol) was added dropwise at 0 °C. The mixture was 
allowed to reach r.t., NO-7 (1 mmol) added and the mixture stirred overnight at 50 °C 
(1, 4-dioxane, if used, was then removed by evaporation and replaced with DCM). 
The mixture was washed with water (50 ml), the organic layer dried over MgSO4 and 
the solvent removed by evaporation. The crude product was purified with flash silica 
gel column chromatography after solvent evaporation and N-oxide NO-7 was 
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obtained in 80% yield (15% staring material recovered). 1H NMR (400 MHz, CDCl3) 
δ 8.11 (s, 1H), 4.42 (q, J = 7.1 Hz, 4H), 2.84 (s, 6H), 1.42 (t, J = 7.1 Hz, 6H); 13C 
NMR (125 MHz, CDCl3) δ 164.70, 153.64, 126.48, 126.28, 62.22, 15.97, 14.16; 
296.15; IR (neat): 2993, 1725, 1366, 1299, 1232, 1065; MS (ES+) Calculated for 
[C13H18NO5]+: 268.12; Found: 268.12. 
NO-8a 
 
Hantzsch Ester NO-8a was prepared in 65% yield according to the literature 
procedure.[34] 1H NMR (500 MHz, CDCl3) δ 5.19 (s, 1H), 4.17 (q, J = 7.1 Hz, 4H), 
3.27 (s, 2H), 2.61 (q, J = 7.5 Hz, 4H), 1.28 (dd, J = 9.1, 5.2 Hz, 6H), 1.15 (td, J = 7.6, 
3.7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 167.53, 150.47, 98.56, 59.62, 25.78, 
24.88, 14.43, 12.61.  
NO-8b 
 
Pyridine NO-8b was prepared in 92% yield in the same way to NO-7b. 1H NMR (400 
MHz, CDCl3) δ 8.59 (s, 1H), 4.39 (q, J = 7.1 Hz, 4H), 3.18 (q, J = 7.5 Hz, 4H), 1.41 (t, 
J = 7.1 Hz, 6H), 1.30 (t, J = 7.5 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 166.78, 
166.13, 141.02, 122.55, 61.36, 30.43, 14.23, 13.82; IR (neat): 2979, 1725, 1594, 1292, 
1236, 1106; MS (ES+) Calculated for [C15H22NO6]+: 280.15; Found: 280.16. 
NO-8 
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N-oxide 4e was prepared in 65% yield (30% starting material recovered) in the same 
way to NO-7. 1H NMR (400 MHz, cdcl3) δ 8.02 (s, 1H), 4.41 (q, J = 7.1 Hz, 4H), 3.31 
(q, J = 7.3 Hz, 4H), 1.41 (t, J = 7.1 Hz, 6H), 1.30 (t, J = 7.3 Hz, 6H); 13C NMR (125 
MHz, CDCl3) δ 164.73, 157.88, 126.41, 126.33, 62.15, 22.77, 14.14, 10.55; IR (neat): 
2983, 1724, 1297, 1206, 1082; MS (ES+) Calculated for [C15H22NO5]+: 296.15; Found: 
296.15. 
 
General Procedure B: Preparation of Chroman-3-Ones 3-7 
 
Pyridine N-oxide NO-7 (0.65 mmol, 1.3 equiv.) or NO-8 (0.6 mmol, 1.2 equiv.) 
was added to a solution of the propargyl aryl ether 3-6 (0.50 mmol) in DCE (10 mL. 
0.05M) at room temperature, followed by Me4tBuXPhosAuNTf2 (0.025 mmol, 5 
mol %). The reaction mixture was stirred at r.t. and the progress of the reaction was 
monitored by TLC. The reaction typically took 1 – 3 h. Upon completion, the mixture 
was concentrated and the residue was purified by chromatography on silica gel (eluent: 
hexanes/ethyl acetate) to afford the desired products 3-7. 
3-7a 
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This compound was prepared in 82% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (600 MHz, CDCl3) δ 7.30 – 7.24 (m, 1H), 7.16 – 7.10 
(m, 1H), 7.00 (d, J = 8.5 Hz, 1H), 4.40 (s, 2H), 3.63 (s, 2H), 1.32 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 207.99, 152.21, 146.32, 125.70, 125.37, 120.73, 117.04, 73.02, 
41.21, 34.31, 31.46; IR (neat): 2961, 1736, 1615, 1502, 1262, 1042; GCMS m/z 
204.00 (M+). 
3-7b 
 
This compound was prepared in 76% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.26 – 7.20 (m, 1H), 7.12 (dd, J = 
7.8, 0.8 Hz, 1H), 7.05 (dd, J = 11.3, 4.4 Hz, 2H), 4.41 (s, 2H), 3.62 (s, 2H); 13C NMR 
(125 MHz, CDCl3) δ 207.48, 154.50, 128.91, 128.40, 123.27, 121.46, 117.63, 77.25, 
77.00, 76.74, 72.90, 40.83. 
3-7c 
 
This compound was prepared in 78% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (400 MHz, CDCl3) δ 7.14 – 7.06 (m, 1H), 6.98 – 6.92 
(m, 2H), 4.42 (s, 2H), 3.60 (s, 2H), 2.29 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
208.24, 152.77, 129.68, 127.20, 126.34, 122.88, 121.20, 77.32, 77.00, 76.68, 72.85, 
41.09, 15.60; IR (neat): 2922, 1730, 1601, 1476, 1038, 763; GCMS m/z 162.00 (M+). 
3-7d 
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This compound was prepared in 67% yield (p:o = 12:1) using NO-7 as oxidant 
according to the general procedure B.1H NMR (500 MHz, CDCl3) δ 7.00 (d, J = 7.5 
Hz, 1H), 6.87 (d, J = 8.9 Hz, 2H), 4.38 (s, 2H), 3.57 (s, 2H), 2.34 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 207.75, 154.33, 138.58, 128.57, 124.04, 118.20, 118.09, 72.91, 
40.47, 21.09. IR (neat): 1621, 1582, 1506, 1431, 1267, 1238, 1148, 1120, 928, 813; 
GCMS m/z 162(M+). 
3-7e 
 
This compound was prepared in 74% yield (p:o = 16:1, mixed with 3% 3-7a) using 
NO-7 as oxidant according to the general procedure B. 1H NMR (500 MHz, CDCl3) δ 
7.09 (dt, J = 4.2, 1.8 Hz, 2H), 7.06 (dt, J = 8.4, 0.8 Hz, 1H), 4.41 (s, 2H), 3.59 (s, 2H), 
1.32 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 207.75, 154.17, 152.30, 128.41, 120.36, 
118.21, 114.65, 73.01, 40.39, 31.26; IR (neat): 2963, 1737, 1504, 1276, 1050; GCMS 
m/z 189(M+). 
3-7f 
 
This compound was prepared in 70% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (600 MHz, CDCl3) δ 6.74 (d, J = 11.0 Hz, 2H), 4.37 (s, 
2H), 3.50 (s, 2H), 2.30 (s, 3H), 2.22 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 207.63, 
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154.20, 137.73, 136.64, 125.41, 116.64, 115.72, 72.63, 37.55, 20.96, 18.68; IR (neat): 
2919, 1735,  1583, 1298, 1083; GCMS m/z 175.95 (M+). 
3-7g 
 
This compound was prepared in 83% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 6.97 (d, J = 8.8 Hz, 1H), 6.76 (dd, 
J = 8.8, 2.8 Hz, 1H), 6.64 (d, J = 2.6 Hz, 1H), 4.35 (s, 2H), 3.77 (s, 3H), 3.58 (s, 2H); 
13C NMR (125 MHz, CDCl3) δ 207.62, 155.51, 148.42, 122.54, 118.25, 113.72, 
113.67, 73.14, 55.67, 41.18; IR (neat): 2961, 1732,  1499, 1248, 1198, 1058;  
GCMS m/z 177.95 (M+). 
3-7h 
 
This compound was prepared in 70% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.00 (t, J = 7.9 Hz, 1H), 6.85 (d, 
J = 7.6 Hz, 1H), 6.73 (dd, J = 7.6, 0.8 Hz, 1H), 4.46 (s, 2H), 3.90 (s, 3H), 3.61 (s, 2H); 
13C NMR (125 MHz, CDCl3) δ 207.39, 149.30, 143.56, 123.36, 122.61, 120.47, 
110.79, 73.07, 56.00, 40.74; IR (neat): 2963, 1733, 1588, 1486, 1270, 1088; GCMS 
m/z 177.95 (M+). 
3-7i 
 
143 
 
This compound was prepared in 75% yield (p:o = 11:1) at 0 °C using NO-8 as 
oxidant according to the general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.01 (d, 
J = 9.2 Hz, 1H), 6.62 (dd, J = 6.0, 2.5 Hz, 2H), 4.39 (s, 2H), 3.79 (s, 3H), 3.55 (s, 2H); 
13C NMR (125 MHz, CDCl3) δ 207.56, 159.94, 155.29, 129.32, 113.09, 109.59, 
103.14, 72.92, 55.43, 40.07. IR (neat): 1733, 1620, 1587, 1506, 1447, 1290, 1274, 
1201, 1158, 1108; GCMS m/z 178(M+). 
3-7j 
 
This compound was prepared in 70% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (600 MHz, CDCl3) δ 6.91 (d, J = 8.7 Hz, 1H), 6.69 (dd, 
J = 8.7, 2.8 Hz, 1H), 6.59 (d, J = 2.8 Hz, 1H), 4.36 (s, 2H), 3.55 (s, 2H), 0.98 (s, 9H), 
0.21 – 0.13 (m, 6H); 13C NMR (150 MHz, CDCl3) δ 207.79, 151.31, 148.82, 122.44, 
119.78, 119.64, 118.16, 73.14, 41.10, 25.63, 18.12, -4.50; IR (neat): 2930, 2858, 1737, 
1493, 1252, 1199, 968, 839; GCMS m/z 277.95 (M+). 
3-7k 
 
This compound was prepared in 86% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.37 (m, 4H), 7.37 – 7.31 
(m, 1H), 6.99 (d, J = 8.8 Hz, 1H), 6.85 (dd, J = 8.8, 3.0 Hz, 1H), 6.74 (d, J = 2.9 Hz, 
1H), 5.03 (s, 2H), 4.37 (s, 2H), 3.58 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 207.61, 
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154.66, 148.60, 136.82, 128.55, 127.97, 127.36, 122.57, 118.29, 114.83, 114.74, 
73.12, 70.54, 41.18; IR (neat): 1732,  1494, 1196, 1044; GCMS m/z 253.90 (M+). 
3-7l 
 
This compound was prepared in 63% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.08 – 7.03 (m, 1H), 6.97 – 6.91 
(m, 1H), 6.87 (dt, J = 6.8, 2.9 Hz, 1H), 4.40 (d, J = 1.9 Hz, 2H), 3.60 (s, 2H), 2.31 – 
2.26 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 206.66, 169.69, 152.11, 145.94, 122.53, 
121.81, 121.47, 118.47, 77.25, 77.00, 76.75, 72.90, 40.79, 20.99; IR (neat): 1758, 
1736, 1493, 1213, 1189, 1040; MS (ES+) Calculated for [C11H10KO4]+: 245.02; Found: 
245.09. 
3-7m 
 
This compound was prepared in 81% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.77 (s, 1H), 7.39 (d, J = 2.1 Hz, 
1H), 7.18 (dd, J = 8.6, 2.4 Hz, 1H), 6.95 (d, J = 8.6 Hz, 1H), 4.35 (s, 2H), 3.53 (s, 2H), 
2.13 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 207.24, 168.65, 151.03, 133.26, 121.94, 
121.00, 120.46, 117.83, 72.94, 40.85, 24.24; IR(neat): ) 3288, 1732, 1663,  1552, 
1498, 1423, 1256, 1205, 1043; ESI(M+Na+): 228.07  
3-7n 
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This compound was prepared in 54% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.01 (dd, J = 8.9, 4.7 Hz, 1H), 
6.95 – 6.90 (m, 1H), 6.87 – 6.83 (m, 1H), 4.39 (s, 2H), 3.60 (s, 2H); 13C NMR (125 
MHz, CDCl3) δ 206.64, 158.49 (d, JC-F = 240 Hz), 150.57, 123.14 (d, JC-F = 8.8 Hz), 
118.80 (d, JC-F = 8.8 Hz), 115.22 (d, JC-F = 25 Hz), 115.01 (d, JC-F = 23.8 Hz), 72.99, 
40.89; IR (neat): 1736,1493, 1436, 1196, 1042, 820; GCMS m/z 166(M+). 
3-7o 
 
This compound was prepared in 50% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.34 (ddd, J = 8.6, 1.8, 0.6 Hz, 
1H), 7.28 – 7.24 (m, 1H), 6.94 (d, J = 8.6 Hz, 1H), 4.40 (s, 2H), 3.59 (s, 2H); 13C 
NMR (125 MHz, CDCl3) δ 206.13, 153.60, 131.55, 131.37, 123.61, 119.45, 115.48, 
72.83, 40.41; IR (neat): 2892, 1727, 1485, 1262, 1179, 1044, 821; GCMS m/z 225.9 
(M+). 
3-7p 
 
This compound was prepared in 43% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.96 – 7.90 (m, 1H), 7.86 – 7.83 
(m, 1H), 7.08 (d, J = 8.5 Hz, 1H), 4.47 (s, 2H), 3.90 (s, 3H), 3.66 (s, 2H); 13C NMR 
(125 MHz, CDCl3) δ 205.75, 166.33, 158.10, 130.96, 130.33, 125.16, 121.07, 117.70, 
146 
 
72.76, 52.11, 40.38; IR (neat): 1715, 1615, 1498, 1438, 1263, 770; GCMS m/z 206 
(M+). 
3-7q 
 
This compound was prepared in 68% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.1 Hz, 1H), 7.74 (dd, 
J = 8.4, 3.6 Hz, 2H), 7.55 (ddd, J = 8.4, 6.9, 1.3 Hz, 1H), 7.44 (ddd, J = 8.0, 6.9, 1.1 
Hz, 1H), 7.24 (d, J = 8.9 Hz, 1H), 4.53 (s, 2H), 3.91 (s, 2H); 13C NMR (125 MHz, 
CDCl3) δ 206.09, 151.67, 131.86, 129.97, 128.86, 128.74, 127.02, 124.41, 121.39, 
118.51, 112.52, 72.49, 36.21, IR (neat): 1732, 1625, 1601, 1470, 1399, 1243, 1216, 
1088, 1038, 814; GCMS m/z 198(M+). 
3-7r 
 
This compound was prepared in 81% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (600 MHz, cdcl3) δ 8.23 (d, J = 8.1 Hz, 1H), 7.86 – 
7.81 (m, 1H), 7.59 – 7.48 (m, 3H), 7.19 (d, J = 8.3 Hz, 1H), 4.59 (s, 2H), 3.73 (s, 2H); 
13C NMR (150 MHz, cdcl3) δ 207.53, 149.68, 133.63, 127.63, 126.39, 126.17, 126.10, 
125.22, 122.79, 121.35, 115.08, 72.94, 40.41; IR (neat): 3053, 2924, 1734, 1580, 
1384, 1266, 1100, 811; GCMS m/z 198.00 (M+). 
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3-7s 
 
This compound was prepared in 83% yield using NO-8 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.26 – 7.22 (m, 1H), 7.11 – 7.07 
(m, 1H), 6.96 (d, J = 8.5 Hz, 1H), 4.23 (dd, J = 8.5, 4.3 Hz, 1H), 3.58 (s, 2H), 1.85 – 
1.72 (m, 2H), 1.61 – 1.49 (m, 2H), 1.31 (s, 9H), 0.96 (t, J = 7.4 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ 209.42, 151.51, 145.94, 125.34, 125.22, 121.16, 117.23, 81.92, 
40.96, 34.28, 32.88, 31.48, 18.36, 13.68; IR (neat): 2873, 1728, 1612, 1499, 1463, 
1364, 1265, 1238, 1136, 825; GCMS m/z 246(M+).  
3-7t 
 
This compound was prepared in 66% yield using NO-7 as oxidant according to the 
general procedure B. 1H NMR (500 MHz, CDCl3) δ 7.27 – 7.23 (m, 1H), 7.10 – 7.06 
(m, 1H), 6.97 (d, J = 8.5 Hz, 1H), 3.98 (d, J = 4.8 Hz, 1H), 3.55 (s, 2H), 2.32 (dtd, J = 
13.7, 6.9, 4.8 Hz, 1H), 1.30 (s, 9H), 1.05 (dd, J = 58.4, 6.9 Hz, 6H); 13C NMR (125 
MHz, CDCl3) δ 209.04, 151.86, 145.77, 125.33, 125.24, 120.95, 117.05, 86.44, 41.68, 
34.26, 31.48, 30.24, 18.83, 17.02; IR (neat):1729, 1501, 1240, 1010;  GCMS m/z 
246 (M+). 
3-7u 
 
148 
 
This compound was prepared in 60% yield (l:o = 8:1) at 0 °C using NO-8 as oxidant 
according to the general procedure B. 1H NMR (500 MHz, CDCl3) δ 6.84 (s, 2H), 
4.38 (s, 4H), 3.59 (s, 4H); 13C NMR (125 MHz, CDCl3) δ 206.93, 150.26, 121.77, 
117.62, 73.09, 40.80; IR (neat): 1733, 1496, 1442, 1406, 1261, 1188, 1169, 1048, 898, 
726; GCMS m/z 218(M+). 
3-7v 
 
This compound was prepared in 61% yield (l:o = 3.5:1) at 0 °C using NO-8 as 
oxidant according to the general procedure B. 1H NMR (500 MHz, CDCl3) δ 6.91 – 
6.83 (m, 1H), 6.78 (s, 1H), 4.39 (s, 4H), 3.56 (s, 4H); 13C NMR (125 MHz, CDCl3) δ 
206.83, 154.39, 128.62, 116.47, 107.23, 72.91, 40.24; IR (cm-1) 1730, 1505, 1161, 
1115; GCMS m/z 218 (M+). 
 
Synthesis of Me4tBuXPhosAuNTf2 
Me4tBuXPhosAuCl: Chloro(2-Di-tert-butylphosphino-3,4,5,6-tetramethyl-2’,4’,6’- 
triisopropyl-1,1’-biphenyl)gold(I) 
 
To a suspension of 2-Di-tert-butylphosphino-3,4,5,6-tetramethyl-2’,4’,6’- 
triisopropyl-1,1’-biphenyl (480.8 mg, 1 mmol) in anhydrous DCM was added 
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chloro(dimethylsulfide)gold(I) (294.5 mg, 1 mmol). The mixture was stirred for 1 h at 
room temperature. The solvent was evaporated off under reduced pressure to give the 
desired gold complex (677 mg, 95%) as a white powder.  
Me4tBuXPhosAuNTf2 
 
To a suspension of Chloro(2-Di-tert-butylphosphino-3,4,5,6-tetramethyl- 
2’,4’,6’-triisopropyl-1,1’-biphenyl)gold(I) (677 mg, 0.95 mmol) in anhydrous DCM 
was added AgNTf2 (386 mg, 0.95 mmol). The mixture was stirred for 1 h at room 
temperature. The AgCl was filtered and the solvent was evaporated off under reduced 
pressure to give the desired gold complex in quantitive yield. 1H NMR (600 MHz, 
CDCl3) δ 7.15 (s, 2H), 2.97 (m, 1H), 2.63 (s, 3H), 2.39 – 2.28 (m, 5H), 2.24 (s, 3H), 
1.54 (d, J = 18 Hz, 18H), 1.48 (s, 3H), 1.35 (d, J = 6 Hz, 6H), 1.29 (d, J = 6 Hz, 6H), 
0.87 (d, J = 6 Hz, 6H); 13C NMR (150 MHz, CDCl3) δ148.79, 146.25, 145.65 (d, J = 
18 Hz), 140.79, 137.68 (d, J = 3 Hz), 137.51, (d, J = 7.5 Hz), 135.99 (d, J = 7.5 Hz), 
123.26, 122. 80, 122.49, 120.65, 118.50, 42.59 (d, J = 21 Hz), 33.64, 33.22 (d, J = 7.5 
Hz), 30.84, 28.15, 25.40, 24.68, 23.82, 22.55 (d, J = 2.7 Hz), 17.76, 17.27; 31P NMR 
(162 MHz, CDCl3) δ 76.61.  
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4. Homogeneous Au-Catalyzed Indole Synthesis 
4.1. Au-Catalyzed Synthesis of 2-Alkylindole from N-Arylhydroxyl- 
amines and Terminal Alkynes 
4.1.1. Introduction and Design 
Indole derivatives are probably the most ubiquitous heterocycles in nature. On 
account of the great structural diversity and biological activity of indoles, it is not 
surprising that the indole ring has become an extremely important structural 
component in pharmaceuticals,[ 1 ] agrochemicals[ 2 ] and even material science.[ 3 ] 
Substituted indoles have been always referred to as “privileged structures” since they 
are capable of binding to many receptors with high affinity.[4] For well over a century, 
the synthesis and functionalization of indoles has been a hot research area for 
synthetic organic chemists, and numerous methods for the preparation of indoles have 
been developed.[5] Starting material availability and functional group tolerance often 
serve as the key factors to decide that which particular indole synthesis will be 
suitable.  
One of the oldest but most reliable methods for synthesizing substituted indoles is 
the Fischer indole synthesis, which has been subjected to extensive 
modifications/improvements and applied extensively including in the synthesis of 
various indole alkaloids since the original report by Fischer in 1893. This annulation 
between an arylhydrazine and a ketone relies on a crucial 3,3-sigmatropic 
rearrangement of an N-alkenyl-N’-arylhydrazine intermediate. While it has been 
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subjected to various modifications/improvements, there are still notable deficiencies 
including: 1) harsh reaction conditions, like strong acidic conditions and high 
temperature; 2) the difficulty in achieving excellent regioselectivities with 
unsymmetric ketones; 3) failure to indolize α,β-unsaturated ketones due to the 
preferred formation of pyrazolines; 4) and low efficiencies with substrates containing 
electron-withdrawing substituents on the aromatic ring. While catalytic 
hydroamination of alkynes has been developed as an alternative approach to 
N-alkenylhydrazines, the reported reaction scopes are mostly limited to arylalkynes 
and reaction conditions are still strong.[6,7] 
Similarly to Fisher indole synthesis, 3,3-rearrangements of 
O-vinyl-N-arylhydroxylamines or its derivatives can lead to indole synthesis upon 
successive cyclodehydration. A prominent example is the Bartoli indole synthesis. 
While this indolization typically proceeds at much lower temperatures than in the case 
of the Fischer indole synthesis, three equivalents of vinyl Grignard reagent were 
obligatory if nitroarenes are the substrates; for nitrosoarene, two equivalents of 
Grignard reagent were indispensable. Considering being severely limited by the 
requirement of an ortho substitution in the nitroarene substrate, the functional group 
tolerance and the moderate efficiency of this reaction, it’s safe to say that there is a 
lack of mild, general and straightforward methods for the generation of 
O-alkenyl-N-arylhydroxylamines.  
We anticipated that these O-alkenyl-N-arylhydroxylamine intermediates 4-1B 
could be formed via gold-promoted addition of the HO group of 
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N-arylhydroxylamines 4-1 onto C-C triple bonds. After the facile 3,3-sigmatropic 
rearrangement, intermediates 4-1C were formed and gave the 2-substituted indoles 
4-2 through dehydrated cyclization (Scheme 63). By using alkynes as substrates, this 
indole synthesis may offer solutions to some of the difficulties in the Fischer indole 
synthesis and Bartoli indolization. To our surprise, this strategy has not been realized 
although related reactions using propiolates and hydroxamic acids in the presence of 
bases have been reported.[8,9] 
 
Scheme 63. Formation of O-Alkenyl-N-phenylhydroxylamines via HO Addition to 
Alkynes en Route to Indoles  
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Gold-catalyzed synthesis of indoles has been realized long time ago and the first 
example was reported by Utimoto et al.[ 10 ] in 1988. Catalyzed by NaAuCl4, 
2-substitued indoles were efficiently prepared starting from 2-alkylnylanilines in THF 
by an intramolecular 5-endo-dig cyclization. N-protected anilines reacted analogously 
to give N-protected indoles in good yields. Sixteen years later, Marinelli et al.[11] came 
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up with a broader substrates scope for this reaction with the same catalyst but 
different solvent (Scheme 64)  
 
Scheme 64. Au(III)-Catalyzed Indole Synthesis from 2-Alkylnylalines 
 
 
An efficient method involving a formal tandem hydrohydrazination/Fischer 
indolization reaction to synthesize 2-methyl-3-substituted indoles from alkynes and 
arylhydrazines was developed by Patil et al.[ 12 ] in 2010 using a 
Ph3PAuNTf2/pTSA·H2O binary catalytic system (Scheme 65). One feather of this 
methodology is that the reaction is not sensitive to moisture since water is essential to 
get the reaction going. The mechanism of these reactions has been investigated and 
the authors proposed an interesting mechanistic dichotomy. When alkynes have 
OH/COOH groups in the tether, hydroalkoxylation/hydrocarboxylation occurred to 
generate exocyclic enol ethers/lactones that reacted with hydrazines to produce 
indoles. In cases where the alkynes lack OH/COOH groups, Au/acid promoted 
hydration occurs first to generate ketones, which then react with arylhydrazines to 
give the desired indoles. 
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Scheme 65. Formal Tandem Hydrohydrazination/Fischer Indolization Catalyzed 
by Ph3PAuNTf2/pTSA Binary System 
 
 
In 2011, Fujii and Ohno reported that through a gold-catalyzed intramolecular 
cascade 5-endo-dig hydroamination followed by a 6-endo-dig cycloisomerization, 
diynes 4-3 were smoothly converted to various fused indoles 4-4, such as 
aryl-annulated carbazoles, dihydrobenzo indoles, and azepino- or oxepinoindole 
derivatives, in good to excellent yields (Scheme 66).[13] 
 
Scheme 66. Gold(I)-Catalyzed Fused-indole Synthesis 
 
 
Early in 2011, through the reaction of oximes 4-5 with activated alkynes 
promoted by base or Ph3PAu(I), Camp et al.[14] synthesized O-vinyl oximes 4-6, 
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which undergo a 1,3-hydrogen shift to afford 1,5-diene 4-6A. Subsequent gold 
catalysis introduced 3,3-rearrangement to give intermediates 4-6B, followed by 
cyclodehydration to yield the highly substituted pyrroles 4-7 in an efficient and 
region-controlled process (Scheme 67).  
 
Scheme 67. Gold-Catalyzed Pyrrole Synthesis from Oxime and Activated Alkynes 
 
 
Efficient additions of various nucleophiles (NuH) to C–C triple bonds have been 
successfully realized in gold catalysis; however, hydroxylamines have not been used 
as nucleophiles so far. We envisioned that O-alkenyl-N-arylhydroxylamine 4-1B 
(Scheme 63) should be easily formed via the nucleophilic attacks of 
N-arylhydroxylamines 4-1 toward the gold-activated alkynes under mild reaction 
conditions.  
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4.1.2. Conditions Study 
 Having this design shown in Scheme 63 in mind, I quickly put the idea to the 
test. The results of condition optimization were summarized in Table 12. 
N-phenylhydroxylamine 4-1a was selected to be the standard nucleophile as it’s easy 
to access from the reduction of nitrobenzene, and two equivalents of 1-dodecyne was 
used as the reaction partner. When the first time I run the reaction with Ph3PAuNTf2 
as the catalyst, delightfully 2-n-decylindole 4-2a was indeed formed in 57% yield at 
room temperature after 18 h (entry 1). Methyl ketone 4-8a was the major side product 
(62% yield, based on 1 equivalent of 4-1a), plus small amount of diazene N-oxide 
4-9a and aniline 4-10a (10%). We ascribed the formation of 4-8a partly to the 
competitive N-H addition of 4-1a to the alkyne and subsequent hydrolysis of nitrone 
4-1a’ (Scheme 68-A), and partly to direction gold-catalyzed hydration of alkynes. 
H2O consumed in these hydration processes should mostly come from the 
cyclodehydrative indole formation. To minimize the costume of alkynes, 4Å 
molecular sieve was added to the reaction, but unfortunately it slowed down the 
reaction rate significantly, giving less than 20% product after 18 h. 
N-arylhydroxylamine 4-1a is known to disproportionate easily to produce aniline 
4-10a and nitrosobenzene 4-11a, which was probably in-situ trapped by 4-1a, 
followed by dehydration to give diazene N-oxide 4-9a.  
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Table 12. Condition Optimization  
 
a Anhydrous solvents were used; [1a] = 0.1 M; under nitrogen. b Estimated by 1H NMR using 
diethyl phthalate as internal reference. c 84% isolated yield. Ar = 2,4-di-tert-butylphenyl.  
 
 Different gold catalysts were immediately screened (entries 2-7). When the 
ligand changed from Ph3P to more electron-deficient (4-CF3Ph)3P, the reaction was 
improved from 57% (entry 1) to 74% (entry 2). Gold catalyst based on electron-rich 
ligands (i.e., IPr, Et3P, BrettPhos and QPhos) gave no promising results (entries 3, 5, 
entry catalyst x Solvent a Yield 
b 
4-2a 4-8a 4-9a 4-10a 
1 Ph3PAuNTf2 2 DCM 57% 62% trace 9% 
2 (4-CF3Ph)3PAuNTf2 2 DCM 74% 72% trace 6% 
3 IPrAuNTf2 2 DCM 63% 55% trace 8% 
4 (ArO)3PAuNTf2 2 DCM 83% 74% 1% 3% 
5 Et3PAuNTf2 2 DCM 46% 61% trace 10% 
6 BrettphosAuNTf2 2 DCM 21% 67% 0% 10% 
7 (F5Ph)3PAuNTf2 2 DCM 4% 8% 9% 7% 
8 QPhosAuNTf2 2 DCM 30% 70% 3% 20% 
9 (ArO)3PAuNTf2 2 DCE 94% 71% 2% 4% 
10 (ArO)3PAuNTf2 2 Et2O 93% 80% 3% 1% 
11 (ArO)3PAuNTf2 2 THF 40% 78% 6% 2% 
12 (ArO)3PAuNTf2 2 acetone 52% 66% 4% 5% 
13 (ArO)3PAuNTf2 2 CH3CN 38% 24% 4% 5% 
14 (ArO)3PAuNTf2 2 toluene 93% 65% 1% 2% 
15 (ArO)3PAuNTf2 2 hexanes 28% 60% trace 4% 
16 (ArO)3PAuOTf 2 DCE 55% 57% 3% 4% 
17 Ph3PAuClO4 2 DCE 57% 45% 2% 6% 
18 Hg(OTf)2 2 DCE 2% 35% 15% 13% 
19 (ArO)3PAuNTf2 1.8 DCE 86%c 75% 1% 2% 
20 (ArO)3PAuNTf2 1.6 DCE 76% 63% 2% 4% 
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6, 8), and (F5Ph)3PAuNTf2 turned out to be useless for unknown reasons (entry 7). 
More electron-deficient phosphite-based cationic gold(I) complex, (ArO)3PAuNTf2 
(Ar = 2,4-di-tert-butylphenyl), gave the best 83% yield (entry 4). 
Dichloro(2-picolinato)Au(III) only provided significant amount of diazene N-oxide 
4-9a, but no desired product was detected.  
 
Scheme 68. Possible Pathways of By-products Formation 
 
 
 During the catalyst screening, I found out that more electron-rich gold(I) 
catalysts yielded more aniline 4-10a, 10% for Et3PAuNTf2, 10% for BrettphosAuNTf2 
and 20% for even more electron-rich QPhosAuNTf2. These results might indicate that 
another pathway could also possibly contributed to the formation of 4-10a (Scheme 
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68-C). Just like the pyridine N-oxide, it’s possible that 4-1a oxidizes the alkyne to 
α-oxo gold carbene and generate aniline as the side-product. Higher temperature was 
also tried, but hydroxylamine 4-1a decomposed even at 40 °C, giving around 40% 
yield. 
 After the catalyst investigation, solvents were then examined. To my surprise, 
DCE somehow was a better solvent than DCM, and the yield was increased to 94% 
(entry 9). While diethyl ether provided as good yield as DCE (entry 10, 93%), more 
polar THF, acetone and acetonitrile gave worse results (entries 11-13). Relatively 
non-polar toluene worked very well (entry 14, 93%), but extremely non-polar hexanes 
gave very poor result (entry 15). With DCE as the ideal solvent, (ArO)3PAuOTf, 
which is only different from the contour ion of the best catalyst, was then tested but 
gave very lousy outcome (entry 16); so do did Ph3PAuClO4 (entries 17). Nonsterically 
demanding π-acid Hg(OTf)2 was also investigated; 4-8a (35%), 4-9a (15%) and 4-10a 
(13%) were the major products observed and the desired indole 4-2a was only formed 
in 2% yield (entry 18). The reaction yield decreases as the amount of the alkyne 
decreases (entries 19 and 20). With 1.8 equivalent of 1-dodecyne, the reaction yield 
was still pretty good, and the isolated yield was 84%.  
 
4.1.3. Substrates Scope 
 After the optimal conditions got figured out, the scope of alkynes was first 
studied. As shown in Table 13, this gold-catalyzed indole synthesis worked well with 
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various cycloalkylacetylenes (4-2b/c/d), including cyclopropylacetylene (4-2d). 
Linear aliphatic terminal alkynes containing various functional groups also reacted 
well. These functional groups include phenyl (4-2e), benzyl protected hydroxyl group 
(4-2f), chloro (4-2h), free carboxylic acid (4-2i) and a protected amino group (4-2j). 
Of particular note is the tolerance of the acid labile THP group (4-2g), confirming the 
exceptionally mild nature of this indolization; again, in contrast, the Fischer indole 
synthesis is typically performed under highly acidic environment. This mild reaction 
conditions also permit the preparation of chloroindole 4-2h without affecting with the 
chloro moiety. However, terminal enynes and internal alkynes (Figure 13) were not 
suitable substrates and the reactions gave either complicated results or low 
reactivities.  
 The scope of N-arylhydroxylamines 4-1 were then inspected. A weakly 
electron-donating methyl group (4-2k) or electron-withdrawing halides (4-2l/m/o/p) 
and ester group (4-2n) at the benzene ring para or meta to the hydroxylamine moiety 
permitted good to efficient reaction outcomes although there was almost no 
regioselectivity for N-(3-chlorophenyl)hydroxylamine (4-2p). A few limitations still 
exist: an ortho-Me group led to poor yield (<10%), and 
N-(4-methoxyphenyl)hydroxylamine was too labile for this chemistry. The general 
allowance of electron-withdrawing groups in this chemistry nicely complement the 
Fischer indole synthesis, where low yields are normally obtained. For the above 
examination of substrate scope, Dr. Longwu Ye offered tremendous help.  
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Table 13. Reaction Scope Studies 
 
   
4-2b, 77%,  
 
4-2c, 62% a 
 
4-2d, 70% 
 
   
4-2e, 89% 
 
4-2f, 84% 
 
4-2g, 67% 
 
  
4-2h, 74% 
 
4-2i, 73% 
 
4-2j, 72% 
 
  
4-2k, 64% 
 
4-2l, 86% 
 
4-2m, 82% 
 
  
 
4-2n, 76%,  4-2o, 63%, 4-2p, 85% (4-Cl/6-Cl  = 1/1.3.) 
a Toluene as the solvent. Ar = 2,4-di-tert-butylphenyl.  
 
Figure 13. Problematic Alkynes 
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An important feature of this methodology is the exclusive selectivity toward 
2-alkylindoles, and no 3-alkylindoles were observed. This excellent regioselectivity 
benefits from the Markovnikov additions of N-arylhydroxylamines to the 
gold-activated terminal alkynes. In contrast, with corresponding methyl ketones as 
substrates coupled with N-arylhydrazines in the Fischer indole synthesis, strongly 
acidic mediums (e.g., 5 % P2O5/neat MsOH[15] or neat polyphosphoric acid[16]) are 
compulsory to yield 2-alkylindoles, and the regioselectivities were typically low to 
moderate. 
 
4.1.4. Conclusions 
A novel access to O-alkenyl-N-arylhydroxylamines via the first gold-catalyzed 
addition of N-arylhydroxylamines to aliphatic terminal alkynes has been 
developed. This mild gold catalysis took advantage of a facile in situ 
3,3-rearrangement and subsequent cyclodehydration, affording 2-alkylindoles 
regiospecifically in typically good yields under exceptionally mild reaction 
conditions. An additional feature of this strategy is the allowance of 
electron-withdrawing substituents on the benzene ring, offering corresponding 
indole products with much higher yields than in the case of the Fischer indole 
synthesis. To overcome the limitation of this chemistry, which is limited substrate 
scope of alkynes, we came up with following methodology, a strategic push-pull 
dual catalysis. 
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4.2. Combining Zn ion Catalysis with Homogeneous Gold Catalysis: 
an Efficient Annulation Approach to N-Protected Indoles 
4.2.1. Introduction 
Although the above chemistry represents a significant improvement in the 
synthesis of 2-alkylindoles over the Fischer indole synthesis and Bartoli 
indolization, our attempts to extend this methodology to the synthesis of other 
types of indoles were thwarted by intrinsic slow rate of the reactions and terrible 
thermo stabilities of N-arylhydroxylamines. The aliphatic terminal alkynes used in 
the previous studies seem to be the only effective substrates for this chemistry, and 
the reactions still required 18 h or so to reach completion at room temperature 
under the protection of inert atmosphere. Increasing reaction temperature was 
injurious as N-arylhydroxylamines easily underwent disproportionation and/or 
decomposition. When less reactive internal alkynes, terminal arylalkynes and 
enynes were employed, the reaction yields were generally less than 15%. As a 
result, an improved synthetic approach to access the key intermediates 
O-alkenyl-N-arylhydroxylamines or their derivatives is crucial in order to establish 
a broadly applicable alternative to the Fischer and Bartoli indole synthesis. 
Additional drawbacks with the previous work are the necessity to use large excess 
of alkynes (typically 1.8 equivalent) in order to compensate the competing 
hydration reaction of alkynes resulting from in situ formed H2O, and often 
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difficulties in separating the indole products from the generated methyl ketones.  
 
4.2.2. Conditions Study and New Design 
Reasoning that the thermostability of N-arylhydroxylamines can be 
considerably improved by mounting the nitrogen with electron-withdrawing 
groups, I converted the N-phenylhydroxylamine 4-1a into N-hydroxycarbamates 
(4-11a, 4-11b) and hydroxamic acid (4-11c) (Figure 14); however, this 
modification is at the expense of the nucleophilicity of the HO group and hence the 
reaction rate would decrease for sure.  
 
Figure 14. N-Protected Arylhydroxylamines 
 
 
Terminal enyne 1-Ethynylcyclohex-1-ene was used to test the reactivity of 
N-protected hydroxylamines 4-11a/b/c since it’s one of the challenging substrates 
and it would afford synthetically valuable 2-alkenylindole. We thought that 
increasing the reaction temperature might compensate the loss of reaction rate, but 
little improvement was realized for N-hydroxycarbamates 4-11a and 4-11b. 
Surprisingly, when hydroxamic acid 4-11c was then tested in toluene with 10 mol 
% gold(I) complex at 100 °C, both desired indole product 4-13c and the 
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intermediate 4-11c’ before the cyclodehydration step were observed. Simple 
Ph3PAuNTf2 gave a 31% yield and its electron-deficient version 
(4-CF3Ph)3PAuNTf2 improved the yield to 50% (entries 1, 2). Again, similarly to 
the cases of N-arylhydroxylamines (Table 12): electron-rich Et3PAuNTf2 led to a 
disappointing result (entry 3), and more electron-deficient phosphite-based 
cationic gold(I) complex, (ArO)3PAuNTf2 (Ar = 2,4-di-tert-butylphenyl) provided 
an optimal 59% yield (entry 5). Although only 14% 4-13c was afforded for 
IPrAuNTf2, 35% intermediate 4-11c’ also formed, which gave a decent combined 
yield of 49%. Considering the good thermal stability of this catalyst, longer 
reaction time could potentially lead to a high yield, but no further experiment was 
run to demonstrate this possibility because the high catalyst loading and harsh 
thermal condition would not be ideal. Nano gold supported on ZrO2 or CeO2 did 
not deliver any product 4-12c or intermediate 4-11c’ (entries 6, 7). Notably, most 
gold(I) catalysts were not stable at such high temperature except IPrAuNTf2, and 
gold(0) metal were often observed after 1-2 hours at a such high temperature. A 
few more polar solvents were also examined, but none of them gave any promising 
results (entries 8-10), which is also consistent with Table 12. Slightly high 
temperature gave a slightly better yield, 66% 4-12c and 4% 4-11c’ (entry 11). 
Again, the gold catalyst (ArO)3PAuNTf2 crashed out in less than 2 hours. 
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Table 14. Catalysts Screening a 
 
entry catalyst solvent temp time 4-13c 4-11c’ 
1 Ph3PAuNTf2 toluene 100 °C 2 h 31% trace 
2 (4-CF3Ph)3PAuNTf2 toluene 100 °C 2 h 50% trace 
3 Et3PAuNTf2 toluene 100 °C 2 h 6% trace 
4 IPrAuNTf2 toluene 100 °C 2 h 14% 35% 
5 (ArO)3PAuNTf2 b toluene 100 °C 2 h 59% - 
6 Au/ZrO2 toluene 100 °C 12 h - - 
7 Au/CeO2 toluene 100 °C 12 h - - 
8 (ArO)3PAuNTf2 CH3CN 100 °C 2 h trace 26% 
9 (ArO)3PAuNTf2 anisole 100 °C 2 h 27% - 
10 (ArO)3PAuNTf2 1,4-dioxane 100 °C 2 h 4% - 
11 (ArO)3PAuNTf2 toluene 110 °C 2 h 66% 4% 
a Yield was estimated by 1H NMR using diethyl phthalate as internal reference. Ar = 
2,4-di-tert-butylphenyl. 
 
Variation of other reaction conditions did not offer any further improvement, 
we concluded that a new scheme had to be developed to dramatically improve this 
chemistry. A push-pull strategy came to our mind: with the gold catalyst 
coordinating to the alkyne and enhancing its electrophilicity, the most promising 
breakthrough relies on the enhancement of the nucleophilicity of the N-protected 
hydroxylamines in some special way. 
Inspired by the fact that metal ions are able to enhance the nucleophilicity of 
H2O by forming metal hydroxides in metalloenzyme catalysis (Scheme 69-A),[17] 
we believed that the nucleophilicity of 4-11 could be boosted in a similar 
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enzyme-mimicking style as well. In fact, compared with H2O, 4-11 possesses a 
stronger capability to coordinate metal ions which could be bound by the two 
oxygen atoms of 4-11. In the area of coordination chemistry, it’s well-known that 
hydroxamic acids are excellent ligands for their chelating competence. 
 
Scheme 69. Enhancing the Nucleophilicity of 4-11 by a Metal Ion. 
 
 
As shown in Scheme 69-B, 4-11 could react with a metal ion to form metal 
chelate 4-11-M and proton reversibly. Because of the bidentate nature of the 
deprotonated 4-11, 4-11-M should be generated in a significant amount.[18] As in 
metalloenzyme catalysis, 4-11-M should be more nucleophilic than 4-11 owing to 
the increased negative charge on the deprotonated oxygen. I looked up our 
inventory trying to find out which metal salt could be applicable to this design, and 
Zn(OTf)2 was chosen to be the partner of this gold-catalyzed reaction for three 
reasons: 1) Zn(II) was a hard Lewis acid which would bind with the two oxygens 
of 4-11 very tightly; 2) OTf- is a very week counter ion that enhance the acidity of 
Zn(II) and would not trap Au(I) to decrease its catalytic activity; 3) it might also 
assist the last cyclodehydration step. 
When Zn(OTf)2 (10 mol %) was added as a cooperative catalyst, the reaction 
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was drastically accelerated even with 5 mol % gold catalyst, and indole product 
4-13c was formed in 70% yield with 24% intermediate 4-11c’ uncyclized after 3 h 
at only 60 °C (Scheme 70). This stands for a much more efficient dual-catalysis 
approach under milder reaction conditions comparing to the previous solo gold 
catalysis under severe thermal conditions, the best result of which was 66% 4-13c 
plus 4% 4-11c’ with 10 mol % gold catalyst at 110 °C (Table 14, entry 11). It’s 
worthy to mention that the most common metal employed in hydrolytic or 
hydration metalloenzymes (e.g., human carbonic anhydrase II) is Zn(II). 
 
Scheme 70. Zn Effect 
 
 
Pleasingly, N-arylcarbamates 4-11a and 4-11b also provided very good results 
by this strategy, which will be reported later. When the terminal aliphatic alkyne 
(i.e., 1-dodecyne) served as the substrate, an even better outcome was achieved. 
Then I began a comprehensive investigation about the reaction conditions by using 
tert-butyl-N-hydroxy-N-phenylcarbamate 4-11a and 1-dodecyne as the standard 
substrates, to see if this dual catalysis was a general method to solve the problems 
mentioned earlier in this section. The reason why carbamate 4-11a was chosen 
instead of hydroxamic acid 4-11c is that it could be prepared not only via 
sequential nitrobenzene reduction and protection, but also through Cu-[ 19] or 
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Pd-catalyzed[20] cross coupling reactions.  
As shown in Table 15, in the presence of a slight excess of 1-dodecyne and 
catalytic (ArO)3PAuNTf2 (Ar = 2,4-di-tert-butylphenyl), only a little indole 4-12a 
was formed in toluene at 60 °C after 12 h without Zn(OTf)2. Instead, the hydration 
product, methyl ketone 4-8a, became significant over time (Table 1, entry 1). This 
result confirmed our initial concern that heating the reaction might not compensate 
the diminished nucleophilicity of 4-11a. After only 5 mol % Zn(OTf)2 was added 
to the reaction, a satisfying 91% yield was obtained in only 2 hours (entry 2). With 
Cu(OTf)2 as the co-catalyst, a very disappointing result was gained (entry 4, 18%) 
possibly due to the oxidative property of Cu(II), but still better than the case 
without additive (entry 1, 4%). Sc(OTf)3 led to a decent result (entry 3, 75%), and 
Dy(OTf)3 worked even better (entry 5, 89%), almost as well as Zn(OTf)2.  
Subsequent variations of the gold catalyst (entries 6-12) showed that 
(ArO)3PAuNTf2 (Ar = 2,4-di-tert-butylphenyl) gave the best yield of the desired 
product once more (Table 15, entry 8). Ph3AuNTf2 provided moderate yield (entry 
6), and more electron-deficient (4-CF3Ph)3PAuNTf2 offered a better yield (entry 
7). Electron-rich IPrAuNTf2 and Et3AuNTf2 failed to give good yields just as 
expected (entries 8, 9), and much less effective dichloro(2-picolinato)Au(III) and 
PtCl2 only yielded none or 5% product (entries 11, 12). To my surprise, 
BrettPhosAuNTf2 worked pretty well (entry 10, 83%), which did not deliver 
satisfactory results in the previous indole synthesis from free 
N-arylhydroxylamines (Table 12, entry 6). (ArO)3PAuOTf was also tested to see if 
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the same counter ion to Zn(OTf)2 could offer any improvement compared to NTf2, 
but the result was very much alike (entry 13, 91%).  
 
Table 15. Catalysts and Additives Investigation a 
 
entry gold catalyst additive (5 mol %) time yield 
b 
4-12a 4-8a 
1 (ArO)3PAuNTf2 - 12 h 4% 76% 
2 (ArO)3PAuNTf2 Zn(OTf)2 2 h 91% c 32% 
3 (ArO)3PAuNTf2 Sc(OTf)3 2 h 75% 50% 
4 (ArO)3PAuNTf2 Cu(OTf)2 12 h 18% 86% 
5 (ArO)3PAuNTf2 Dy(OTf)3 2 h 89% 40% 
6 Ph3PAuNTf2 Zn(OTf)2 6 h 62% 45% 
7 (4-CF3Ph)3PAuNTf2 Zn(OTf)2 6 h 77% 37% 
8 IPrAuNTf2 Zn(OTf)2 6 h 40% 60% 
9 Et3PAuNTf2 Zn(OTf)2 6 h 41% 11% 
10 BrettphosAuNTf2 Zn(OTf)2 6 h 83% 39% 
11 dichloro(2-picolinato)gold(III) Zn(OTf)2 6 h 0% 1% 
12 PtCl2 Zn(OTf)2 6 h 5% 24% 
13 (ArO)3PAuOTf Zn(OTf)2 2 h 91% 34% 
14 - Zn(OTf)2 6 h - - 
15 (ArO)3PAuNTf2 HOTf (10 %)h 3 h 6% 64% 
16 (ArO)3PAuNTf2 NaHCO3 (100 %) 12 h 48% 27% 
 a Reaction run in vials with anhydrous toluene; [4-11a] = 0.1 M. Ar = 2,4-di-tert-butylphenyl. 
b Estimated by 1H NMR using diethyl phthalate as the internal reference. c 90% isolated yield. 
 
A control reaction without gold catalyst was run with 5 mol % Zn(OTf)2 
present, and no reaction was detected (entry 14). The importance of Zn(OTf)2 was 
again confirmed by replacing it with HOTf (10 mol %) (entry 15), and only 6% 
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4-12a was obtained after 3 hours. This result indicates that the Brønsted acid 
generated in Scheme 69–B is not responsible for the dramatic rate acceleration, but 
it is critical for catalyst turnover as the reaction was substantially slowed down in 
the presence of 1 equivalent of NaHCO3 (entry 16).  
It is noteworthy that only 5 mol % of Zn(OTf)2 was required, therefore making 
this strategy an even more interesting cooperation between a gold catalysis and an 
enzyme-mimicking Zn catalysis. Particularly, this kind of cooperative dual metal 
catalysis involving gold is rather rare.[21-23] 
  
Table 16. Solvents Screening a 
 
entry solvent time yield 
b 
4-12a 4-8a 
1 toluene 2 h 91% 32% 
2 hexanes 3 h 94% 35% 
3 EtOAc 12 h 58% 56% 
4 DCE 6 h 59% 51% 
5 DCM 6 h 63% 51% 
6 Et2O 6 h 59% 72% 
7 CH3CN 12 h 8% 27% 
8 THF 12 h 8% 97% 
9 toluene (40 °C) 8 h 76% 61% 
a Ar = 2,4-di-tert-butylphenyl. b Estimated by 1H NMR using diethyl phthalate as the internal 
reference 
 
Solvents were then inspected and the results are summarized in Table 16. To 
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our surprise, extremely non-polar hexanes performed even better than toluene, 
giving an excellent yield of 94% (entry 1). Relatively polar solvents, including 
ethyl acetate, 1,2-dichloroethane, dichloromethane and diethylether, provided a 
moderate yield around 60% (entries 3-6). More polar acetonitrile and THF were 
the worst solvents investigated, as usual, likely due to their coordinating property 
thus slowing down the reaction rate. Although hexanes delivered a slightly better 
outcome than toluene (94% over 91%), toluene was selected to be solvent used in 
study of substrates scope due to its better solvating property than hexanes.  
 
4.2.3. Substrates Scope 
The scope of this methodology was then fully studied after the optimal 
conditions were figured out. As shown in Table 17, this strategy worked very well 
with various cycloalkylacetylenes (4-12a/b/c) and linear aliphatic terminal alkynes 
containing various functional/protecting groups, including phenyl (4-12d), chloro 
(4-12f/j), benzyl and TIPS protected HO groups (4-12h/i), protected amino group 
(4-12j) and an ester group (4-12k); the desired N-protected-2-alkylindoles were 
formed regiospecifically in good to excellent yield (82 – 96%). Comparing to our 
previous indolization based on N-arylhydroxylamines, this method necessitates 
much shorter reaction time (2-8 h vs. ~20 h) and less amount of alkyne (1.4 equiv. 
vs. 1.8 equiv.), generally results in higher yields and allows much smoother 
product purification.  
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Table 17. Formation of N-Protected 2-Alkylindoles a 
 
   
4-12b, 83%,  
 
4-12c, 89% 
 
4-12d, 84% 
 
  
4-12e, 96% 
 
4-12f, 87% 
 
4-12g, 95% 
 
  
4-12h, 83% 
 
4-12i, 78% 
 
4-12j, 93% 
 
   
4-12k, 82% 
 
4-12l, 94% 
 
4-12m, 80% 
 
   
4-12n, 91%,  
 
4-12o, 78% (1.25/1) b 
 
   
4-12p, 80% b,c 
 
4-12q, 81% b,d 
 
4-12r, 90% b 
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a Reactions were run in oven-dried vials; isolated yields w reported; Ar = 
2,4-di-tert-butylphenyl. b 2 equivalents of dodecyne. c 10% Zn(OTf)2. d DCE as the solvent 
 
In spite of the upraised reaction temperature (60 °C) and the use of catalytic 
Lewis acid Zn(OTf)2, the reaction conditions were still very mild as the Boc group 
remained untouched. In comparison, the Fischer indolization, in addition to the 
afore-mentioned issues (i.e., harsh acidic conditions and moderate 
regioselectivities), could not afford the N-unprotected forms of chloro-containing 
indoles 4-12f and 4-12g, due to the interference of the chloro group;[24,25] indole 
4-12h could also be problematic due to the likely elimination of benzyl alcohol 
from the corresponding methyl ketone substrate under strongly acidic conditions. 
Thanks to Dr. Lianzhu Liu for helping me finish most cases of Table 17.  
Without any surprise, substituents on the benzene ring para to the 
hydroxylamine moiety can vary from electron-withdrawing fluoride and ester 
(4-12l/m) to electron-donating methyl and methoxy groups (4-12n/o/p) with good 
to excellent reaction efficiencies (78 – 94%). With a strong electron-donating 
p-MeO group, the N-Boc-hydroxylamine was labile at this reaction temperature, 
and the obtained yield was only 40%; however, replacing the Boc group with an 
acetyl permits sufficient substrate stability with good reactivity remaining, and the 
isolated yield was improved to 80% in the presence of 10% Zn(OTf)2 (4-12p). 
Remarkably, N-(4-methoxyphenyl)hydroxylamine, the corresponding free 
hydroxylamine, is extremely labile even at the ambient temperature and, 
consequently, could not be employed in our previous indole synthesis. An 
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ortho-Me group only led to 25 % yield of the desired product, which is probably 
ascribed to sterics but can be complemented by the Bartoli indolization. A 
meta-Me group led to a good combined yield of 78% though with a very low 
regioselectivity (4-12o, 1.25:1). While this approach delivers N-protected indoles 
with readily removable Boc groups, other protecting groups such as 
methoxycarbonyl (4-12m/o/q) and acetyl (4-12r) are also suitable for this 
chemistry (78 – 90%). Due to the fact that protection of the indole N-H group is 
often necessary in multi-step synthesis and alkoxycarbonyl or acyl groups are 
frequently used for this purpose, this strategy, which can directly offer such 
N-protected indoles, can potentially prove to be advantageous and valuable in the 
total synthesis of indole alkaloids. 
Although the above studies have firmly documented that this novel dual 
Zn/Au dual catalysis is superior to my previous synthesis of 2-alkylindoles in 
pretty much every level, counting substrate scope, synthetic efficiency, reaction 
time and even ease of purification, we still want to assure a categorical supremacy 
of this new approach by expanding the reaction scope far beyond what the 
previous chemistry has achieved. Since both terminal enynes and internal alkynes 
were not suitable substrates in the previous work, consequently, their scope was 
then further examined. 
In the case of terminal enyne substrates, 2-alkenylindoles were the desired 
products. Remarkably, not only did they fail to be accessed by my previous 
approach, but also they couldn’t be prepared via Fischer indole synthesis, as the 
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corresponding ketone substrates, which are α,β-unsaturated ketones, typically react 
with arylhydrazines to form pyrazolines instead of indoles.[26] Bartoli indolization 
has not been able to access these diene-type indoles either so far. 
This type of synthetically useful 2-alkenylinodles were prepared without any 
trouble based on the push-pull strategy and their scope was shown in Table 18. 
Different protecting groups on the nitrogens of N-arylhydroxylamines were first 
inspected this time. To our delight, with this cooperative Au/Zn dual catalysis, 
hydroxylamines protected by tert-butoxycarbonyl, methoxycarbonyl and acetyl all 
reacted very smoothly with sterically demanding 1-cyclohexenylacetylene 
affording the diene-type indole products 4-13a, 4-13b and 4-13c in high yields (83 
– 92%). Other diene-type indoles[27] were also readily prepared by using various 
terminal enynes as the reaction partners; different alkenyl groups (4-13a/d/e/f/g) 
including conjugated β-styryl (4-13e) were readily installed at the indole 
2-position (68 – 90%). For 4-13d, due to the low boiling point of 
2-methyl-1-buten-3-yne, two equivalents of enynes were required to achieve a 
decent 68% yield and the efficiency might be improved by using more enynes. For 
4-13g, acid-promoted isomerization might attribute to the increased product E/Z 
ratio; another possible reason could be that the Z-enyne is sterically less favored 
toward the nucleophilic attack of 4-11a compared with the E-enyne, hence 
increasing the product E/Z ratio. 
  
180 
 
Table 18. Formation of N-Protected 2-Alkenylindoles a 
 
   
4-13a, 83%,  
 
4-13b, 86% e 
 
4-13c, 92% 
 
   
4-13d, 68% b,c 
 
4-13e, 74% c 
 
4-13f, 90% c 
 
   
4-13g, 86% c,d 
 
4-13h, 75% 
 
4-13i, 65% 
 
  
4-13j, 77% e  
 
4-13k, 71% (1.5/1) e 
 
  
 
4-13l, 80% 4-13m, 75% b,f  
a Reactions run in oven-dried vials; isolated yields are reported; Ar = 2,4-di-tert-butylphenyl. 
b 2 equiv of the enyne. c The reaction was run at 60 °C for 12 h.  d The enyne E/Z = 9:1, and 
the product E/Z >19:1. e Solvent: DCE. f 10 mol % Zn(OTf)2. 
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Both electron-withdrawing (i.e., F, Br, CO2Me) and electron-donating 
substituents (i.e., Me, OMe) on the benzene ring of N-protected 
arylhydroxylamines were readily tolerated (4-13h/i/j/k/l/m, 65 – 80%). In the 
cases of N-arylhydroxylamines protected by methoxycarbonyl groups, 
1,2-dichloroethane turned out to be a better solvent that toluene (4-13b/j/k). 
Importantly, for all the cases involving more sterically demanding cyclohexenyl 
groups the last step, cyclodehydration to form indoles, did not go to completion 
until further heating at a slightly high temperature of 80 °C for 4 - 8 h. Similar to 
the aliphatic terminal alkynes, the reaction was regiospecific as well, and 
2-alkenylindole was the only isomer observed. 
A characteristic problem of the Fischer indole synthesis is the low 
regioselectivity[28,29] coming with unsymmetrical ketones which fit the following 
generic formulae, R1CH2C(O)CH2R2 (R1, R2 ≠ H, Ar). To find out whether this 
methodology offers a solution to this long standing issue, I surveyed various 
internal alkynes with N-hydroxy-N-phenylacetamide (4-11c) serving as the 
nucleophile and the reaction outcomes are summarized in Table 19. First of all, 
internal alkynes with moderate steric demand were readily allowed; one 
substituent on one end of the C–C triple bond must be a primary alkyl group, and 
the other one could be a primary alkyl or phenyl group. Due to their diminished 
reactivities comparing to the terminal alkynes, the reactions were slower and 
normally took 18 - 30 h to finish even with increased amount of Zn(OTf)2 (20 mol 
%); the yields were generally lower as well. Furthermore, a much more 
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thermostable NHCAu(I) complex, IPrAuOTf, yet less reactive, was a better 
catalyst than (ArO)3PAuNTf2 as the reaction could not proceed to completion 
within the lifetime of the latter catalyst.  
For the symmetric 6-dodecyne, the corresponding indole product 4-14a was 
isolated in 74% yield. For internal alkynes with a methyl group at one end, the 
regioisomers with Me at the 2 position were always favored; apparently due to its 
smaller size the attack from hydroxamic acid 4-11c preferred to happen at that end. 
With primary groups at the other end, the selectivities were around 6-8:1 
(4-14b/d/e, 52 – 68%). Interestingly, a similar regioselectivity of 8:1 was observed 
with a phenyl group (4-14g, 61%), suggesting that steric control is dominating 
over electronic one.  
By increasing the steric bulkiness of the substituent (i.e., a cyclohexyl group, 
4-14c), the selectivity was enhanced to >19:1 with a moderate 67% yield. There is 
a remarkable electronic effect when a strongly inductive phthalimide group 
(PhthN) is present (4-14f), and both the regioselectivity and the reaction yield 
were synthetically appealing (16.6:1, 80%). While in most cases the 
2-methylindole products (4-14b/c/e/f/g) mentioned above could be obtained 
selectively by the Fischer indolization using the corresponding methyl ketones, the 
ketone-containing indole product 4-14d, which couldn’t be achieved through the 
Fischer approach, was successful produced in a decent 68% yield by this approach, 
demonstrating another example of functional group tolerance allowed by this 
chemistry. 
183 
 
Table 19. Regioselective Formation of N-Acetyl-2,3-disubstituted Indoles a 
 
   
4-14a, 74%,  
 
4-14b, 61% (7.1:1) b 
 
4-14c, 67% (>19:1) b 
 
   
4-14d, 68% (6.8:1) b 
 
4-14e, 52% (6:1) b 
 
4-14f, 80% (16.6:1) b 
 
   
4-14g, 61% (8:1) b 
 
4-14h, 75% (2.5:1) b,c,d 
 
4-14i, 65% (10.3:1) b,c 
 
   
4-14j, 77% (5.6:1) b,c  
 
4-14k, 86% (2/1) b,c 
 
4-14l, 69% (12/1) b,c 
 
  
 
4-14m, 70% (2.9:1) b,c 4-14n, 66% (>19:1) b  
a Reactions run in oven-dried vials; isolated yields of the major isomers are reported if not 
specified.; Ar = 2,4-di-tert-butylphenyl. b Regioselectivity; the major isomer is shown. c 
Overall yields of both isomers are reported. d 2 equiv of 6-methylhept-3-yne was used. 
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For internal alkynes with one end substituted by a primary alkyl group, the 
other one with a cyclohexyl group on the other end of the alkyne (i.e., 
but-1-ynylcyclohexane) seemed to be sterically too demanding, and the reaction 
was so sluggish that only 21% yield was attained. Efforts (gold catalysts, Lewis 
acids, temperature, time, etc.) spent on this particular reaction did not offer much 
improvement. With a smaller isobutyl group, the reaction progressed well (4-14h, 
75%), and the small steric difference between the two alkyne ends (ethyl vs. 
isobutyl) was reflected by a regioselectivity of 2.5/1, favoring the indole product 
with less hindered ethyl group at the 2 position. With an array of ethyl alkynes 
with hydroxyethyl differently protected on the other end (4-14i/j/k), the trend of 
regioselectivities apparently correlated to the inductive effect of the 
electron-withdrawing protecting groups. Therefore, a synthetically useful 
selectivity and yield (10.3:1, 65%) were achieved by using a trifluoroacetate 
substrate (4-14i); a cooperation between sterics and induction resulted in an even 
better regioselectivity and efficiency for the indole product 4-14l (12:1, 69%). It is 
notable that the trifluoroacetyl group can be easily removed, which permits a 
convenient and regioselective access to various 2-substituted indole-3-ethanols. In 
comparison, fully deprotected indole 4-14i could be obtained according to Patil et 
al. [12] (Ph3PAuNTf2/TsOH, toluene, 100 °C) but only as a minor isomer (20%), 
and the direct Fischer indole synthesis would be very likely to deliver a similar 
result. These results established, once more, that unreachable regioselectivities in 
the Fischer indolization could be achieved by judicial choices of protecting groups 
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on the alkynes in this operative dual catalysis of gold and Zinc.  
Comparing to the methyl group (4-14g), the use of a somewhat bulkier Et 
group (4-14m) expectedly afforded a diminished regioselectivity (8:1 vs. 2.9:1), 
but the indole product with the phenyl group at the 3 position was still preferred. 
Ethyl 3-phenylpropiolate led selectively to the only regioisomer 4-14n in a yield of 
66% through an initial Michael addition due to triple bond being the more 
electronically biased,[30,31] and the reaction yield could be possibly improved 
further by using more alkynes since all the alkyne was consumed during the 
reaction with some hydroxamic acid 4-11c left. 
 
4.2.4. Mechanism and Discussion  
The reaction mechanism is proposed in Scheme 71. First, the hydroxamic acid 
or related carbamate substrate 4-11 is activated by the hard Lewis acid Zn(OTf)2 
via the formation of the zinc chelate 4-11-Zn, which should be generated in a 
significant amount during the equilibrium. This more O-nucleophilic intermediate 
can then attack the gold-activated alkyne very efficiently, forming the 
N-aryl-O-alkenyl precursor 4-15 after protodeauration. The succeeding key 
3,3-sigmatropic rearrangement generates intermediate 4-16, which then aromatizes 
to 4-17, followed by cyclodehydration facilitated by the Lewis acidic Zn(OTf)2, 
leading to the final indole product 4-12/13/14.  
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Scheme 71. Proposed Mechanism 
 
 
The observed regioselectivities are rationalized in Figure 15: first of all, the 
Zinc hydroxamate 4-11-Zn is sterically bulky, likely due to additional ligands on 
the metal, and favors the attacks at the less hindered end of internal alkynes 
(Figure 15-A). With terminal aliphatic alkynes and enynes, although the internal 
end of the C–C triple bond is more hindered than the terminus, but it’s much less 
negatively charged than the latter. For example, the difference of the natural 
charges (NC) of the alkyne ends computed by using DFT calculations 
(B3LYP/6-31G*) is 0.22 when R is an ethyl group (Figure 15-B), which is also 
reflected by the 13C chemical shifts of both ends (∆δ = 14.47 ppm). The substantial 
electronic difference totally overrides the steric disparity and result in an exclusive 
nucleophilic attack at the more electrophilic internal end, leading to regiospecific 
formation of indoles. For electronically biased alkynes (i.e., with conjugated 
electron-withdrawing groups), the polarization of the triple bond is again 
significant: for example, as shown in Figure 15-C, ∆NC and ∆δ(13C) between the 
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two carbons of C–C triple bond are 0.249 and 15.33 ppm, respectively; this 
electronic difference, quantitatively comparable to that in the terminal alkyne 
1-butyne (Figure 15-B, 0.22 and 14.47 ppm), is consistent with the observed 
excellent regioselectivity (only one isomer was detected).  
 
Figure 15. Rationales for the Reaction Regioselectivity on Alkynes 
 
 
For those alkynes without conjugated electron-withdrawing groups, the often 
overlooked inductive effect[32] can be the key factor. Such an induction results in 
less electron density at the distal end of the C–C triple bond than the proximal end, 
which is established by the calculated NCs and the observed 13C chemical shifts of 
some alkyne substrates in Table 19 (Figure 15-D). In the absence of significant 
steric discrepancy, this electronic partiality dominates successfully the selective 
attack by the nucleophilic hydroxamate at the distal end and, furthermore, 
correlates in a roughly quantitative way with the regioselectivity observed in 
4-14f/i/j/k, Table 19. A matched combination of inductive effect and sterics bias 
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could lead to a more pleasing outcome (4-14i/l).  
To validate the view that catalytic Zn(OTf)2 enhances the nucleophilicity of 
N-arylhydroxamic acids/N-aryl-N-hydroxycarbamates 4-11, an array of 
competition reactions between the addition of 4-11a to and the hydration of 
1-dodecyne were run by varying the amount of the Lewis acid. As shown in Table 
20, the reactions were stopped before the reactions go to completion (30 min) in 
order to establish the rate differences at the early stage. When toluene saturated by 
H2O was used as the solvent, there was a clear correlation between the amount of 
Zn(OTf)2 and the ratio of products due to 4-11a addition (i.e., 4-12a and 4-17a) 
and hydration (i.e., 4-8a): the more Zn(OTf)2 was used, the higher the ratio was 
obtained, indicating that Zn(OTf)2 does increase the reaction rate of 4-11a addition 
(entries 1-5). Notably, the amount of the hydration product, methyl ketone 4-8a, 
did not change much as the amount of the zinc salt increased, suggesting that 
hydration was not much affected by Zn(OTf)2. In comparison, under anhydrous 
conditions, a positive correlation was observed when the amount of Zn(OTf)2 was 
varied from 0% to 5 mol % (entries 6 - 8); additionally, the preference of 4-11a 
addition was better than that in the wet toluene as expectedly. The decreased 
preferences in entries 9 and 10 reflect the significant increase of the amount of 
byproduct H2O generated upon the cyclodehydration of 4-17a, which leads to 
increasing hydration. The above results do support the role of Zn(OTf)2 we 
proposed in Scheme 71.  
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Table 20. Examine the Role of Zn(OTf)2  
 
entry toluene Zn(OTf)2 yield 
a (4-12a + 
4-17a)/4-8 
4-12a/ 
4-12a 4-8 4-17a 4-17a 
1 wetb 0 <1 18% <1 - - 
2 wetb 1 mol% 9% 19% 16% 1.3 0.6 
3 wetb 5 mol% 29% 21% 27% 2.7 1.1 
4 wetb 10 mol% 50% 21% 25% 3.6 2.0 
5 wetb 20 mol% 67% 21% 19% 4.1 3.5 
6 dry c 0 <1 1.4% <1 - - 
7 dry c 1 mol% 13% 7% 16% 4.1 0.8 
8 dry c 5 mol% 41% 9% 25% 7.3 1.6 
9 dry c 10 mol% 57% 11% 20% 7.0 2.9 
10 dry c 20 mol% 78% 17% 13% 5.4 6 
a NMR yield estimated by using diethyl phthalate as the internal reference. b Saturated with 
deionized water, and reactions run in vials. c Reaction run in Schlenck tubes. 
 
Scheme 72. Control Reaction of Cyclodehydration without Zn(OTf)2 
 
 
This zinc salt, being Lewis acidic, also facilitated the cyclodehydration: the 
more Zn(OTf)2 was present in the reaction, the higher ratio of 4-12a/4-17a was 
observed. Remarkably, the gold catalyst was found out to be capable to assist this 
process as well notwithstanding much slower by running a control reaction: 
carbamate intermediate 4-17a was converted into indole product 4-12a in a 91% 
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yield and 94% conversion with 5 mol % (ArO)3PAuNTf2 in toluene at 60 °C for 6 
h in the absence of Zn(OTf)2 (Scheme 72). 
 
4.2.5. Conclusions 
An efficient and general synthesis of N-protected indoles via a 
gold/Zn-catalyzed annulation of easily prepared N-arylhydroxamic 
acids/N-aryl-N-hydroxycarbamates and readily available alkynes. It is 
conceptually different from and synthetically much superior to my previous 
indolization based on free N-hydroxyamines. The reaction scope is much broader, 
yields are generally higher, time is shorter and the reaction conditions are still 
relatively mild. The indole nitrogens are protected by either acyl or 
alkoxycarbonyl groups, which could be advantageous as these groups are often 
used in the multi-step synthesis of complex molecules to offer desirable and 
flexible N-protections. With terminal alkynes, this reaction is regiospecific and 
offers 2-substituted indoles exclusively and tolerates a range of functional and 
protecting groups. Particularly, various 2-alkenylindoles, valuable substrates for 
the Diels-Alder reaction to build up polycyclic structures as dienes but 
inaccessible via the Fischer or Bartoli indole synthesis, can be readily prepared 
from terminal enynes. This strategy can also be applied to internal alkynes of 
moderate steric demand to yield 2,3-disubstituted indoles, and the regioselectivity 
are controlled by both sterics and/or electronics: the small substituents on the C–C 
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triple bond ends up selectively at the indole 2-positions, and the 
electron-withdrawing groups direct the substituents to the indole 3 positions via 
either inductive effect or conjugation. With judiciary choices of protecting groups, 
good to excellent regioselectivities with internal alkynes can be achieved. Notably, 
this strategy is a rare example of cooperative dual catalysis involving gold, and the 
first example of gold-catalyzed intermolecular addition of hydroxamic 
acids/N-aryl-N-hydroxycarbamates to alkynes. Catalytic Zn(OTf)2 not only 
enhances the nucleophilicity of these hydroxylamine derivatives via the formation 
of deprotonated metal chelates, which mimics the metal ion catalysis in 
metalloenzymes, but also facilitates the cyclodehyrative step to form the final 
indole products.  
 
4.3. Experimental Section 
General Procedure A: Preparation of N-Arylhydroxylamines 4-1 
 
N-Arylhydroxylamines 4-1 were prepared according to literature procedure.[33] 
To a stirred mixture of nitrobenzene (21 mmol) and NH4Cl (1.3 g, 24 mmol) in 
H2O (40 mL) was slowly added zinc dust (90%, 3.08 g, 42 mmol) while 
maintaining the temperature below 60 °C. After 15 min’s stirring, the reaction 
mixture was filtered while still warm and the solid was washed with hot water (10 
mL). The filtrate was saturated with NaCl and cooled to 0 °C and the resulting 
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solid was collected and dried. This crude N-phenylhydroxylamine 4-1 was 
recrystallized from hexane-petroleum ether to get the pure compound.  
 
General Procedure B: Preparation of 2-Alkylindoles 4-2 
  An oven-dried vial was charged with N-arylhydroxylamine 4-1 (0.3 mmol, 1 
equiv), alkyne (0.54 mmol, 1.8 equiv) and anhydrous DCE (3 mL, 0.1 M); then 
(ArO)3PAuNTf2 (Ar = 2,4-di-tert-butylphenyl, 16.8 mg, 5 mol %) was added. 
After being stirred at room temperature for 16 – 24 h until the alkyne was 
completely consumed, the reaction mixture was concentrated under vacuum. The 
residue was purified via silica gel flash chromatography (eluents: ethyl acetate: 
hexanes = 1: 100) to give the desired product 4-2. 
4-2a 
 
This compound was prepared in 84% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.86 (bs, 
1H), 7.53 (d, J = 7.6 Hz), 7.30 (d, 1H, J = 7.6 H), 7.12 (td, 1H, J1 = 7.6 Hz, J2 = 1.2 
Hz), 7.07 (td, 1H, J1 = 7.2 Hz, J2 = 1.2 Hz), 6.24 (d, 1H, J = 0.8 Hz), 2.75 (t, 2H, J = 8 
Hz), 1.68 – 1.76 (m, 2H), 1.20 – 1.41 (m, 14H), 0.887 (t, 3H, J = 6.8 Hz); 13C NMR 
(125 MHz, CDCl3) δ 140.0, 135.8, 128.8, 120.9, 119.7, 119.5, 110.2, 99.4, 31.9, 29.6, 
29.5, 29.4, 29.3, 29.2, 28.2, 22.7, 14.1; IR (neat): 3387, 3377, 3052, 2953, 2919, 2849, 
1457; MS (ES+) Calculated for [C18H28N]+: 258.22; Found: 258.16. 
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4-2b 
NH  
This compound was prepared in 77% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (500 MHz, CDCl3) δ 7.89 (bs, 
1H), 7.56 (dd, 1H, J1 = 7.5 Hz, J2 = 1 Hz), 7.31 (d, 1H, J = 8.5 Hz), 7.14 (td, 1H, J1 = 
7.5 Hz, J2 = 1.5 Hz), 7.09 (td, 1H, J1 = 7.5 Hz, J2 = 1 Hz), 6.25 – 6.26 (m, 1H), 2.72 
(tt, 1H, J1 = 11 Hz, J2 = 3.5 Hz), 2.08 – 2.11 (m, 2H), 1.86 – 1.90 (m, 2H), 1.76 – 1.81 
(m, 1H), 1.39 – 1.55 (m, 4H), 1.29 – 1.35 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
145.1, 135.5, 28.6, 120.9, 119.8, 119.5, 110.3, 97.4, 37.3, 32.9, 26.2, 26.1; IR (neat): 
3392, 2929, 2851, 1597, 1557, 1444, 1414; MS (ES+) Calculated for [C14H18N]+: 
200.14; Found: 200.16. 
4-2c 
 
This compound was prepared in 62% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.89 (bs, 
1H), 7.53 (dd, 1H, J1 =7.6Hz, J2 =0.8Hz), 7.30 (d, 1H, J =7.6Hz), 7.12 (td, 1H, J1 
=7.2Hz, J2 =1.2Hz), 7.04 – 7.09 (m, 1H), 6.24 – 6.2(m, 1H), 3.15 – 3.23 (m, 1H), 2.10 
– 2.16 (m, 2H), 1.65 – 1.85 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 143.9, 135.8, 
128.6, 120.9, 119.8, 119.5, 110.2, 97.9, 38.8, 32.8, 25.2; IR (neat): 3584, 3054, 2954, 
2868, 1547, 1458, 1289; MS (ES+) Calculated for [C13H16N]+: 186.13; Found: 186.15. 
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4-2d 
 
This compound was prepared in 70% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (500 MHz, CDCl3) δ 7.90 (bs, 
1H), 7.53 (d, 1H, J = 7.5 Hz), 7.28 (d, 1H, J = 8 Hz), 7.14 (td, 1H, J1 = 7.5 Hz, J2 = 1 
Hz), 7.09 (td, 1H, J1 = 7.5 Hz, J2 = 1 Hz), 6.18 (d, 1H, J = 1 Hz), 1.94 – 1.99 (m, 1H), 
0.96 – 1.00 (m, 2H), 0.78 – 0.81 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 147.1, 135.7, 
128.6, 120.9, 119.67, 119.62, 110.2, 97.6, 8.80, 7.29; IR (neat): 3584, 3396, 3086, 
3054, 3008, 2916, 2848, 1556, 1458, 1415; MS (ES+) Calculated for [C11H11NNa]+: 
180.08; Found: 180.18 
4-2e 
 
This compound was prepared in 89% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.74 (bs, 
1H), 7.54 (d, 1H, J = 8 Hz), 7.32 (tt, 2H, J1 = 6.8 Hz, J2 = 2 Hz), 7.22 – 7.38 (m, 3H), 
7.13 (td, 1H, J1 = 8 Hz, J2 = 1.6 Hz), 7.08 (td, 1H, J1 = 7.2 Hz, J2 = 1.2 Hz), 6.29 (m, 
1H), 3.03 – 3.12 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 141.2, 140.0, 135.7, 128.6, 
128.5, 128.4, 126.8, 121.1, 119.8, 119.6, 110.3, 99.8, 35.6, 30.1; IR (neat): 3584, 
3395, 3058, 3021, 2915, 2852, 1553, 1456, 1416; MS (ES+) Calculated for 
[C16H16N]+: 222.13; Found: 222.15. 
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4-2f 
 
This compound was prepared in 84% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 8.58 (bs, 
1H), 7.54 (d, 1H, J = 7.6 Hz), 7.26 – 7.41 (m, 5H), 7.13 (t, 1H, J = 7.6 Hz), 7.07 (t, 
1H, J = 7.6 Hz), 6.26 (s, 1H), 4.60 (s, 2H), 3.81 (t, 2H, J = 6 Hz), 3.07 (t, 2H, J = 6 
Hz); 13C NMR (100 MHz, CDCl3) δ 137.9, 137.7, 135.9, 128.5, 128.3, 127.85, 127.78, 
121.0, 119.8, 119.4, 110.5, 99.8, 73.3, 69.9, 28.6; IR (neat): 3584, 3407, 3056, 3029, 
2914, 2861, 1553, 1456, 1287, 1096; MS (ES+) Calculated for [C17H17NNaO]+: 
274.12; Found: 274.15. 
4-2g 
 
This compound was prepared in 67% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (500 MHz, CDCl3) δ 8.58 (bs, 
1H), 7.54 (d, 1H, J = 7.5 Hz), 7.31 (d, 1H, J = 8 Hz), 7.12 (t, 1H, J = 7.5 Hz), 7.07 (t, 
1H, J = 7 Hz), 6.27(s, 1H), 4.66 (t, 1H, J = 8.5 Hz), 4.06 – 4.11 (m, 1H), 3.82 – 3.87 
(m, 1H), 3.73 (dt, 1H, J1 = 9.5 Hz, J2 = 6 Hz), 3.50 – 3.54 (m, 1H), 3.07 (t, 2H, J = 6 
Hz), 1.85 – 1.90 (m, 1H), 1.76 – 1.82 (m, 1H), 1.52 – 1.70 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 137.7, 135.9, 128.4, 120.9, 119.8, 119.4, 110.4, 99.9, 99.3, 67.2, 62.6, 
30.8, 28.6, 25.3, 19.8; IR (neat): 3401, 3316, 3055, 2943, 2869, 1553, 1457, 1134, 
1030; MS (ES+) Calculated for [C15H19NNaO2]+: 268.13; Found: 268.15. 
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4-2h 
 
This compound was prepared in 62% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.87 (bs, 
1H), 7.54 (dd, 1H, J1 = 7.6 Hz, J2 = 0.8 Hz), 7.31 (d, 1H, J = 8 Hz), 7.14 (td, 1H, J1 = 
7.6 Hz, J2 = 1.2 Hz), 7.09 (td, 1H, J1 = 7.6 Hz, J2 = 1.2 Hz), 6.27 (d, 1H, J = 0.8 Hz), 
3.58 (t, 2H, J = 6 Hz), 2.81 (t, 2H, J = 6.8 Hz), 1.87 – 1.90 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 138.8, 135.8, 128.7, 121.1, 119.8, 119.7, 110.3, 99.8, 44.8, 31.9, 27.4, 
26.3; IR (neat): 3402, 3056, 2941, 2864, 1551, 1457, 1415, 1286; MS (ES+) 
Calculated for [C12H15ClN]+: 208.09; Found: 208.11. 
4-2i 
 
This compound was prepared in 73% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.93 (bs, 
1H), 7.5 (d, 1H, J = 7.6 Hz), 7.30 (d, 1H, J = 8 Hz), 7.05 – 7.14 (m, 2H), 6.25 (s, 1H), 
2.80 (t, 2H, J = 7 Hz), 2.42 (t, 2H, J = 6.8 Hz), 1.70 – 1.83 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 178.5, 140.0, 135.8, 128.7, 121.1, 119.8, 119.6, 110.3, 99.7, 33.4, 
28.4, 27.8, 24.1; IR (neat): 3584, 3390, 3045, 2939, 2861, 1700, 1457, 1412; MS (ES+) 
Calculated for [C13H15NNaO2]+: 240.10; Found: 240.10. 
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4-2j 
 
This compound was prepared in 72% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (500 MHz, CDCl3) δ 8.76 (bs, 
1H), 7.82 – 7.87 (m, 2H), 7.71 – 7.73 (m, 2H), 7.50 (d, 1H, J = 7.5 Hz), 7.35 (d, 1H, J 
= 8 Hz), 7.11 (td, 1H, J1 = 7.5 Hz, J2 = 1 Hz), 7.04 (td, 1H, J1 = 7.5 Hz, J2 = 1 Hz), 
6.27 (d, 1H, J = 1 Hz), 3.81 (t, 2H, J = 6.5 Hz), 2.80 (t, 2H, J = 7 Hz), 2.07 – 2.13 
(m,2H); 13C NMR (100 MHz, CDCl3) δ 168.9, 138.5, 135.9, 134.1, 131.9, 128.7, 
123.3, 121.0, 119.7, 119.5, 110.6, 99.8, 37.2, 28.8, 25.1; IR (neat): 3584, 3393, 3058, 
2922, 2851, 1769, 1703, 1398; MS (ES+) Calculated for [C19H16N2NaO2]+: 327.11; 
Found: 327.11. 
4-2k 
 
This compound was prepared in 64% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.76 (bs, 
1H), 7.32 (d, 1H, J = 0.8 Hz), 7.18 (d, 1H, J = 8.4 Hz), 6.94 (dd, 1H, J1 = 8.4 Hz, J2 = 
0.8 Hz), 6.14 – 6.16 (m, 1H), 2.73 (t, 2H, J = 7.6 Hz), 2.43 (s, 3H), 1.75 – 1.66 (m, 
2H), 1.20 – 1.40 (m, 14H), 0.89 (t, 3H, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3) δ 
140.1, 134.0, 129.1, 128.7, 122.3, 119.5, 109.9, 98.9, 31.9, 29.59, 29.55, 29.4, 29.3, 
29.2, 28.3, 22.7, 21.4, 14.1; IR (neat): 3376, 2953, 2918, 2850, 1470, 1412; MS (ES+) 
Calculated for [C19H30N]+: 272.24; Found: 272.27. 
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4-2l 
 
This compound was prepared in 86% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.89 (bs, 
1H), 7.63 – 7.64 (m, 1H), 7.14 – 7.20 (m, 2H), 2.73 (t, 2H, J = 7.6 Hz), 1.66 – 1.74 (m, 
2H), 1.22-1.40 (m, 14H), 0.89 (t, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3) δ 
141.4, 134.4, 130.6, 123.6, 122.2, 112.7, 111.6, 99.1, 31.9, 29.7, 29.6, 29.6, 29.4, 
29.30, 29.27, 29.0, 28.2, 22.7, 14.2; IR (neat): 3403, 3315, 3055, 2943, 2870, 1457, 
1418, 1134, 1030; MS (ES+) Calculated for [C18H27BrN]+: 336.13; Found: 336.08. 
4-2m 
 
This compound was prepared in 82% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.85 (bs, 
1H), 7.15 – 7.20 (m, 2H), 6.82 – 6.88 (m, 1H), 6.19 – 6.21 (m, 1H), 2.74 (t, 2H, J = 
7.6 Hz), 1.67 – 1.75 (m, 2H), 1.22 – 1.40 (m, 14H), 0.89 (t, 3H, J = 6.8 Hz); 13C NMR 
(100 MHz, CDCl3) δ 157.9(d, J = 231 Hz), 142.0, 132.2, 129.2 (d, J = 9 Hz), 110.6 (d, 
J = 10 Hz), 108.9 (d, J = 26 Hz), 104.6 (d, J = 24 Hz), 99.7 (d, J = 4 Hz), 31.9, 29.6, 
29.5, 29.4, 29.3, 29.1, 28.3, 22.7, 14.1; IR (neat): 3465, 3417, 2954, 2926, 2854, 1585, 
1486, 1452, 1169, 852; MS (ES+) Calculated for [C18H26FNNa]+: 298.19; Found: 
298.16. 
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4-2n 
 
This compound was prepared in 76% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 
8.27 (bs, 1H), 7.84 (dd, 1H, J1 = 8.4 Hz, J2 = 1.2 Hz), 7.29 (d, 1H, J = 8.4 HZ), 6.32 
(s, 1H), 3.93 (s, 3H), 2.75 (t, 2H, 8 Hz), 1.68 – 1.76 (m, 2H), 1.20 – 1.40 (m, 14H), 
0.89 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3) δ 168.4, 141.6, 138.5, 128.4, 
122.6, 112.4, 121.4, 109.9, 100.6, 51.8, 31.9, 29.6, 29.5, 29.4, 29.3, 29.0, 28.2, 22.6, 
14.1. 
4-2o 
 
This compound was prepared in 63% yield according to the general procedure B 
(eluents: ethyl acetate: hexanes = 1: 100). 1H NMR (400 MHz, CDCl3) δ 7.96 (bs, 
1H), 7.17 (dd, 1H, J1 = 1.6 Hz, J2 = 1.2 Hz), 7.09 (d, 1H, J = 1.2 Hz), 6.30 – 6.32 (m, 
1H), 2.73 (t, 2H, J = 7.6 Hz), 1.68 - 1.75 (m, 2H), 1.22 – 1.40 (m, 14H), 0.89 (t, 3H, J 
= 7.2 Hz); 13C NMR (100 MHz, CDCl3) δ 141.5, 136.2, 126.4, 126.4, 125.2, 119.7, 
109.0, 98.2, 31.9, 29.6, 29.5, 29.4, 29.3, 29.2, 28.9, 28.2, 22.7, 14.1; IR (neat): 2953, 
2927, 2854, 1614, 1577, 1468, 1328; MS (ES+) Calculated for [C18H25Cl2NNa]+: 
348.13; Found: 348.16. 
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4-2p and 4-2p’ (1.3:1) 
 
These two compound was prepared in 85% yield (1.3: 1) according to the general 
procedure B (eluents: ethyl acetate: hexanes = 1: 100). 4-2p: 1H NMR (500 MHz, 
CDCl3) δ 7.84 (bs, 1H), 7.41 (d, 1H, J = 9 Hz), 7.27 (t, 1H, J = 0.8 Hz), 7.02 – 7.05 
(m, 1H), 6.20 – 6.21 (m, 1H), 2.73 (t, 2H, J = 7.5 Hz), 1.68 – 1.72 (m, 1H), 1.20 – 
1.40 (m, 14H), 0.89 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3) δ 140.8, 136.1, 
127.4, 126.6, 120.4, 120.2, 110.2, 99.5, 31.9, 29.6, 29.5, 29.4, 29.31, 29.28, 29.0, 28.2, 
22.7, 14.1; IR (neat): 3584，3403, 2954, 2924, 1543, 1467, 1397; MS (ES+) Calculated 
for [C18H27ClN]+:  292.18; Found: 292.18. 4-2p’: 1H NMR (400 MHz, CDCl3) δ 
7.99 (bs, 1H), 7.19 (dt, 1H, J1 =8Hz, J2 =0.8Hz), 7.02 – 7.08 (m, 2H), 6.34 – 6.35 (m, 
1H), 2.76 (t, 2H, J = 8 Hz), 1.69 – 1.77 (m, 2H), 1.23 – 1.43 (m, 14H), 0.88 (t, 3H, J = 
6.8 Hz); 13C NMR (100 MHz, CDCl3) δ 140.8, 136.4, 127.6, 125.0, 121.5, 119.3, 
108.8, 98.1, 31.9, 29.6, 29.5, 29.4, 29.30, 29.28, 29.1, 28.2, 22.7, 14.1; IR (neat): 
3584, 3410, 2922, 2851, 1608, 1433; MS (ES+) Calculated for [C18H27ClN]+:  292.18; 
Found: 292.19. 
 
General Procedure C: Preparation of N-Arylhydroxylcarbamates 4-11 
 
  The precursor N-phenylhydroxylamine was synthesized according to literature 
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procedures. [33] To a solution of N-phenylhydroxylamine (10 mmol) in dry diethyl 
ether (50 mL) was added di-t-butyl dicarbonate (2.8 g, 10 mmol) at room 
temperature. After 12 h, the reaction was concentrated and the residue was purified 
through silica gel flash chromatography to give the desired product tert-butyl 
hydroxy(aryl)carbamate 4-11. 
4-11a 
 
This compound was prepared in 70% yield according to the general procedure C 
(eluents: ethyl acetate: hexanes = 1:20). 1H NMR (500 MHz, CDCl3) δ 7.67 (bs, 1H), 
7.47 (dt, 2H, J1 = 8.5 Hz, J2 = 1.5 Hz), 7.35 (t, 2H, J = 8 Hz), 7.16 (t, 1H, J = 7.5 Hz), 
1.52 (S, 9H); 13C NMR (125 MHz, CDCl3) δ 154.3, 140.7, 128.3, 125.1, 121.4, 83.4, 
28.2; IR (neat): 3218, 2979, 2933, 1682, 1596, 1495, 1368, 1125. 
4-11b 
 
This compound was prepared in 66% yield according to the general procedure C 
(eluents: ethyl acetate: hexanes = 1:15). 1H NMR (400 MHz, CDCl3) δ 8.26 (bs, 1H), 
7.37 – 7.42 (m, 2H), 6.99 – 7.05 (m, 2H), 1.47 (s, 9H); 13C NMR (125 MHz, CDCl3) 
δ 160.2 (d, J = 243 Hz), 154.7, 137.1, 124.0 (d, J = 9 Hz), 115.1 (d, J = 23 Hz), 83.4, 
28.2; IR (neat): 3238, 3232, 2980, 2934, 1695, 1683, 1507, 1369, 1230, 1126, 836; 
250.09; HRMS-(ESI+) calculated for [C11H14FNNaO3]+: 250.0855, found 250.0853. 
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4-11c 
 
This compound was known and prepared in 70% yield according to the general 
procedure C (eluents: ethyl acetate: hexanes = 1:15). 1H NMR (400 MHz, CDCl3) 
δ 7.82 (bs, 1H), 7.32 (d, 2H, J = 8.8 Hz), 7.14 (d, 2H, J = 8Hz), 2.34 (s, 3H), 1.49 
(s, 9H); 13C NMR (100 MHz, CDCl3) δ 154.5, 138.3, 135.1, 128.9, 121.9, 28.2, 
20.9; IR (neat): 3194, 3130, 2975, 2925, 1694, 1667, 1509, 1367, 1161, 1122, 
1106. 
4-11d 
 
This compound was prepared in 60% yield according to the general procedure C 
(eluents: ethyl acetate: hexanes = 1:25). 1H NMR (400 MHz, CDCl3) δ 7.92 (bs, 
1H), 7.44 (dt, 2H, J1 = 9.2 Hz, J2 = 2.4 Hz), 7.34 (dt, 2H, J1 = 9.2 Hz, J2 = 2.4 Hz), 
1.50 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 154.0, 139.9, 131.3, 122.7, 118.0, 
83.9, 28.2; IR (neat): 3239, 2978, 2931, 1691, 1486, 1370, 1340, 1130; 
HRMS-(ESI+) calculated for [C11H14BrNNaO3]+: 310.0055, found 310.0046. 
4-11e 
 
This compound was prepared in 70 % yield according to literature procedures. [2] 
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(eluents: ethyl acetate: hexanes = 1:8). 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 2H, 
J = 8.4 Hz), 7.60 (d, 2H, J = 8.8 Hz), 3.90 (s, 3H), 3.88 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 166.8, 154.9, 144.3, 130.2, 126.0, 119.0, 54.1, 52.2; IR (neat): 
3582, 3304, 3007, 2955, 2847, 1717, 1606, 1439, 1338, 1282, 1113; 
HRMS-(ESI+) calculated for [C10H11NNaO5]+: 248.0535, found 248.0523. 
 
General Procedure D: Preparation of N-Protected-2-alkyl Indoles 4-12 
 
To a solution of N-protected hydroxylamine 4-11 (0.3 mmol, 1 equiv) in dry 
toluene (3 mL, 0.1 M) was added the corresponding alkyne (0.42 mmol, 1.4 
equiv), Zn(OTf)2 (0.015 mol%) and (ArO)3PAuNTf2 (Ar = 2,4-di-tert-butylphenyl, 
0.015 mmol, 5 mol%) at room temperature. The reaction mixture was stirred at 60 
°C for 2 – 8 h. Once the reaction finished by TLC, it was concentrated and the 
residue was purified through silica gel flash chromatography to give the pure 
desired product 4-12. 
4-12a 
 
This compound was prepared in 90% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:80). 1H NMR (500 MHz, CDCl3) δ 8.12 (d, 1H, J 
= 8.5 Hz), 8.46 – 8.48 (d, 1H, J = 8 Hz), 7.19 – 7.27 (m, 2H), 6.36 (d, 1H, J = 1 Hz), 
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3.02 (t, 2H, J = 8 Hz), 1.69 – 1.74 (m, 11 H), 1.41 – 1.48 (m, 2H), 1.30 – 1.39 (m, 
12H), 0.91 (t, 3H, J = 7 Hz); 13C NMR (125 MHz, CDCl3) δ 150.5, 142.5, 136.6, 
129.3, 123.0, 122.4, 119.5, 115.5, 106.9, 83.5, 31.9, 30.2, 29.7, 29.6, 29.5, 29.4, 29.0, 
28.3, 22.7, 14.2; IR (neat): 3051, 2954, 2925, 2854, 1734, 1454, 1369, 1327, 1166, 
1118, 1086; HRMS-(ESI+) calculated for [C23H35NNaO2]+: 380.2565, found 
380.2562. 
4-12b 
N
Boc  
This compound was prepared in 83% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.09 (d, 1H, J 
= 8.0 Hz), 7.45 (dd, 1H, J1 = 7.6 Hz, J2 = 0.8 Hz), 7.15 – 7.23 (m, 2H), 6.37 (s, 1H), 
3.35 (m, 1H, Hz), 2.10 (d, 1H, J = 12.8 Hz), 1.83 – 1.87 (m, 2H), 1.69 (s, 9H), 1.24 – 
1.50 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 150.5, 147.9, 136.7, 129.4, 123.1, 122.4, 
119.7, 115.5, 104.8, 83.5, 37.4, 33.7, 28.3, 26.7, 26.4; IR (neat): 2977, 2929, 2852, 
1730, 1454, 1369, 1324, 1158, 1113, 1084; HRMS-(ESI+) calculated for 
[C19H25NNaO2]+: 322.1783, found 322.1774. 
4-12c 
 
This compound was prepared in 89% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.07 (d, 1H, J 
= 8.0 Hz), 7.45 (dd, 1H, J1 = 7.2 Hz, J2 = 0.8 Hz), 7.16-7.24 (m, 2H), 6.37 (d, 1H, J = 
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0.8 Hz), 3.74 (m, 1H, J = 7.6 Hz), 2.13 – 2.17 (m, 2H), 1.71 – 1.77 (m, 2H), 1.56 – 
1.70 (m, 13H); 13C NMR (100 MHz, CDCl3) δ 150.5, 146.5, 136.8, 129.2, 123.1, 
122.4, 119.7, 115.4, 104.6, 83.5, 39.4, 33.0, 28.2, 24.8. IR (neat): 3050, 2959, 2869, 
2852, 1732, 1454, 1369, 1327, 1159, 1115, 1089; HRMS-(ESI+) calculated for 
[C18H23NNaO2]+: 308.1626, found 308.1616. 
4-12d 
 
This compound was prepared in 84% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.13 (d, 1H, J 
= 8.0 Hz), 7.43 (dd, 1H, J1 = 7.6 Hz, J2 = 0.8 Hz), 7.17 – 7.24 (m, 2H), 6.24 (s, 1H), 
2.34 – 2.40 (m, 1H), 1.70 (s, 9H), 0.94 – 1.00 (m, 2H), 0.72 – 0.78 (m, 2H); 13C NMR 
(100 MHz, CDCl3) δ 150.6, 143.9, 136.8, 129.0, 123.3, 122.5, 119.8, 115.3, 105.6, 
83.4, 28.3, 11.2, 7.6; IR (neat): 3050, 2979, 2930, 2851, 1730, 1454, 1369, 1335, 
1165, 1118, 1096; HRMS-(EI+) calculated for [C16H19NO2]+: 257.1416, found 
257.1425. 
4-12e 
 
This compound was prepared in 96% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.10 (d, 1H, J 
= 8.4 Hz), 7.47 (dd, 1H, J1 = 7.2 Hz, J2 = 0.8 Hz), 7.21 – 7.34 (m, 7H), 6.38 (d, 1H, J 
= 0.8 Hz), 3.37 (d, 2H, J = 7.2 Hz), 3.05 (d, 2H, J = 7.2 Hz), 1.71 (s, 9H); 13C NMR 
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(100 MHz, CDCl3) δ 150.6, 141.7, 141.5, 136.5 129.3, 128.4, 128.3, 126.0, 123.3, 
122.6, 119.8, 115.6, 107.4, 83.8, 35.3, 31.9, 28.4; IR (neat): 3051, 2977, 2925, 2851, 
1732, 1460, 1369, 1328, 1158, 1115, 1086; HRMS-(ESI+) calculated for 
[C21H23NNaO2]+: 344.1626, found 344.1623. 
4-12f 
 
This compound was prepared in 87% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.08 (d, 1H, J 
= 8.0 Hz 7.46 (dd, 1H, J1 = 7.8 Hz, J2 = 1.2 Hz), 7.19 – 7.25 (m, 2H), 6.40 (s, 1H), 
3.62 (t, 2H, J = 6.4 Hz), 3.20 (t, 2H, J = 7.2 Hz), 2.10 – 2.25 (m, 2H), 1.70 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 150.4 140.1, 136.6, 129.1, 123.5, 122.7, 119.8, 115.6, 
107.9, 83.9, 44.4, 31.7, 31.5, 30.6, 28.3, 27.3; IR (neat): 3050, 2977, 2925, 2851, 
1732, 1460, 1369, 1328, 1158, 1115, 1086; HRMS-(ESI+) calculated for 
[C16H20ClNNaO2]+: 316.1080, found 316.1085. 
4-12g 
 
This compound was prepared in 95% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.07 (d, 1H, J 
= 8.4 Hz 7.45 (dd, 1H, J1 = 6.8 Hz, J2 = 1.6 Hz), 7.18 – 7.23 (m, 2H), 6.37 (s, 1H), 
3.60 (t, 2H, J = 6.4 Hz), 3.20 (t, 2H, J = 6.8 Hz), 1.86 – 1.90 (m, 2H), 1.70 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 150.5, 141.5, 136.6, 129.2, 123.3, 122.6, 119.7, 115.6, 
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107.3, 83.8, 45.0, 32.3, 29.5, 28.3, 26.3; IR (neat): 3050, 2977, 2925, 2851, 1732, 
1454, 1370, 1327, 1158, 1115, 1087; HRMS-(ESI+) calculated for [C17H22ClNNaO2]+: 
330.1237, found 330.1259. 
4-12h 
 
This compound was prepared in 83% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 8.12 (d, 1H, J 
= 8.2 Hz 7.47 – 7.49 (m, 1H), 7.19 – 7.36 (m, 7H), 6.45 (d, 1H, J = 0.8 Hz), 4.59 (s, 
2H), 3.83 (t, 2H, J = 7.2 Hz), 3.38 (td, 2H, J1 = 6.4 Hz, J2 = 0.8 Hz), 1.68 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 150.4, 138.4, 138.2, 136.5, 129.2, 128.3, 127.7, 127.5, 
123.4, 122.6, 119.8, 115.5, 108.3, 83.8, 72.9, 69.0, 30.6, 28.1; IR (neat): 3050, 2977, 
2930, 2858, 1732, 1454, 1370, 1328, 1158, 1118, 1092; HRMS-(ESI+) calculated for 
[C22H25NNaO3]+: 374.1732, found 374.1732. 
4-12i 
 
This compound was prepared in 78% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:200). 1H NMR (400 MHz, CDCl3) δ 8.02 (dd, 1H, 
J1 = 8.8 Hz, J2 = 0.8 Hz), 7.35 – 7.37 (m, 1H), 7.08 – 7.16 (m, 2H), 6.28 (d, 1H, J = 
0.8 Hz), 3.67 (t, 2H, J = 6.0 Hz), 2.95 (t, 2H, J = 7.6 Hz), 1.69 – 1.74 (m, 2H), 1.57 – 
1.62 (m, 12H), 0.95 – 0.99 (m, 18H); 13C NMR (100 MHz, CDCl3) δ 150.6, 142.3, 
136.6, 129.4, 123.1, 122.5, 119.6, 115.5, 107.0, 83.6, 63.2, 32.7, 29.9, 28.2, 25.2, 18.0, 
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11.9; IR (neat): 3050, 2977, 2941, 2865, 1734, 1454, 1369, 1303, 1165, 1116, 1095; 
HRMS-(ESI+) calculated for [C26H43NNaSiO3]+: 468.2910, found 468.2897. 
4-12j 
 
This compound was prepared in 93% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:40). 1H NMR (400 MHz, CDCl3) δ 8.07 (d, 1H, J 
= 8.0 Hz), 7.83 – 7.85 (m, 2H), 7.69-7.2 (m, 2H), 7.42-7.44 (m, 2H), 7.16-7.21 (m, 
2H), 6.34 (s, 1H), 3.75 (t, 2H, J = 7.2 Hz), 3.04 (t, 2H, J = 7.2 Hz), 1.75-1.82 (m, 4H), 
1.66 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 168.3, 150.4, 141.5, 136.6, 133.8, 132.1, 
129.2, 123.2, 123.1, 122.5, 119.7, 115.6, 107.3, 83.7, 37.9, 29.8, 28.4, 28.3, 26.3; IR 
(neat): 3050, 2977, 2925, 2851, 1707, 1460, 1369, 1328, 1158, 1116, 1086; 
HRMS-(ESI+) calculated for [C25H26N2NaO4]+: 441.1790, found 441.1784. 
4-12k 
 
This compound was prepared in 82% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:80). 1H NMR (500 MHz, CDCl3) δ 8.09 (d, 1H, J 
= 8.5 Hz), 7.17 – 7.23 (m, 2H), 6.36 (d, 1H, J = 0.5 Hz), 3.69 (s, 3H), 3.03 (t, 2H, J = 
7.5 Hz), 2.40 (t, 2H, J = 7.5 Hz), 1.75 – 1.78 (m, 4H), 1.70 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 173.9, 150.5, 141.7, 136.6, 129.3, 123.2, 122.6, 119.7, 115.5, 107.2, 
83.7, 51.6, 34.0, 29.9, 28.4, 28.3, 24.7. IR (neat): 3050, 2977, 2925, 2851, 1732, 1455, 
1369, 1328, 1161, 1115, 1086; HRMS-(ESI+) calculated for [C19H25NNaO4]+: 
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354.1681, found 354.1684. 
4-12l 
 
This compound was prepared in 94% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:80). 1H NMR (400 MHz, CDCl3) δ 8.04 (dd, 1H, 
J1 = 9.2 Hz, J2 = 4.8 Hz), 7.09 (dd, 1H, J1 = 8.8 Hz, J2 = 2.8 Hz), 6.93 (td, 1H, J1 = 
8.8 Hz, J2 = 2.4 Hz), 6.30 (s, 1H), 2.97 (t, 2H, J = 7.6 Hz), 1.68 (s, 9H), 1.21 – 1.44 
(m, 16H), 0.89 (t, 3H, J = 7.2 Hz); 13C NMR (125 MHz, CDCl3) δ  160.1, 158.2, 
150.3, 144.2, 132.9, 132.0 (d, J = 10.3 Hz), 116.4 (d, J = 9.0 Hz), 110.6 (d, J = 9.0 
Hz), 106.6 (d, J = 3.4 Hz), 105.0 (d, J = 23.1 Hz), 83.8, 32.0, 30.4, 29.7, 29.6, 29.5, 
29.48, 29.41, 28.9, 28.3, 22.8, 14.2. IR (neat): 3050, 2977, 2925, 2851, 1732, 1460, 
1369, 1327, 1158, 1115, 1086; HRMS-(EI+) calculated for [C23H34NFO2]+: 375.2574, 
found 375.2570. 
4-12m 
 
This compound was prepared in 80% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:40). 1H NMR (400 MHz, CDCl3) δ 8.16 (d, 1H, J 
= 1.6 Hz), 8.09(d, 1H, J = 8.8 Hz), 7.92 (dd, 1H, J1 = 8.8 Hz, J2 = 1.6 Hz), 7.42 (d, 1H, 
J = 0.8 Hz), 4.06 (s, 3H), 3.93 (s, 3H), 2.99 (t, 2H, J = 7.6 Hz), 1.67-1.71 (m, 2H), 
1.27-1.42 (m, 14H), 0.88 (t, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3) δ 167.5, 
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152.2, 144.0, 139.1, 129.3, 124.8, 124.7, 121.9, 115.2, 107.7, 53.7, 52.0, 31.9, 29.9, 
29.6, 29.5, 29.3, 28.6, 22.7, 14.1; IR (neat): 3050, 2977, 2925, 2851, 1732, 1707, 
1441, 1369, 1328, 1158, 1115, 1086; HRMS-(EI+) calculated for [C22H31NNaO4]+: 
396.2151, found 396.2153. 
4-12n 
 
This compound was prepared in 91% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 7.96 (d, 1H, J 
= 8.8 Hz), 7.23-7.26 (m, 1H), 7.04 (d, 1H, J = 8.8 Hz), 6.27 (s, 1H), 2.98 (t, 2H, J = 
7.6 Hz), 2.42 (s, 3H), 1.68-1.70 (m, 11H), 1.27-1.41 (m, 14H), 0.89 (t, 3H, J = 6.4 
Hz); 13C NMR (100 MHz, CDCl3) δ 150.6, 142.6, 134.8, 131.9, 129.6, 124.3, 119.6, 
115.2, 106.7, 83.4, 76.8, 43.9, 31.9, 30.3, 29.7, 29.6, 29.5, 29.48, 29.42, 29.0, 28.3, 
22.8, 21.3, 14.2; IR (neat): 3050, 2977, 2925, 2851, 1732, 1460, 1369, 1327, 1158, 
1116, 1086; HRMS-(ESI+) calculated for [C24H37NNaO2]+: 394.2722, found 
394.2713. 
4-12o and 4-12o’ (1.25:1) 
 
These two compounds were prepared as a pair of inseparable mixtures in 78% yield 
according to the general procedure D (eluents: ethyl acetate: hexanes = 1:100). The 
position of the methyl group is determined by 1H nosey; 1H NMR (400 MHz, CDCl3) 
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δ 7.90-7.92 (m, 1H), 7.32 (d, 0.44 H, J = 8.4 Hz), 7.12-7.16 (m, 0.63H), 7.00-7.12 (m, 
1H), 6.40 (d, 0.54 H, J = 0.4 Hz), 6.40 (d, 0.43 H, J = 0.8 Hz), 4.04 (s, 3H), 2.97-3.02 
(m, 2H), 2.47-2.49 (m, 3H), 1.68-1.71 (m, 2H), 12.8-14.6 (m, 16H), 0.87.-0.90 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 152.6, 142.0, 141.8, 136.8, 136.1, 133.2, 129.0, 128.9, 
127.2, 124.2, 123.4, 123.3, 119.3, 115.8, 113.1, 107.4, 105.9, 53.34, 53.31, 43.8, 31.9, 
29.99, 29.91, 29.84, 29.62, 29.53, 29.47, 29.39, 29.35, 29.30, 29.17, 28.89, 28.79, 
23.84, 22.69, 21.98, 18.39, 14.17　 IR (neat): 3050, 2977, 2925, 2851, 1732, 1460, 
1369, 1328, 1158, 1115, 1086; HRMS-(EI+) calculated for [C21H31NO2]+: 329.2355, 
found 329.2362. 
4-12p 
 
This compound was prepared in 80% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:100). 1H NMR (400 MHz, CDCl3) δ 7.64 (d, 1H, J 
= 8.8 Hz), 6.95 (d, 1H, J = 2.8 Hz), 6.84 (dd, 1H, J1 = 9.2 Hz, J2 = 2.4 Hz), 6.34 (s, 
1H), 3.85 (s, 3H), 2.97 (t, 2H, J = 7.6 Hz), 2.72 (s, 3H), 1.66 – 1.74 (m, 2H), 1.20 – 
1.43 (m, 14H), 0.88 (t, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3) δ 169.9, 155.9, 
143.7, 131.04, 130.96, 115.7, 150.5, 11.5, 108.2, 102.9, 5.6, 31.9, 30.6, 29.6, 29.5, 
29.3, 28.8, 27.5, 22.7, 14.2; IR (neat): 2995, 2925, 2853, 1704, 1614, 1478, 1371, 
1308, 1206; HRMS-(ESI+) calculated for [C21H31NNaO2]+: 352.2252, found 
352.2241. 
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4-12q 
 
This compound was prepared in 81% yield according to the general procedure D (2 
equiv of 1-dodecyne was used; reaction solvent was DCE; eluents: ethyl acetate: 
hexanes = 1:75). 1H NMR (400 MHz, CDCl3) δ 8.08 (dd, 1H, J1 = 8 Hz, J1 = 0.8 Hz), 
7.46 (dd, 1H, J1 = 8 Hz, J2 = 0.8 Hz), 7.19 – 7.27 (m, 2H), 6.38 (s, 1H), 4.05 (s, 3H), 
3.00 (t, 2H, J = 7.6 Hz), 1.66 – 1.74 (m, 2H), 1.28 – 1.46 (m, 14H), 0.89 (t, 3H, J = 
6.4 Hz); 13C NMR (100 MHz, CDCl3) δ 152.6, 142.6, 136.4, 129.5, 123.3, 122.9, 
119.7, 115.5, 53.4, 31.9, 29.9, 29.6, 29.5, 29.3, 28.7, 22.7, 14.1; HRMS-(ESI+) 
calculated for [C20H29NNaO2]+: 338.2096, found 338.2102. 
4-12r 
 
This compound was prepared in 90% yield according to the general procedure D 
(eluents: ethyl acetate: hexanes = 1:40). 1H NMR (400 MHz, CDCl3) δ 7.84 (d, 1H, J 
= 8.0 Hz), 7.47-7.50 (m, 1H), 7.21-7.26 (m, 2H), 6.41 (d, 1H, J = 0.8 Hz), 2.99 (t, 2H, 
J = 7.2 Hz), 2.76 (s, 3H), 1.68-1.74 (m, 2H), 1.20-1.43 (m, 14H), 0.89 (t, 3H, J = 6.8 
Hz); 13C NMR (100 MHz, CDCl3) δ 70.3, 143.0, 136.3, 129.9, 123.4, 122.9, 120.1, 
114.7, 108.1, 31.9, 30.5, 29.6, 29.5, 29.3, 28.9, 27.7, 22.7, 14.1; IR (neat): 3050, 2954, 
2925, 2851, 1707, 1460, 1369, 1301, 1208; HRMS-(ESI+) calculated for 
[C20H29NNaO] 322.2147, found 322.2153. 
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General Procedure E: Preparation of N-Protected-2-alkenyl Indoles 4-13  
 
To a solution of N-protected hydroxylamine 4-11 (0.3 mmol, 1 equiv) in dry 
toluene (3 mL, 0.1 M) was added the corresponding 1,3-enyne (0.42 mmol, 1.4 
equiv), Zn(OTf)2 (0.015 mmol, 5 mol%) and (ArO)3PAuNTf2 (Ar = 
2,4-di-tert-butylphenyl, 0.015 mmol, 5 mol%) at room temperature. The reaction 
mixture was stirred at 60 °C for 4 – 8 h. Once TLC indicated there was no starting 
material left, the reaction was raised up to 80 °C, stirred for additional 4 - 8 h, and 
then concentrated. The residue was purified through silica gel flash 
chromatography to give the desired product 4-13. 
4-13a 
N
Boc  
This compound was prepared in 83% yield according to the general procedure E 
(eluents: ethyl acetate: hexanes = 1:50). 1H NMR (500 MHz, CDCl3) δ 8.09 (dd, 1H, 
J1 = 8.5 Hz, J2 = 1 Hz), 7.50 (d, 1H, J = 7.5 Hz), 7.26 – 7.29 (m, 1H), 7.21 (td, 1H, J1 
= 7.5 Hz, J1 = 1 Hz), 6.39 (s, 1H), 5.89 – 5.92 (m, 1H), 2.27 – 2.30 (m, 2H), 2.21 – 
2.25 (m, 2H), 1.78 – 1.83 (m, 2H), 1.70 – 1.75 (m, 2H), 1.67 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 150.3, 143.7, 136.9, 132.5, 129.3, 126.5, 123.6, 122.6, 120.1, 115.1, 
107.8, 83.4, 29.1, 28.2, 25.4, 22.7, 21.9; IR (neat): 3051, 2979, 2932, 2859, 2834, 
1731, 1453, 1369, 1326, 1161, 1126; HRMS-(ESI+) calculated for [C19H23NNaO2]+: 
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320.1626, found 320.1627. 
4-13b 
 
This compound was prepared in 86% yield according to the general procedure E 
(reaction solvent: DCE, eluents: ethyl acetate: hexanes = 1:50). 1H NMR (500 MHz, 
CDCl3) δ 8.11 (d, 1H, J = 8.5 Hz), 7.50 (dt, 1H, J1 =7.5 Hz, J2 = 1 Hz), 7.22 – 7.31 (m, 
2H), 6.40 (s, 1H), 5.88 – 5.90 (m, 1H), 4.09 (S, 3H), 2.22 – 2.27 (m, 4H), 1.72 – 1.75 
(m, 2H), 1.77 – 1.81 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 125 152.0, 143.5, 136.4, 
132.5, 129.5, 127.1, 123.8, 122.9, 120.2, 115.4, 108.3, 53.5, 29.4, 25.5, 22.8, 22.1; IR 
(neat): 3027, 2932, 2856, 2834, 1744, 1455, 1324, 1213; HRMS-(ESI+) calculated for 
[C16H17NNaO2]+: 278.1157, found 278.1146. 
4-13c 
N
Ac  
This compound was prepared in 92% yield according to the general procedure E 
(eluents: ethyl acetate: hexanes = 1:30). 1H NMR (500 MHz, CDCl3) δ 8.26 (d, 1H, J 
= 8.5 Hz), 7.50 (d, 1H, J = 7.5 Hz), 7.31 (td, 1H, J1 = 7 Hz, J2 = 1.5 Hz), 7.25 (td, 1H, 
J1 = 7.5 Hz, J2 = 1.5 Hz), 6.46 (S, 1H), 5.98 – 6.00 (m, 1H), 2.30 – 2.33 (m, 2H), 2.23 
– 2.27 (m, 2H), 1.78 – 1.83 (m, 2H), 1.71 – 1.75 (m, 2H); 13C NMR (125MHz, CDCl3) 
δ 171.2, 142.3, 137.1, 131.8, 129.8, 129.0, 124.4, 123.3, 120.0, 115.6, 109.0, 30.0, 
26.4, 25.6, 22.7, 21.8; IR (neat): 3049, 2930, 2857, 2834, 1701, 1450, 1367, 1303; 
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HRMS-(ESI+) calculated for [C16H17NNaO]+: 262.1208, found 262.1195. 
4-13d 
 
This compound was prepared in 68% yield according to the general procedure E (2 
equiv enyne was used; eluents: ethyl acetate: hexanes = 1:30, 60 °C, 12 h). 1H NMR 
(500 MHz, CDCl3) δ 8.19 (ddd, 1H, J1 = 8.5 Hz, J2 = 2 Hz,	J3 = 1 Hz), 7.52 (ddd, 1H, 
J1 = 8 Hz, J2 = 2 Hz, J3  = 1 Hz, ), 7.31 – 7.34 (m, 1H), 7.24 – 7.27 (m, 1H), 6.56 (d, 
1H, J = 1 Hz), 5.31 – 5.32 (m, 1H), 5.26 (s, 1H), 2.62 (s, 3H), 2.15 (dd, 3H, J1 = 1.5 
Hz, J2 = 1 Hz); 13C NMR (125 MHz, CDCl3) δ 171.0, 141.6, 138.0, 137.3, 128.9, 
124.8, 123.4, 120.4, 117.3, 115.3, 109.8, 26.8, 23.3; IR (neat): 3084, 3050, 2954, 
2923, 2854, 1706, 1451, 1368, 1299, 1187; HRMS-(ESI+) calculated for 
[C13H13NNaO]+: 222.0895, found 222.0887. 
4-13e 
 
This compound was prepared in 74% yield according to the general procedure E 
(eluents: ethyl acetate: hexanes = 1: 50). 1H NMR (500 MHz, CDCl3) δ 8.15 (d, 1H, J 
= 8.5 Hz), 7.78 (d, 1H, J = 16.5 Hz), 7.56 (d, 3H, J = 7.5 Hz), 7.39 (t, 2H, J = 7.5 Hz), 
7.28 – 7.32 (m, 2H), 7.24 – 7.27 (m, 1H), 7.08 (d, 1H, J = 16.5 Hz), 6.88 (S, 1H), 1.73 
(S, 9H); 13C NMR (125 MHz, CDCl3) δ 150.5, 139.5, 137.1, 136.8, 130.5, 129.3, 
128.6, 127.7, 126.6, 124.1, 122.9, 120.7, 120.2, 115.7, 106.7, 84.1, 28.4; IR (neat): 
3058, 3023, 2976, 2931, 1730, 1450, 1370, 1327, 1157; HRMS-(ESI+) calculated for 
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[C21H21NNaO2]+: 342.1470, found 342.1468. 
4-13f 
 
This compound was prepared in 90% yield according to the general procedure E 
(pent-2-en-4-yn-1-ylcyclohexane (E/Z> 30:1) was used; eluents: ethyl acetate: 
hexanes = 1:50). 1H NMR (500 MHz, CDCl3) δ 8.11 (d, 1H, J = 8.5 Hz), 8.48 (d, 1H, 
J = 8 Hz), 7.25 (td, 1H, J1 = 7.5 HZ, J2 = 1.5 Hz), 7.20 (td, 1H, J1 = 7.5 Hz, J2 = 1.0 
Hz), 6.91 (d, 1H, J = 16 Hz), 6.64 (S, 1H), 6.16 (dd, 1H, J1 = 15.5 Hz, J2 = 2 Hz), 
2.18 – 2.21 (m, 1H), 1.87 (dd, 1H, J1 = 14 Hz, J2 = 2 Hz), 1.80 (dt, 2H, J1 = 13 Hz, J2 
= 3.5 Hz), 1.71 (S, 9H), 1.31 – 1.39 (m, 3H), 1.19 – 1.27 (m, 3H); 13C NMR (125 
MHz, CDCl3) δ 150.5, 140.0, 139.1, 136.5, 129.4, 123.5, 122.7, 119.87, 119.81, 115.5, 
105.8, 83.8, 41.2, 32.8, 28.4, 26.2, 26.1; IR (neat): 2927, 2853,1731, 1451, 1370, 
1328, 1159; HRMS-(EI+) calculated for [C21H27NO2]+: 325.2042, found 325.2040. 
4-13g 
 
This compound was prepared in 86% yield (E/Z> 15:1) according to the general 
procedure E (non-3-en-1-yne (E/Z = 9:1) was used; eluents: ethyl acetate: hexanes = 
1:50). 1H NMR (500 MHz, CDCl3) δ 8.11 (d, 1H, J = 8 Hz), 7.49 (d, 1H, J = 8 Hz), 
7.19 – 7.27 (m, 2H), 6.64 (s, 1H), 6.20 (dt, 1H, J1 = 16 Hz, J2 = 7 Hz), 2.24 – 2.29 (m, 
2H), 1.71 (s, 9H), 1.51 – 1.57 (m, 2H), 1.36 – 1.40 (m, 4H), 0.94 (t, 3H, J = 7 Hz); 
13C NMR (125 MHz, CDCl3) δ 150.5, 139.8, 136.4, 133.7, 129.4, 123.5, 122.7, 122.1, 
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119.9, 115.5, 105.9, 83.8, 33.1, 31.5, 28.9, 28.3, 22.6, 14.1; IR (neat): 3051, 2957, 
2856, 1731, 1451, 1327, 1159, 1116, 962; HRMS-(EI+) calculated for [C20H27NO2]+: 
313.2042, found 325.2041. 
4-13h 
 
This compound was prepared in 75% yield according to the general procedure E 
(eluents: ethyl acetate: hexanes = 1:50). 1H NMR (400 MHz, CDCl3) δ 8.00 (dd, 1H, 
J1 = 8.8 Hz, J2 = 4.4 Hz), 7.12 (dd, 1H, J1 = 8.8 Hz, J2 = 2.8 Hz), 6.97 (td, 1H, J1 = 
8.8 Hz, J2 = 2.8 Hz), 6.31 (s,1H), 5.87 – 5.89 (m, 1H), 2.18 – 2.27 (m, 4H), 1.75 – 
1.80 (m, 2H), 1.68 – 1.73 (m, 2H), 1.64 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 159.2 
(d, J = 236 Hz), 150.1, 145.3, 133.2, 132.3, 130.1 (d, J = 11 Hz), 127.0, 116.1 (d, J = 
11 Hz), 111.2 (d, J = 24 Hz), 107.5, 105.5 (d, J = 24 Hz), 83.7, 29.1, 28.1, 25.3, 22.6, 
21.9; IR (neat): 2979, 2970, 2933, 2860, 2834, 1732, 1471, 1370, 1314, 1115; 
HRMS-(ESI+) calculated for [C19H22NNaO2]+: 338.1532, found 338.1523. 
4-13i 
 
This compound was prepared in 65% yield according to the general procedure E 
(eluents: ethyl acetate: hexanes = 1:50). 1H NMR (500 MHz, CDCl3) δ 7.93 (d, 1H, J 
= 9 Hz), 7.60 (d, 1H, J = 2 Hz), 7.33 (dd, 1H, J1 =9 HZ, J2 = 2 Hz), 6.29 (S, 1H), 5.87 
– 5.89 (m, 1H), 2.23 – 2.26 (m, 2H), 2.18 – 2.22 (m, 2H), 1.75 – 1.79 (m, 2H), 1.68 – 
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1.72 (m, 2H),  1.64 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 149.9, 144.8, 135.6, 
132.0, 131.0, 127.2, 126.3, 122.6, 116.6, 115.8, 106.9, 83.9, 29.1, 28.2, 25.4, 22.7, 
21.9; IR (neat): 3111, 2965, 2932, 2859, 2834, 1733, 1446, 1348, 1155, 1013; 
HRMS-(ESI+) calculated for [C19H22BrNNaO2]+: 398.0732, found 398.0738. 
4-13j 
 
This compound was prepared in 77% yield according to the general procedure E 
(reaction solvent: DCE; eluents: ethyl acetate: hexanes = 1:30). 1H NMR (400 MHz, 
CDCl3) δ 8.20 (d, 1H, J = 1.6 Hz), 8.10 (d, 1H, J = 8.8 Hz), 7.96 (dd, 1H, J1 = 8.8 Hz, 
J2 = 2 Hz), 6.43 (s, 1H), 5.87 – 5.89 (m, 1H), 4.02 (s, 3H), 3.93 (s, 3H), 2.19 – 2.22 
(m,4H), 1.68 – 1.77 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 167.5, 151.8, 144.8, 
139.2, 132.1, 129.3, 127.9, 125.2, 124.9, 122.4, 115.1, 108.5, 53.8, 52.0, 29.3, 25.4, 
22.7, 21.9; IR (neat): 3022, 2933, 2856, 1741, 1722, 1444, 1338, 1210; HRMS-(ESI+) 
calculated for [C18H19NNaO4]+: 336.1212, found 336.1205. 
4-13k 
 
These two compounds were prepared as a pair of inseparable mixtures in 71% yield 
according to the general procedure E (reaction solvent: DCE; eluents: ethyl acetate: 
hexanes = 1:40). 1H NMR (400 MHz, CDCl3) δ 7.92 – 7.94 (m, 0.75H), 7.37 (d, 
0.39H, J = 8 Hz), 7.19 (t, 0.48H, J = 8 Hz), 7.03 – 7.07 (m, 0.83H), 6.45 (d, 0.47H, J 
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= 0.8 Hz), 6.34 (d, 0.34H, J = 0.8 Hz), 5.86 – 5.91(m, 0.86H), 4.01 (s, 2.70H), 2.51 (s, 
1.5H), 2.50 (s, 1.2H), 2.21 – 2.25 (m, 4H), 1.60 – 1.79 (m, 4H); 13C NMR (100 MHz, 
CDCl3) δ 152.2, 152.1, 143.04, 142.95, 136.9, 136.2, 133.8, 132.7, 129.6, 129.0, 
127.2, 127.0, 126.9, 124.3, 123.9, 123.4, 119.8, 115.6, 112.9, 108.2, 106.9, 53.50, 
53.47, 29.42, 29.39, 25.4, 22.8, 22.1, 22.0, 18.4; IR (neat): 3025, 2931, 2856, 2834, 
1734, 1441, 1327, 1129; HRMS-(ESI+) calculated for [C17H19NNaO2]+: 292.1313, 
found 292.1293. 
4-13l 
 
This compound was prepared in 80% yield according to the general procedure E 
(eluents: ethyl acetate: hexanes = 1:50). 1H NMR (400 MHz, CDCl3) δ 7.93 (d, 1H, J 
= 8.4 Hz), 7.27 (s, 1H), 7.07 (d, 1H, J = 8.8 Hz), 6.29 (s, 1H), 5.87 – 5.89 (m, 1H), 
2.42 (s, 3H), 2.23 – 2.26 (m, 2H), 2.19 – 2.21 (m, 2H), 1.75 – 1.81 (m, 2H), 1.67 – 
1.73 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 150.3, 143.8, 135.1, 132.6, 132.0, 129.5, 
126.3, 124.9, 120.1, 114.8, 107.6, 83.2, 29.1, 28.2, 25.3, 22.7, 21.9, 21.2; IR (neat): 
2978, 2932, 2857, 2834,1731, 1474, 1352, 1134; HRMS-(ESI+) calculated for 
[C20H25NNaO2]+: 334.1783, found 334.1779. 
4-13m 
 
This compound was prepared in 75% yield according to the general procedure E 
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(eluents: ethyl acetate: hexanes = 1:60). 1H NMR (400 MHz, CDCl3) δ 8.16 (d, 1H, J 
= 8.8 Hz), 6.95 (d, 1H, J = 2.8 Hz), 6.89 (dd, 1H, J1 = 9.2 Hz, J2 = 2.8 Hz), 6.36 (s, 
1H), 5.94 – 5.97 (m, 1H), 3.84 (s, 3H), 2.55 (s, 3H), 2.26 – 2.30 (m, 2H), 2.20 – 2.25 
(m, 2H), 1.75 – 1.81 (m, 2H), 1.68 – 1.73 (m, 2H); 13C NMR (100MHz, CDCl3) δ 
170.9, 156.3, 143.1, 132.0, 130.0, 129.9, 116.7, 112.7, 109.1, 102.9, 55.7, 30.1, 26.1, 
25.6, 22.7; IR (neat): 2996, 2927, 2856, 2832, 1697, 1609, 1472, 1368, 1305, 1212, 
1141; HRMS-(ESI+) calculated for [C17H19NNaO2]+: 292.1313, found 292.1300. 
 
General Procedure F: Preparation of N-Acetyl-2,3-disubstituted Indoles 4-14 
 
To a solution of 4-11c (0.3 mmol, 1 equiv) in dry toluene (3 mL, 0.1 M) was 
added corresponding internal alkyne (0.54 mmol, 1.8 equiv), Zn(OTf)2 (0.06 
mmol, 20 mol%) and IPrAuOTf (0.015 mmol, 5 mol%) at room temperature. The 
reaction mixture was stirred at 60 °C for 18 - 30 h. Once TLC indicated there was 
no starting material left, the reaction was concentrated. The residue was purified 
through silica gel flash chromatography to give the desired product 4-14. 
4-14a 
 
This compound was prepared in 74% yield according to the general procedure F. 1H 
NMR (500 MHz, CDCl3) δ 7.80 – 7.72 (m, 1H), 7.52 – 7.45 (m, 1H), 7.29 – 7.20 (m, 
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2H), 2.99 (t, J = 8.0 Hz, 2H), 2.77 (s, 3H), 2.65 (t, J = 8.0 Hz, 2H), 1.66 – 1.54 (m, 
4H), 1.44 – 1.31 (m, 8H), 0.98 – 0.85 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 170.00, 
138.26, 135.60, 130.87, 123.27, 122.53, 120.10, 118.66, 114.45, 31.97, 31.91, 30.03, 
29.91, 27.67, 27.01, 23.93, 22.56, 22.48, 14.04, 14.02. IR (neat): 2957, 2930, 2859, 
1705, 1463, 1368, 1216; HRMS-(EI+) calculated for [C20H29NO]+: 299.2249, found 
299.2257. 
4-14b 
 
This compound was prepared in 61% yield (regioselectivity 7.4: 1) according to the 
general procedure F. 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.93 (m, 1H), 7.49 – 7.44 
(m, 1H), 7.28 – 7.21 (m, 2H), 2.73 (s, 3H), 2.64 (t, J = 7.5 Hz, 2H), 2.56 (s, 3H), 1.63 
– 1.53 (m, 2H), 1.41 – 1.23 (m, 8H), 0.89 (dd, J = 7.1, 6.5 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 170.19, 135.70, 132.49, 130.64, 123.50, 122.74, 120.38, 118.24, 
115.00, 31.84, 29.94, 29.56, 29.20, 29.15, 27.55, 23.87, 22.64, 14.38, 14.07; IR (neat): 
2956, 2929, 2856, 1701, 1458, 1368, 1311, 1216745; HRMS-(EI+) calculated for 
[C18H25NO]+: 271.1926, found 271.1948. 
4-14c 
 
This compound was prepared in 67% yield (regioselectivity > 19: 1) according to the 
general procedure F. 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.93 (m, 1H), 7.75 – 7.69 
222 
 
(m, 1H), 7.26 – 7.19 (m, 2H), 2.80 (tt, J = 12.4, 3.7 Hz, 1H), 2.73 (s, 3H), 2.58 (s, 3H), 
2.02 – 1.86 (m, 4H), 1.86 – 1.79 (m, 1H), 1.79 – 1.71 (m, 2H), 1.49 – 1.31 (m, 3H); 
13C NMR (125 MHz, CDCl3) δ 170.40, 135.99, 131.49, 129.44, 124.37, 123.11, 
122.27, 119.95, 114.90, 36.45, 31.80, 27.74, 27.12, 26.22, 14.42. IR (neat): 2928, 
2853, 1699,1449, 1375, 1314, 1212, 1034, 756; HRMS-(EI+) calculated for 
[C17H21NO]+: 255.1623, found 255.1628. 
4-14d 
 
This compound was prepared in 68% yield (regioselectivity 6.8:1) according to the 
general procedure F. 1H NMR (500 MHz, CDCl3) δ 7.98 – 7.90 (m, 1H), 7.51 – 7.44 
(m, 1H), 7.27 – 7.20 (m, 2H), 2.71 (s, 3H), 2.66 (t, J = 7.5 Hz, 2H), 2.55 (s, 3H), 2.44 
(t, J = 7.0 Hz, 2H), 2.35 (t, J = 7.5 Hz, 2H), 1.90 – 1.81 (m, 2H), 1.57 – 1.48 (m, 3H), 
1.32 – 1.23 (m, 2H), 0.91 – 0.86 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
210.87, 170.16, 135.61, 132.91, 130.40, 123.62, 122.84, 119.29, 118.20, 114.96, 
42.51, 41.75, 27.51, 25.83, 23.60, 23.01, 22.27, 14.34, 13.79; IR (neat): 2958, 2933, 
2873, 1707, 1458, 1369, 1311, 748; HRMS-(ESI+) calculated for [C19H25NNaO2]+: 
322.1783, found 322.1781. 
4-14e 
 
This compound was prepared in 52% yield (regioselectivity 6:1) according to the 
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general procedure F. 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.94 (m, 1H), 7.52 – 7.46 
(m, 1H), 7.29 – 7.22 (m, 2H), 3.85 (t, J = 7.5 Hz, 2H), 2.95 (t, J = 7.3 Hz, 2H), 2.73 (s, 
3H), 2.60 (s, 3H), 1.10 – 1.00 (m, 21H); 13C NMR (125 MHz, CDCl3) δ 170.22, 
135.68, 133.78, 130.65, 123.62, 122.85, 118.17, 116.76, 115.01, 62.91, 27.94, 27.54, 
17.98, 17.93, 14.53, 11.92; IR (neat): 2944, 2867, 1704, 1463, 1367, 1310, 1102, 742; 
HRMS-(ESI+) calculated for [C22H35NNaO2Si]+: 396.2349, found 396.2342. 
4-14f 
 
This compound was prepared in 80% yield (regioselectivity 16.6:1) according to the 
general procedure F. 1H NMR (600 MHz, CDCl3) δ 7.96 – 7.89 (m, 1H), 7.82 (m, 2H), 
7.73 – 7.67 (m, 2H), 7.66 – 7.60 (m, 1H), 7.27 – 7.21 (m, 2H), 3.85 (t, J = 7.8 Hz, 2H), 
3.02 (t, J = 7.8 Hz, 2H), 2.71 (s, 3H), 2.59 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 
170.20, 168.15, 135.61, 134.03, 133.94, 132.04, 130.06, 123.87, 123.19, 123.11, 
118.10, 115.90, 115.00, 37.29, 27.57, 23.19, 14.30. IR (neat): 3061, 2945, 1772, 1713, 
1436, 1368, 1311, 1011, 722; HRMS-(EI+) calculated for [C21H18N2O3]+: 346.1317, 
found 346.1321. 
4-14g 
 
This compound was prepared in 61% yield (regioselectivity 8:1) according to the 
general procedure F. 1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 8.3 Hz, 1H), 7.51 (m, 
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3H), 7.45 (m, 2H), 7.44 – 7.38 (m, 1H), 7.35 – 7.30 (m, 1H), 7.28 – 7.22 (m, 1H), 
2.80 (s, 3H), 2.63 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.47, 135.70, 133.45, 
133.08, 130.11, 129.95, 128.53, 127.17, 124.07, 123.21, 122.49, 119.13, 115.04, 
27.58, 15.25; IR (neat): 3052, 2929, 1701, 1367, 1309, 747; HRMS-(EI+) calculated 
for [C17H15NO]+: 249.1154, found 249.1155. 
4-14h and 4-14h’ (2.5:1) 
 
These two compounds were prepared in 75 % overall yield (regioselectivity 2.5:1) 
according to the general procedure F. 1H NMR (500 MHz, CDCl3) δ 7.79 – 7.73 (m, 
1H, 4-14h + 4-14h’), 7.55 – 7.51 (m, 1H, 4-14h’), 7.46 – 7.50 (m, 1H, 4-14h), 7.28 – 
7.20 (m, 2H, 4-14h + 4-14h’), 3.05 (q, J = 7.3 Hz, 2H, 4-14h), 2.89 (d, J = 7.0 Hz, 2H, 
4-14h’), 2.79 (s, 3H, 4-14h), 2.77 (s, 3H, 4-14h’), 2.70 (q, J = 7.5 Hz, 2H, 4-14h’), 
2.54 (d, J = 7.4 Hz, 2H, 4-14h), 2.03 – 1.90 (m, 1H, 4-14h + 4-14h’), 1.26 – 1.20 (m, 
3H, 4-14h + 4-14h’), 0.97 (d, J = 6.6 Hz, 6H, 4-14h), 0.93 (d, J = 6.7 Hz, 6H, 4-14h’); 
13C NMR (125 MHz, CDCl3) δ 170.20, 169.93, 140.20, 136.63, 135.82, 135.54, 
131.29, 130.43, 123.35, 123.27, 122.51, 122.49, 122.39, 119.04, 118.75, 114.43, 
114.34, 35.60, 33.07, 29.20, 28.95, 27.75, 27.68, 22.84, 22.44, 20.36, 17.40, 14.63, 
14.47; IR (neat): 2958, 2933, 2870, 1705, 1463, 1367, 1312, 1204, 743; HRMS-(EI+) 
calculated for [C16H21NO]+: 243.1623, found 243.1631. 
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4-14i and 4-14i’ (10:1) 
 
These two compounds were prepared in 65% overall yield (regioselectivity 10:1) 
according to the general procedure F. 4-14i: 1H NMR (500 MHz, CDCl3) δ 7.78 – 
7.74 (m, 1H), 7.55 – 7.51 (m, 1H), 7.32 – 7.27 (m, 2H), 4.52 (t, J = 7.0 Hz, 2H), 3.15 
(t, J = 7.0 Hz, 2H), 3.07 (q, J = 7.4 Hz, 2H), 2.80 (s, 3H), 1.25 (t, J = 7.4 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 169.91, 157.45, (q, J = 43.1 Hz)141.68, 135.43, 129.96, 
123.88, 122.95, 118.16, 114.51, 113.08, 67.04, 27.62, 23.00, 20.27, 14.82; IR (neat): 
2968, 2930, 1785, 1707, 1464, 1352, 745; HRMS-(ESI+) calculated for 
[C16H16F3NaNO3]+: 350.0980, found 350.0970. 
4-14j and 4-14j’ (4.6:1) 
 
These two compounds were prepared in 77% overall yield (regioselectivity 4.6:1) 
according to the general procedure F. 4-14j: 1H NMR (500 MHz, CDCl3) δ 7.77 – 
7.71 (m, 1H), 7.56 – 7.51 (m, 1H), 7.29 – 7.24 (m, 3H), 4.25 (t, J = 7.0 Hz, 2H), 3.06 
(q, J = 7.0 Hz, 2H), 3.01 (t, J = 7.0 Hz, 2H), 2.79 (s, 3H), 2.04 (s, 3H), 1.24 (t, J = 7.0 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.98, 169.92, 141.20, 135.45, 130.47, 
123.65, 122.80, 118.51, 114.77, 114.45, 77.25, 77.00, 76.75, 63.74, 27.66, 23.49, 
20.99, 20.30, 14.90; IR (neat): 2968, 2937, 1739, 1704, 1464, 1368, 1312, 1241, 1034, 
745; HRMS-(ESI+) calculated for [C16H19NNaO3]+: 296.1263, found 296.1257. 
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4-14k and 4-14l’ (2:1) 
 
These two compounds were prepared in 88% overall yield (regioselectivity 2:1) 
according to the general procedure F. 4-14k: 1H NMR (600 MHz, CDCl3) δ 7.77 – 
7.72 (m, 1H), 7.54 – 7.49 (m, 1H), 7.28 – 7.21 (m, 2H), 3.58 (t, J = 7.6 Hz, 2H), 3.55 
– 3.47 (q, J = 7.6 Hz, 2H), 3.05 (q, J = 7.3 Hz, 2H), 2.96 (t, J = 7.6 Hz, 2H), 2.77 (s, 
3H), 1.23 (t, J = 7.6 Hz, 3H), 1.21 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
169.88, 140.79, 135.47, 130.70, 123.46, 122.64, 118.53, 115.75, 114.44, 70.11, 66.30, 
27.60, 24.71, 20.29, 15.18, 14.91; 4-14k’: 1H NMR (600 MHz, CDCl3) δ 7.73 – 7.67 
(m, 1H), 7.51 (m, 1H), 7.28 – 7.21 (m, 2H), 3.65 (t, J = 7.0 Hz, 2H), 3.49 (q, J = 7.0 
Hz, 2H), 3.30 (t, J = 7.0 Hz, 2H), 2.77 (s, 3H), 2.71 (q, J = 7.6 Hz, 2H), 1.22 (t, J = 
7.6 Hz, 3H), 1.18 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 170.13, 135.55, 
134.15, 130.44, 123.55, 123.13, 122.60, 118.79, 114.36, 70.26, 66.21, 27.84, 27.83, 
17.10, 15.23, 14.81. IR (neat): 2973, 1935, 2872, 1702, 1463, 1368, 1310, 1108, 943; 
HRMS-(EI+) calculated for [C16H21NO2]+: 259.1572, found 259.1574. 
4-14l and 4-14l’ (12:1) 
 
These two compounds were prepared in 69% overall yield (regioselectivity 12:1) 
according to the general procedure F. 4-14l: 1H NMR (500 MHz, CDCl3) δ 7.79 – 
7.71 (m, 1H), 7.59 – 7.52 (m, 1H), 7.33 – 7.24 (m, 2H), 5.34 (h, J = 6.4 Hz, 1H), 3.14 
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(dd, J = 14.4, 6.6 Hz, 1H), 3.08 (ddd, J = 14.6, 7.3, 2.9 Hz, 2H), 2.99 – 2.91 (dd, J = 
14.4, 6.6 Hz, 1H), 2.80 (s, 3H), 1.40 (t, J = 7.0 Hz, 3H), 1.26 – 1.21 (t, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 169.95, 157.06 (q, J = 41.8 Hz), 141.73, 135.43, 
130.24, 123.83, 122.92, 118.64, 114.47 (q, J = 41.8 Hz), 114.40, 113.52, 75.85, 30.00, 
27.66, 20.32, 19.39, 14.59; IR (neat): 2985, 2943, 1783, 1717, 1383, 1338, 1221, 
1167, 778; HRMS-(ESI+) calculated for [C17H18F3NNaO3]+: 364.1136, found 
364.1121. 
4-14m and 4-14m’ (2.9:1) 
 
These two compounds were prepared in 70% overall yield (regioselectivity 2.9: 1) 
according to the general procedure F. 4-14m: 1H NMR (600 MHz, CDC3) δ 7.83 (d, J 
= 8.4 Hz, 1H), 7.52 - 7.46 (m, 2H), 7.45 – 7.38 (m, 4H), 7.32 – 7.28 (m, 1H), 7.24 – 
7.19 (m, 1H), 3.05 (q, J = 7.3 Hz, 2H), 2.85 (s, 3H), 1.23 (t, J = 7.3 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 170.27, 140.27, 135.50, 133.61, 130.53, 130.08, 128.56, 
127.26, 123.89, 123.03, 121.98, 119.61, 114.45, 27.72, 20.76, 15.19. 4-14m’: 1H 
NMR (600 MHz, cdcl3) δ 8.45 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 7.4 Hz, 1H), 7.51 – 
7.45 (m, 3H), 7.42 – 7.36 (m, 3H), 7.34 – 7.30 (m, 1H), 2.56 (q, J = 7.6 Hz, 2H), 1.95 
(s, 3H), 1.21 – 1.17 (t, J = 7.8 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.07, 
136.95, 134.39, 133.59, 130.22, 129.27, 128.69, 128.57, 125.18, 124.30, 123.38, 
118.71, 116.52, 27.65, 17.60, 14.95. IR (neat): 3054, 2974, 2935, 2875, 1706, 1454, 
1314, 1209, 1186, 747; HRMS-(EI+) calculated for [C18H17NO]+: 263.1310, found 
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263.1313. 
4-14n 
 
This compound was prepared in 66% yield (regioselectivity > 19: 1) according to the 
general procedure F. 1H NMR (500 MHz, CDCl3) δ 8.23 – 8.15 (m, 1H), 7.67 – 7.59 
(m, 1H), 7.37 – 7.29 (m, 6H), 7.25 – 7.19 (m, 1H), 3.99 (s, 3H), 3.74 – 3.67 (t, 2H), 
3.07 – 3.00 (t, 2H), 2.76 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.87, 165.30, 
149.20, 141.34, 134.65, 128.61, 128.38, 127.50, 126.05, 124.17, 123.71, 122.14, 
113.47, 110.35, 51.30, 36.05, 29.74, 27.62. IR (neat): 3027, 2951, 2861, 1726, 1706, 
1560, 1435, 1280, 1194, 1088, 751; HRMS-(ESI+) calculated for [C20H19NnaO3]+: 
344.1263, found 344.1269. 
4-17a 
 
This compound was obtained by quenching the reaction to prepare 4-12a right after 
20 min according to the general procedure D (eluents: ethyl acetate: hexanes = 1:10). 
1H NMR (500 MHz, CDCl3) δ 7.72 (d, 1H, J = 8 Hz), 7.51 (bs, 1H), 7.17 – 7.21 (m, 
1H), 7.06 (dd, 1H, J1 = 7.5 Hz, J2 = 1.5 Hz), 6.97 (td, 1H, J1 = 7.5 Hz, J2 = 1 Hz), 
3.68 (s, 2H), 2.55 (t, 2H, J = 7.5 Hz), 1.53 – 1.58 (m, 2H), 1.52 (s, 9H), 1.20 – 1.30 
(m, 14H), 0.87 (t, 3H, J = 7 Hz); 13C NMR (125 MHz, CDCl3) δ 210.5, 153.6, 137.4, 
130.5, 128.2, 125.4, 124.1, 123.4, 80.2, 46.9, 42.7, 31.9, 29.5, 29.4, 29.31, 29.27, 29.0, 
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28.3, 23.5, 22.7, 14.1; IR (neat): 3340, 2954, 2925, 2854, 1731, 1708, 1452, 1239, 
1159; HRMS-(ESI+) calculated for [C23H37NNaO3]+: 398.2671, found 398.2667. 
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5. Appendix: Selected NMR Spectra 
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